% Exported from Psilocybin Research Publication Tracker
% Tracker site: https://psilocybin-research.com
% Publication tracker: https://psilocybin-research.com/
\documentclass[11pt]{article}
\usepackage[T1]{fontenc}
\usepackage[utf8]{inputenc}
\usepackage{enumitem}
\usepackage[hidelinks]{hyperref}
\usepackage[margin=1in]{geometry}
\title{Psilocybin and Psilocin Research Export}
\author{Psilocybin Research Publication Tracker}
\date{2026-07-12}
\begin{document}
\maketitle
\noindent Exported from \href{https://psilocybin-research.com}{psilocybin-research.com}. Records: 1010.

\begin{enumerate}[leftmargin=*]
\item Lin C, Wang X (2026). \textit{Epigenetic landscapes of classical psychedelics and ketamine: molecular mechanisms of long-lasting neuromodulation.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-026-03744-8}{doi:10.1038/s41380-026-03744-8}.
\item University of California, Berkeley (2026). \textit{Investigating the Mechanisms of the Effects of Psilocybin on Visual Perception and Visual Representations in the Brain}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05265546}{source link}.
\item Liu, C.; Ho, E. M.; Enos, A. S.; Baublyte, U. B.; Luna, I. M.; Kosche, A. R.; Sohal, V. S. (2026). \textit{Psilocybin selectively rescues cognitive flexibility impairments caused by aberrant prefrontal error signaling}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.07.05.736652}{doi:10.64898/2026.07.05.736652}.
\item Raul Edison Luna Lazo, Nicole Milagritos Cardoso Azorza, Jatziri Yanina Vilca Yanac, Ahmad Kassem El Zein, Omar Abraham Ramírez Paucar, Luana Mota Ferreira, Roberto Pontarolo (2026). \textit{Therapeutic potential of psilocybin in the pharmacological treatment of obsessive-compulsive disorder: a scoping review protocol.}. Open Science Framework. [published; OpenAlex]. \href{https://doi.org/10.17605/osf.io/guqxr}{doi:10.17605/osf.io/guqxr}.
\item University of Pennsylvania (2026). \textit{Psilocybin: Capturing Brain Mechanisms of Motivation and Neurocognition in Individuals With Opioid Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06810310}{source link}.
\item Baker, J. J.; Kogan, E.; Ma, S.; Lu, J.; Zuo, Y. (2026). \textit{Dissociating the Hallucinogenic and Neuroplastic Effects of Psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.04.06.716778}{doi:10.64898/2026.04.06.716778}.
\item Rosado AF, Yu AL, Yang JH, Rondeau J, Floris G, Basu A, Staszko S, Dibbs M, Feng J, Li Y, Warner-Schmidt J, Kelmendi B, Krystal JH, Pittenger C, Kwan AC, Kaye AP. (2026). \textit{α2-Adrenergic receptor modulates 5-HT2A-mediated behavioral effects of MDMA and psilocybin in mice.}. Molecular Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-026-03713-1}{doi:10.1038/s41380-026-03713-1}.
\item Paslawski W, Doyon D, Ekman CJ, Yngwe H, Mamula D, Zareba-Paslawska J, Beckman M, Xu ZD, Hökfelt T, Tiger M, Lundberg J, Svenningsson P. (2026). \textit{CSF galanin and noradrenaline downregulation by psilocybin therapy in major depressive disorder.}. Neuropsychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1038/s41386-026-02490-3}{doi:10.1038/s41386-026-02490-3}.
\item NYU Langone Health (2026). \textit{Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for Alcohol Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06349083}{source link}.
\item Adler H, Filipic R, Gonzalez M, Kwon K, Lacey J, McDonald G, Sarris J, Chmiel K, Low M, Sinclair J, Grant S. (2026). \textit{The need for another tool: Australian healthcare professionals on the use of psilocybin for existential distress in people with cancer.}. BMC Medicine. [published; Europe PMC]. \href{https://doi.org/10.1186/s12916-026-05024-2}{doi:10.1186/s12916-026-05024-2}.
\item Matthew A. Boehm, Oriana Mayorga (2026). \textit{Policy Considerations for Psychedelics in Research and Medicine - What’s Next on the Schedule?}. Journal of Science Policy \& Governance. [published; OpenAlex]. \href{https://doi.org/10.38126/jspg280103}{doi:10.38126/jspg280103}.
\item Koning E, Richard J, Keshen A. (2026). \textit{Psilocybin as a Transdiagnostic Treatment for Eating Disorders and Comorbid Psychopathology: Implications for Clinical Nosology and Research Directions.}. International Journal of Eating Disorders. [published; Europe PMC]. \href{https://doi.org/10.1002/eat.70164}{doi:10.1002/eat.70164}.
\item Askari M, Surapaneni V. (2026). \textit{Convergent biosynthesis of psilocybin in an ectomycorrhizal lineage: is the psychoactive end-product the selected trait?}. EcoEvoRxiv. [preprint; Europe PMC]. \href{https://doi.org/10.32942/x2fd49}{doi:10.32942/x2fd49}.
\item Pasquini L, Vohryzek J, Escrichs A, Perl YS, Ponce-Alvarez A, Idesis S, Girn M, Roseman L, Mitchell JM, Gazzaley A, Kringelbach M, Nutt DJ, Lyons T, Carhart-Harris RL, Deco G. (2026). \textit{Modeled Long-Term Effects of Psilocybin on Dynamic Activity and Effective Connectivity of Fronto-Striatal-Thalamic Circuits.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/hbm.70596}{doi:10.1002/hbm.70596}.
\item Akbar RJ, Stringer AD, Wiah S, Dachepalli M, Daws SE, Inan S, Rawls SM. (2026). \textit{Psilocybin induces stereotyped movements and reduces defensive responding in planarians through 5-hydroxytryptamine mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/fbp.0000000000000879}{doi:10.1097/fbp.0000000000000879}.
\item Gumpper RH, Nichols DE (2026). \textit{Chemistry/structural biology of psychedelic drugs and their receptor(s).}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.17361}{doi:10.1111/bph.17361}.
\item Askey T, Lasrado R, Maiarú M, Stephens GJ (2026). \textit{Psilocybin as a novel treatment for chronic pain.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.17420}{doi:10.1111/bph.17420}.
\item Nutt DJ, Hunt P, Schlag AK, Fitzgerald P (2026). \textit{The Australia story: Current status and future challenges for the clinical applications of psychedelics.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.17398}{doi:10.1111/bph.17398}.
\item Hoyer D (2026). \textit{Psychedelics, entactogens and psychoplastogens for depression and related disorders.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.70088}{doi:10.1111/bph.70088}.
\item Ippolito A, Vasudevan S, Hurley S, Gilmour G, Westhorpe F, Churchill G, Sharp T (2026). \textit{Evidence that 5-HT receptor signalling efficacy and not biased agonism differentiates serotonergic psychedelic from non-psychedelic drugs.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.70109}{doi:10.1111/bph.70109}.
\item Wittenkeller L, Gudelsky G, Winhusen TJ, Amato D (2026). \textit{Psychedelics as pharmacotherapeutics for substance use disorders: A scoping review on clinical trials and perspectives on underlying neurobiology.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.70181}{doi:10.1111/bph.70181}.
\item Ascone F, Buzzelli V, Mottarlini F, Di Trapano M, Miglioranza P, Rava A, Feo A, Spano F, Hausman M, Sugaya K, Caffino L, Fumagalli F, Trezza V (2026). \textit{Psilocybin improves novel object recognition in a rat model of Fragile X Syndrome through the modulation of the BDNF/TrkB signaling pathway.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/s41386-026-02361-x}{doi:10.1038/s41386-026-02361-x}.
\item Wang Y, Wang H, Lin C, Wang X (2026). \textit{Chemical ecology and convergent evolution of natural hallucinogens: From ecological defense to conserved neural targets.}. Proceedings of the National Academy of Sciences of the United States of America. [published; PubMed]. \href{https://doi.org/10.1073/pnas.2535785123}{doi:10.1073/pnas.2535785123}.
\item Estela-Fernandez CA, Mohamed Yousif Elsheikh R, Beatrice DB, A Alhendal A, Irene Ewe C, Montesinos SY, Wensel J, Mishra AP, Yousif AA, Ali HT. (2026). \textit{Psychedelics in treatment-resistant depression: a comprehensive review of mechanisms, clinical evidence, and recommendations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40211-026-00584-4}{doi:10.1007/s40211-026-00584-4}.
\item Johns Hopkins University (2026). \textit{5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05452772}{source link}.
\item Du Y, Zhao X, Yao Y, Li Y, Wang G, Zhang L. (2026). \textit{Psilocybin reduces fear memory and restores neuroplasticity in the hippocampus and medial prefrontal cortex.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811261453819}{doi:10.1177/02698811261453819}.
\item Anthony P King (2026). \textit{A Pilot Mechanistic RCT of Psilocybin With Mindfulness-based Therapy vs Support for Posttraumatic Stress Disorder (PTSD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07104916}{source link}.
\item Brar PS, Price RB, Ross S, Tofighi B, Sarpal DK (2026). \textit{The intersection between psychedelics and schizophrenia spectrum disorders: Reevaluating risk and therapeutic potential.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811261456191}{doi:10.1177/02698811261456191}.
\item Mauro Pettorruso, Giacomo d’Andrea, Antonio Inserra, Clara Cavallotto, Stefano Censi, Étienne Billard, Antonio Di Stefano, Luisa De Risio, Maria Giulia Tullo, Claudio D’Addario, Giorgio Di Lorenzo, Richard G. Wise, Stefano L. Sensi, Francesca Zoratto, Giovanni Martinotti (2026). \textit{Mechanistic insights toward dissociating therapeutic from psychedelic effects: bridging the gap between psychedelic research and mental health care}. Translational Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41398-026-04203-2}{doi:10.1038/s41398-026-04203-2}.
\item Júlio César Claudino dos Santos, Sofia Januário Bolan, Guilherme Lodetti da Silva, Germano Lapa Viana, Eduardo Pacheco Rico, Cinara Ludvig Gonçalves (2026). \textit{Psychedelics and autism spectrum disorder: Mechanistic insights, translational evidence and ethical challenges}. Journal of Psychiatric Research. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jpsychires.2026.06.035}{doi:10.1016/j.jpsychires.2026.06.035}.
\item Yale University (2026). \textit{Effects of Psilocybin Microdosing on Cognition, Mood and Quality of Life: A Pilot Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07449351}{source link}.
\item Lenka Seillier, Alexandre Seillier, Morgan A. Zvolska, Romana Šlamberová (2026). \textit{Blocking 5-HT2B receptors abolishes psilocybin’s efficacy in the rat forced swim test}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811261458349}{doi:10.1177/02698811261458349}.
\item van den Busken WJ, Dines AM, Eyer F, Heyerdahl F, Hovda KE, Liechti ME, Miró Ò, Vallersnes OM, Wood DM, Yates C, Dargan PI, (on behalf of the Euro-DEN Plus Research Group), Gresnigt FMJ, Euro-DEN Plus Research Group (2026). \textit{Cardiovascular effects associated with acute recreational drug toxicity presentations to the emergency department: a European drug emergencies network (Euro-DEN plus) study.}. Clinical toxicology (Philadelphia, Pa.). [published; PubMed]. \href{https://doi.org/10.1080/15563650.2026.2669671}{doi:10.1080/15563650.2026.2669671}.
\item Roswell Park Cancer Institute (2026). \textit{Low-Dose Psilocybin Therapy for Palliative Care Patients With Chronic Cancer Pain Requiring Opioids}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06827054}{source link}.
\item Eric P. Rubenstein (2026). \textit{Beyond Psychedelic Microdosing: Therapeutic Potential, Neuropharmacology, and Safety Considerations in Low-Dose Psychoactive Use}. Journal of Advances in Developmental Research. [published; OpenAlex]. \href{https://doi.org/10.71097/ijaidr.v17.i1.1997}{doi:10.71097/ijaidr.v17.i1.1997}.
\item Dagnino PC, Acero-Pousa I, Zamora-López G, Escrichs A, Erritzoe D, Nutt DJ, Carhart-Harris RL, Sanz Perl Y, Kringelbach ML, Deco G. (2026). \textit{Distinct brain responses to psilocybin and escitalopram in depression captured by the Fluctuation-Dissipation Theorem}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.06.12.731811}{doi:10.64898/2026.06.12.731811}.
\item Julia Osipowska, Marlena Kwolek, Alicja Judzińska, Bartosz Piech, Kamila Sobczyńska, Justyna Ignarska, Magda Terbosh, Sabina Kubicz `Mzabi, Emilia Trojanowska, Magdalena Dubaj (2026). \textit{THE PSYCHEDELIC AND KETAMINE RENAISSANCE IN THE FACE OF THE CRISIS IN MODERN PSYCHIATRY}. International Journal of Innovative Technologies in Social Science. [published; OpenAlex]. \href{https://doi.org/10.31435/ijitss.2(50).2026.5605}{doi:10.31435/ijitss.2(50).2026.5605}.
\item Brigham and Women's Hospital (2026). \textit{Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder: A Double-Blind, Dose-Comparison Concurrent Control Randomized Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07296094}{source link}.
\item SAIMSARA (2026). \textit{Psilocybin and Mental Health Outcomes: Scoping Review with ☸SAIMSARA}. SAIMSARA Journal. [published; OpenAlex]. \href{https://doi.org/10.62487/saimsara7a54f680}{doi:10.62487/saimsara7a54f680}.
\item Zachary N. Abrahms, Mohammad Majdi, Siena M. Madsen, Chloe J. Morton, Abhishek K. Sen, Niya B. Fried, Lily E. Sawyer, Evelyn R. Cegielski, Sean J. Spezzano, J. Andrew Jones (2026). \textit{Genome-based optimization of psilocybin and N,N-dimethyltryptamine biosynthetic pathways in E. coli using CRISPR-associated transposases}. Metabolic Engineering. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ymben.2026.102490}{doi:10.1016/j.ymben.2026.102490}.
\item Akemini J Udoro, Yadanar Yukyi, Ali Z Ansari, Hiram A Gandara, Fizza Ahmed, Derek Hunt (2026). \textit{Acute Hallucinogen Intoxication Following Ingestion of a Commercially Available Mushroom Extract Product: A Case Report}. Cureus. [published; OpenAlex]. \href{https://doi.org/10.7759/cureus.110791}{doi:10.7759/cureus.110791}.
\item Unknown authors (2026). \textit{Aquahenosis: A non-pharmacological altered state of consciousness induced by Floatation-REST in individuals with anxiety and depression}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/6mj8n\_v2}{source link}.
\item Johns Hopkins University (2026). \textit{PRISMatic: A Phase 1b Randomized, Double-Armed, Parallel-Group, Placebo-Controlled Trial of Psilocybin Efficacy With or Without Pimavanserin Pretreatment}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07610135}{source link}.
\item Jennifer Mitchell (2026). \textit{A Double Blind, Randomized Trial Investigating the Safety, Feasibility, and Mechanisms of Psychedelics in Healthy Older Adults With Low Well-being as Moderated by Biomarkers for Preclinical Alzheimer's Disease}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07386730}{source link}.
\item Samaneh Ahmadian-Moghadam, Shiva Roshan-Milani, Ehsan Saboory (2026). \textit{Prenatal stress, excitatory-inhibitory imbalance, and ADHD risk: a hypothesis-driven perspective on psilocybin-induced neuroplasticity}. Translational Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41398-026-04151-x}{doi:10.1038/s41398-026-04151-x}.
\item Myfanwy Graham, Yimin Ge, Rosalie Liccardo Pacula, Seema Choksy Pessar, Chris Wilkins, Wayne Hall, David Hammond (2026). \textit{A cross-national comparison of nonmedical and medical use of psychedelic drugs in the international cannabis policy study}. International Journal of Drug Policy. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugpo.2026.105348}{doi:10.1016/j.drugpo.2026.105348}.
\item Yale University (2026). \textit{Effects of Repeated Dosing of Psilocybin on Obsessive-Compulsive Disorder: A Randomized, Waitlist-Controlled Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05370911}{source link}.
\item Kevin F. Boehnke, Niloufar Pouyan, Jacob S. Aday (2026). \textit{Classic Psychedelics for Chronic Pain: A Critical Review of the Literature and Practical Advice for Clinicians}. Drugs. [published; OpenAlex]. \href{https://doi.org/10.1007/s40265-026-02339-5}{doi:10.1007/s40265-026-02339-5}.
\item Michel Dorval, Virginie Audet-Croteau, Sue-Ling Chang, Marianne Masse-Grenier, Annie Tremblay, Elodie Bénard, Alexandra Chapdelaine, Nicolas Garel, Jason Robert Guertin (2026). \textit{Bringing Psilocybin-Assisted Therapy to Palliative Oncology: Early Lessons from Real-World Implementation}. Healthcare. [published; OpenAlex]. \href{https://doi.org/10.3390/healthcare14111559}{doi:10.3390/healthcare14111559}.
\item Fotiadis P, Jang H, Dai R, Li D, Cofré R, Timmermann C, Mashour GA, Hudetz AG, Huang Z. (2026). \textit{Reorganization of Human Brain Waves Across Diverse States of Consciousness}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.05.27.728182}{doi:10.64898/2026.05.27.728182}.
\item Christopher W. T. Miller, Zofia Kozak (2026). \textit{Hallucinogen-Assisted Psychotherapy for Trauma Disorders: A Bionian Lens}. Psychodynamic Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1521/pdps.2026.54.2.308}{doi:10.1521/pdps.2026.54.2.308}.
\item C. Poppe, Liisa Lyck, Laura Bechtold, Dimitris Repantis (2026). \textit{Expectations and Motivations for Participation in Clinical Trials Utilizing Psychedelics for Treatment-Resistant Depression: A Qualitative Study}. Brain and Behavior. [published; OpenAlex]. \href{https://doi.org/10.1002/brb3.71544}{doi:10.1002/brb3.71544}.
\item T. Rowe, T. Hurzeler, E. Towers, E. Louie, K. C. Morley (2026). \textit{Psychedelic Therapy and the Role of Music: A Scoping Review of Quantitative Evidence on Subjective and Objective Outcomes}. Brain and Behavior. [published; OpenAlex]. \href{https://doi.org/10.1002/brb3.71533}{doi:10.1002/brb3.71533}.
\item Josh Allen, Bianca Jupp, Tamara L. Baker, Mohammad B. Haskali, Robert Brkljača, Zoe Plummer, Mujun Sun, Justin Brand, Brian R. Christie, Chantel T. Debert, Stuart J. McDonald, Terence J. O’Brien, Pablo M. Casillas-Espinosa, Sandy R. Shultz (2026). \textit{Psilocybin restores behavior and 5-HT2A signaling while reducing microglial density after chronic traumatic brain injury in rats}. Cell Reports Medicine. [published; OpenAlex]. \href{https://doi.org/10.1016/j.xcrm.2026.102867}{doi:10.1016/j.xcrm.2026.102867}.
\item Anna Beatriz Vicentini, Caio Cesar de Paula, José Augusto Silva Reis, José Carlos Bouso, Jaime E. C. Hallak, Rafael G. dos Santos (2026). \textit{Classic psychedelics and personality: An updated systematic review}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811261449386}{doi:10.1177/02698811261449386}.
\item Marcos Lago, Mariana Cerveira, Joe Xavier Simonet (2026). \textit{Transient multidomain functional improvement in advanced Alzheimer’s disease following high-dose psilocybin-containing mushroom administration: a case report}. Frontiers in Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.3389/fnins.2026.1813281}{doi:10.3389/fnins.2026.1813281}.
\item Urban MM, Zillich L, Rieser NM, Herdener M, Spanagel R, Vollenweider FX, Preller KH, Meinhardt MW. (2026). \textit{Epigenome-wide association study of psilocybin-induced methylome changes in alcohol use disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-026-03961-3}{doi:10.1038/s41398-026-03961-3}.
\item Unknown authors (2026). \textit{Serotonergic Psychedelics as a Potential Therapeutic Strategy for Anxiety, A Systematic Review}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/gf7bq\_v1}{source link}.
\item Dallas T Mason (2026). \textit{Psilocybin for Treatment-Resistant Depression: A Comprehensive Review of Mechanisms and Therapeutic Potential}. Digital Showcase Research, Scholarship, \& Creative Works (University of Lynchburg). [published; OpenAlex]. \href{https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6}{source link}.
\item Noah Cavallaro, Priya Rai, David Akins, Sima Soltanpour, Md Taufiq Nasseef, Richard J. Ortiz, Rachel Utama, Caitlyn R. Cody, Anoushka Mistry, Heather C. Brenhouse, Praveen Kulkarni, Craig F. Ferris (2026). \textit{Mescaline Alters Cerebellar Function, Global Connectivity, and Frequency-Selective Acoustic Gating: A BOLD fMRI Study in Awake Rats}. Neuroscience Bulletin. [published; OpenAlex]. \href{https://doi.org/10.1007/s12264-026-01632-3}{doi:10.1007/s12264-026-01632-3}.
\item University of Alabama at Birmingham (2026). \textit{Psilocybin-facilitated Treatment for Cocaine Use}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT02037126}{source link}.
\item University of Calgary (2026). \textit{Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner Violence}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06885996}{source link}.
\item Bartłomiej Kosiarski, Anna Skrzypek, Patrycja Markowicz, Mikołaj Zbrożek, Krzysztof Biłyk, Maciej Hutkowski, Zuzanna Chwostek, Hanna Maruchniak, Wiktoria Marzec, Paulina Biedroń (2026). \textit{Rapid-acting interventions in treatment-resistant depression - a comparative review of esketamine and psilocybin}. Journal of Pre-Clinical and Clinical Research. [published; OpenAlex]. \href{https://doi.org/10.26444/jpccr/221219}{doi:10.26444/jpccr/221219}.
\item Khadija Kamene (2026). \textit{Treatment-Resistant Depression in the 21st Century: A Scoping Review of Psychedelics and Neuromodulation in Transforming Care}. Premier Journal of Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.70389/pjn.100014}{doi:10.70389/pjn.100014}.
\item Jessie Kim, Liam Lochhead, Cory R. Weissman (2026). \textit{From Trials to Clinics: Considerations for Implementing Psychedelic-Assisted Therapy Into Clinical Practice}. Pharmacology Research \& Perspectives. [published; OpenAlex]. \href{https://doi.org/10.1002/prp2.70262}{doi:10.1002/prp2.70262}.
\item John R. Kelly, Christopher Sheridan, Patricia Iusan, Lisa Coakley, Lisa Burke, C. Brennan, Annie Annie MacDonald, Jo-Hanna Ivers, Dominic Trepel, Garrath Tormey, Martha Finnegan, Gareth W. Young, Andrew Harkin (2026). \textit{Trials, trips, and tribulations: pathways for implementing psychedelic therapy in Ireland}. The International Journal of Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1093/ijnp/pyag028}{doi:10.1093/ijnp/pyag028}.
\item Dayna Forsyth, Nicoletta Faraone, Simon G. Lamarre, Suzanne Currie (2026). \textit{The magic of mushrooms: psilocybin influences behavior in the mangrove rivulus fish, Kryptolebias marmoratus}. Frontiers in Behavioral Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.3389/fnbeh.2026.1767175}{doi:10.3389/fnbeh.2026.1767175}.
\item James J. Peters Veterans Affairs Medical Center (2026). \textit{Safety, Tolerability, Outcomes of Psilocybin for Depression (STOP Depression) in Veterans With Spinal Cord Injury}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07251491}{source link}.
\item L Hecker, J M Kleinhenz, C Coarfa, K Kato (2026). \textit{C29-12 Psilocybin Treatment Could Improve Outcomes for Age-associated Lung Diseases}. American Journal of Respiratory and Critical Care Medicine. [published; OpenAlex]. \href{https://doi.org/10.1093/ajrccm/aamag162.144}{doi:10.1093/ajrccm/aamag162.144}.
\item O'Mahony B, Harrington C, Harkin A, Lally N (2026). \textit{Trip killers: Addressing a critical knowledge gap in psychedelic research.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811261431056}{doi:10.1177/02698811261431056}.
\item Marilyn H. Silva (2026). \textit{New Approach Methodologies and Open Access Tools Help Characterize Risks for DART, DNT, or Endocrine Effects From Exposure to Hallucinogens With Potential Pesticide Contaminants}. Birth Defects Research. [published; OpenAlex]. \href{https://doi.org/10.1002/bdr2.70048}{doi:10.1002/bdr2.70048}.
\item Anne-Fiona Griesfeller, Lotte Kooman, Lilian Kloft-Heller, Samuli Kangaslampi, Johannes G Ramaekers, Henry Otgaar (2026). \textit{Evaluating the evidence for repressed memory recovery in psychedelic contexts}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-026-07076-x}{doi:10.1007/s00213-026-07076-x}.
\item Wang H, Li X, Yu F, Wang X (2026). \textit{The Harmonious Dance: A Narrative Review on Psychedelics and Music in Therapeutic Settings.}. Current neuropharmacology. [published; PubMed]. \href{https://doi.org/10.2174/011570159x442471260422110855}{doi:10.2174/011570159x442471260422110855}.
\item Neil K. Savalia, Lingxiao Shao, Cory Knox, A. Gilbert, Quan Jiang, Alex Kwan (2026). \textit{157. Opposing 5-HT Receptors Modulate Psilocybin's Action on Dendritic Calcium Dynamics}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2026.03.391}{doi:10.1016/j.biopsych.2026.03.391}.
\item Low ZXB. (2026). \textit{Serotonergic psychedelics for Autism spectrum disorder: Neurobiological mechanisms and translational prospects.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2026.111717}{doi:10.1016/j.pnpbp.2026.111717}.
\item Hinchcliffe JK, Bartlett J, Thomas CW, Golden CT, Gilmour G, Bortolotto ZA, Robinson ES. (2026). \textit{Distinct Modulatory Effects on Affective Biases by Different Serotonergic Psychedelics and MDMA in Male Rats: Possible Implications for Antidepressant Effects}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.04.20.719483}{doi:10.64898/2026.04.20.719483}.
\item Sivert Drange, Jacob Cohen, Sys Stybe Johansen, Ben Dunkley, Mikael Palner (2026). \textit{Case Report: Repeated low doses of psilocybin reduce perceived symptom severity but fail to restore cognitive flexibility in a case of severe obsessive-compulsive disorder: an observational case study of identical twins}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2026.1819962}{doi:10.3389/fpsyt.2026.1819962}.
\item Brinzei OV. (2026). \textit{Comparative Medico-Legal Frameworks for Psilocybin Regulation: A March 2026 Update}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202604.1423.v1}{doi:10.20944/preprints202604.1423.v1}.
\item Christopher S. Gondi, Manu Gnanamony, Tarun P. Gondi, Lilyt Nersesyan, Lusine Demirkhanyan (2026). \textit{Psychedelics and Autism Therapy: A Review of Current Research and Future Directions}. Current Issues in Molecular Biology. [published; OpenAlex]. \href{https://doi.org/10.3390/cimb48040417}{doi:10.3390/cimb48040417}.
\item Jóźwiak-Bębenista M, Stasiak A, Sienkiewicz M, Kwiatkowski P, Kowalczyk E. (2026). \textit{Psilocybin in Older Adults: Therapeutic Opportunities in Inflammation-Driven Disorders of Aging-From Depression to Neurodegeneration}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202604.1125.v1}{doi:10.20944/preprints202604.1125.v1}.
\item Keenan RJ, Haque RT, Jin X, Mustafa T, Homman-Ludiye J, Elysee K, Wee ZS, Simonds SE, Foldi CJ, Cowley MA. (2026). \textit{Effects of a single dose of psilocybin on diet-induced weight loss in obese mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-026-03995-7}{doi:10.1038/s41398-026-03995-7}.
\item D. P. Effinger, J. L. Hoffman, Sema G. Quadir, C. S. Rollison, D. Toedt, M. Echeveste Sanchez, M. W. High, C. W. Hodge, Melissa A. Herman (2026). \textit{Sex-specific increased reactivity of the PVT and prolonged PVT→CeA circuit engagement following psilocin administration}. Nature Communications. [published; OpenAlex]. \href{https://doi.org/10.1038/s41467-026-71481-1}{doi:10.1038/s41467-026-71481-1}.
\item Gallardo LM. (2026). \textit{Altered States of Consciousness and the Subconscious Mind: A Comprehensive Comparative Review of Disciplines, Neurobiological Mechanisms, Clinical Applications, and Philosophical Frameworks - Including Life Between Lives and Transpersonal Hypnotherapy}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202604.0415.v1}{doi:10.20944/preprints202604.0415.v1}.
\item Johns Hopkins University (2026). \textit{Effects of Psilocybin in Obsessive Compulsive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05546658}{source link}.
\item Saif S. Ali, Robin L. Carhart-Harris, Karl G. Sieg (2026). \textit{Classic psychedelics in obsessive-compulsive disorder: a circuit-based framework}. Nature Mental Health. [published; OpenAlex]. \href{https://doi.org/10.1038/s44220-026-00626-4}{doi:10.1038/s44220-026-00626-4}.
\item Shakila Meshkat, Manish K. Jha, Venkat Bhat (2026). \textit{Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical Implications}. FOCUS The Journal of Lifelong Learning in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.focus.20250043}{doi:10.1176/appi.focus.20250043}.
\item Jordana Kazdan, Karim S. Ladha, M. Ishrat Husain (2026). \textit{Psychedelic Therapies for Comorbid Major Depressive Disorder and Chronic Pain: A Review of Putative Mechanisms of Action}. Pharmacology Research \& Perspectives. [published; OpenAlex]. \href{https://doi.org/10.1002/prp2.70238}{doi:10.1002/prp2.70238}.
\item Manesh Girn, Manoj K. Doss, Leor Roseman, Katrin H. Preller, Fernanda Palhano-Fontes, Lorenzo Pasquini, Frederick S. Barrett, Pablo Mallaroni, Natasha L. Mason, Christopher Timmermann, Drummond E-Wen McCulloch, Patrick M. Fisher, Brian Winston, Flora Moujaes, Felix Muller, Matthias E. Liechti, Franz X. Vollenweider, Johannes G. Ramaekers, Kim Kuypers, Dráulio B. Araújo, Olaf Sporns, Joshua S. Siegel, Nico U.F. Dosenbach, David J. Nutt, Robin L. Carhart-Harris, Emmanuel A. Stamatakis, Danilo Bzdok (2026). \textit{An international mega-analysis of psychedelic drug effects on brain circuit function}. Nature Medicine. [published; OpenAlex]. \href{https://doi.org/10.1038/s41591-026-04287-9}{doi:10.1038/s41591-026-04287-9}.
\item Paula Berman, Janka Hédi Hófer, Herschel Mehlman, Efrat Almekias-Siegl, Olga Khersonsky, Younghui Dong, Uwe Heinig, Liron Sulimani, Let Kho Hao, Shahar Cohen, Yoav Peleg, Sagit Meir, Ilana Rogachev, David Meiri, Sarel J. Fleishman, Asaph Aharoni (2026). \textit{Complete biosynthesis of psychedelic tryptamines from three kingdoms in plants}. Science Advances. [published; OpenAlex]. \href{https://doi.org/10.1126/sciadv.aeb3034}{doi:10.1126/sciadv.aeb3034}.
\item J. Geraci, Erik Viirre, Bessi Qorri, Luca Pani (2026). \textit{Psychedelics and the quantum brain: a falsifiable hypothesis on Posner molecules and spin-dependent pharmacology}. Frontiers in Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.3389/fphar.2026.1777613}{doi:10.3389/fphar.2026.1777613}.
\item Kenji Hashimoto, Feyza Arıcıoğlu, Mesut Çetin (2026). \textit{Therapeutic Potential of Classical Psychedelics and NonHallucinogenic Psychoplastogens in Psychiatric Disorders}. Psychiatry and Clinical Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.65801/pcp.3512}{doi:10.65801/pcp.3512}.
\item Veronica Mäki-Marttunen (2026). \textit{Psilocybin shapes the slow, global propagation of brain activity over the cortical layout of 5HT2a receptors}. Communications Biology. [published; OpenAlex]. \href{https://doi.org/10.1038/s42003-026-09912-4}{doi:10.1038/s42003-026-09912-4}.
\item Donatella Marazziti, Matteo Gambini, Riccardo Gurrieri, Gerardo Russomanno, Giorgia Sità, Elena Pescini, FRANCESCA RITA DIGIUSEPPE, Federico Mucci (2026). \textit{Psychedelic-assisted pharmacotherapy: clinical applications and regulatory considerations}. Expert Opinion on Pharmacotherapy. [published; OpenAlex]. \href{https://doi.org/10.1080/14656566.2026.2654682}{doi:10.1080/14656566.2026.2654682}.
\item Gillet A, Geron C, Vitello MM, Lejeune N. (2026). \textit{Pharmacotherapy in Disorders of Consciousness: A Mechanism-Based Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40263-026-01274-z}{doi:10.1007/s40263-026-01274-z}.
\item Taddei-Tardón M, Medina-Rodríguez L, Maltman JL, Hudson S, Potukanuma S, Jiménez JH, Martín-Guerrero SM, González-Maeso J, López-Giménez JF. (2026). \textit{Integrated 5-HT2A -TrkB and G protein signaling in serotonergic psychedelic responses}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.03.19.712961}{doi:10.64898/2026.03.19.712961}.
\item Malkanthi Evans, Andrew Charrette (2026). \textit{Editorial: Psychedelic-assisted psychotherapies: from clinical trials to credibility}. Frontiers in Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.3389/fnins.2026.1816932}{doi:10.3389/fnins.2026.1816932}.
\item University of New Mexico (2026). \textit{Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07484906}{source link}.
\item Àlvar Farré-Colomés, Olga Rublinetska, Óscar Soto-Angona (2026). \textit{Psilocybin effects on brain functional connectivity: a systematic review of fMRI studies}. Discover Mental Health. [published; OpenAlex]. \href{https://doi.org/10.1007/s44192-026-00384-w}{doi:10.1007/s44192-026-00384-w}.
\item Alessandra Linardi, Ariadiny Lima Caetano, Rodrigo Portes Ureshino (2026). \textit{Editorial: Psychedelic substances and neurological diseases: from basics to clinical application}. Frontiers in Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.3389/fphar.2026.1816812}{doi:10.3389/fphar.2026.1816812}.
\item University of Alabama at Birmingham (2026). \textit{Exploratory Study of the Effects of Low-Dose Psilocybin on Sensory Processing, Neurophysiological Arousal, and Emotional Health}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05227742}{source link}.
\item Shikha Baghel Chauhan, Naziya Akhtar, chirag Jain, Indu Singh (2026). \textit{Strategic Neurodelivery of Psychedelic Compounds: Bridging MolecularPharmacology with Therapeutic Innovation in CNS Disorders}. CNS \& Neurological Disorders - Drug Targets. [published; OpenAlex]. \href{https://doi.org/10.2174/0118715273434237251212095005}{doi:10.2174/0118715273434237251212095005}.
\item Floris G, Jefferson SJ, Rondeau J, Yu AL, Menniti FS, Kwan AC, De Aquino JP, Krystal JH, Pittenger C, Kaye AP. (2026). \textit{Enhancing cGMP signaling with psilocybin reduces head twitch and restructures the synaptic proteome while maintaining antidepressant response}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.03.06.710108}{doi:10.64898/2026.03.06.710108}.
\item Shore Ronald, Dobson Kat, Thomson Nina, Barnim Nigel, Bergman Hailey, Rideout Katie, McKeown Sandra, Olmstead Mary C., Goldie Craig, Dumont Eric (2026). \textit{Behavioural investigations of psilocybin in non-human animals 1962-2021: A scoping review}. Journal of Psychedelic Studies. [published; Crossref]. \href{https://doi.org/10.1556/2054.2025.00364}{doi:10.1556/2054.2025.00364}.
\item Fabiano N, Stubbs B, Lawrence DW, Rosenblat JD, Teixeira PJ, Wong S, Zhou C, Carhart-Harris R (2026). \textit{The combination of exercise and psychedelics for the treatment of major depressive disorder.}. Discover mental health. [published; PubMed]. \href{https://doi.org/10.1007/s44192-026-00408-5}{doi:10.1007/s44192-026-00408-5}.
\item Region Skane (2026). \textit{The Therapeutic Potential of Psilocybin in Anorexia Nervosa in Young Adults}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07169747}{source link}.
\item Claydon MDB, Hinchcliffe JK, Bartlett J, Golden CT, Thomas CW, Gilmour G, Mellor JR, Bortolotto ZA, Robinson ESJ. (2026). \textit{Inhibition of cortico-amygdala projections underlies affective bias modification by psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.03.02.709133}{doi:10.64898/2026.03.02.709133}.
\item Griškova-Bulanova I, Vejmola Č, Páleníček T. (2026). \textit{Serotonergic modulation of cortical gamma synchronization: right-lateralized psilocin effects on 40 Hz auditory steady-state responses in rats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1152/jn.00519.2025}{doi:10.1152/jn.00519.2025}.
\item Bo Jarrett Wood, M. Frances Vest, Catharine Carfagno, Kyla Rose Bartley, Papori Sharma, Adam L. Halberstadt, Bruce E. Blough, Kevin S. Murnane (2026). \textit{Differential Effects of Acute and Chronic Fluoxetine on Psychedelic-Induced Behavior in Mice: Implications for Clinical Trials}. ACS Pharmacology \& Translational Science. [published; OpenAlex]. \href{https://doi.org/10.1021/acsptsci.5c00484}{doi:10.1021/acsptsci.5c00484}.
\item Stanley Kisourin (2026). \textit{Nicotinoyl-Tryptamine Derivatives as Potential Dual-Action Prodrugs for NAD⁺ Enhancement and Neuroprotection}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.18825289}{doi:10.5281/zenodo.18825289}.
\item Ana Deutsch, Luis E. Contreras, Sarah Kratina, Leah M. Mayo (2026). \textit{A scoping review of mystical-type experiences and mood symptom outcomes in psychedelic therapy clinical trials: comparing life-threatening disease and depressive populations}. Therapeutic Advances in Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/20451253261433836}{doi:10.1177/20451253261433836}.
\item Greg Corder, Sophie Rogers, Corinna Oswell (2026). \textit{Psilocybin Reshapes Anterior Cingulate Network Neuropathic Topology to Reduce Chronic Pain}. Journal of Pain. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jpain.2025.105705}{doi:10.1016/j.jpain.2025.105705}.
\item David Wrathall, Hannah Gosnell, Fern Wickson, Erika Spanger, Associates* (2026). \textit{Journeying into Right Relations: Scientists Turn to Psilocybin to Shift Psychological Burdens of Global Environmental Change and Find Transformational Pathways Forward}. Action Research. [published; OpenAlex]. \href{https://doi.org/10.1177/14767503251404263}{doi:10.1177/14767503251404263}.
\item Zhang J, Lin C, Lv X, Zhao H, Wang X. (2026). \textit{Psychedelics and the Extracellular Matrix: Rewiring Neuroplasticity and Metaplasticity for Next-Generation Psychiatric Therapies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.biopsych.2026.02.011}{doi:10.1016/j.biopsych.2026.02.011}.
\item Tianjie Li, Erin. E. Reynolds, Ziqi Wang, Michael P. Torrens-Spence, Jing-Ke Weng, Yi Wang (2026). \textit{Calcium activation mechanism of a noncanonical aromatic L-amino acid decarboxylase from psilocybin mushroom Psilocybe cubensis}. Communications Biology. [published; OpenAlex]. \href{https://doi.org/10.1038/s42003-026-09756-y}{doi:10.1038/s42003-026-09756-y}.
\item Shokr MM, Fawzy MN, Abdelaziz AM. (2026). \textit{Pharmacological regulation of adult brain neuroplasticity: Synergistic roles of neuropeptide signaling, psychedelics, and synaptic modulators.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.mcn.2026.104076}{doi:10.1016/j.mcn.2026.104076}.
\item Edward Jacobs, Zarmeen Zahid, Jared T. Hinkle, Sandeep M. Nayak, David B Yaden (2026). \textit{Psychedelic medicine: mechanisms, evidence, and translation to practice}. BMJ. [published; OpenAlex]. \href{https://doi.org/10.1136/bmj-2024-081723}{doi:10.1136/bmj-2024-081723}.
\item Unknown authors (2026). \textit{Mindfulness-Based Psilocybin-Assisted Therapy (MB-PAT) for cancer-related demoralization in Canada: the case for a hybrid group-based delivery model}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/yrgkf\_v1}{source link}.
\item Zurika Murray, Angélique Lewies, Johannes F. Wentzel, Marietjie Schutte-Smith, Elizabeth Erasmus, Anwar E.M. Noreljaleel, Hendrik G. Visser, Anke Wilhelm, Abdul Rashid Issahaku (2026). \textit{Network pharmacology and molecular simulation reveal the entourage effect mechanisms of psilocybin-producing mushrooms on the brain}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-026-39483-7}{doi:10.1038/s41598-026-39483-7}.
\item Johnston J, Jones G, Peng S, Yuan P, Yavi M, Kadriu B, Henter I, Quintanilla B, Elkahloun AG, Moaddel R, Schulmann A, Akula N, Kvarta M, McMahon F, Zarate C. (2026). \textit{Time-Dependent Effects of Rapid-Acting Antidepressants in iPSC-Derived Neurons from Treatment-Resistant Depression and Healthy Volunteers}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-8733841/v1}{doi:10.21203/rs.3.rs-8733841/v1}.
\item Zen Revista (2026). \textit{Activity-Dependent Neural Rewiring: Mechanisms of Psilocybin-Induced Cortical Network Reorganization}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.18501568}{doi:10.5281/zenodo.18501568}.
\item Zen Revista (2026). \textit{Activity-Dependent Neural Rewiring by Psilocybin: A Monosynaptic Rabies Virus Tracing Study}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.18501514}{doi:10.5281/zenodo.18501514}.
\item Tianyi Xu, Sabrina Wong, Gia Han Le, Christine E. Dri, Kayla M. Teopiz, Andy Lu, Serene M. L. Lee, Taeho Greg Rhee, Liyang Yin, Stavroula I. Bargiota, Roger Ho, Roger S. McIntyre (2026). \textit{Cardiac Consequences Associated with Psychedelic Use: A Systematic Review of Lysergic Acid Diethylamide, 3,4-Methylenedioxymethamphetamine, and 5-Hydroxytryptamine 2B-Mediated Valvular Heart Disease}. Pharmacopsychiatry. [published; OpenAlex]. \href{https://doi.org/10.1055/a-2794-6487}{doi:10.1055/a-2794-6487}.
\item Junhong Liu, Y. Lynn Wang, Ke Xia, Jia-Bin Wu, Danhao Zheng, Aoling Cai, Haitao Yan, Ruibin Su (2026). \textit{Acute psilocin increased cortical activity in rat}. Frontiers in Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.3389/fnins.2026.1593703}{doi:10.3389/fnins.2026.1593703}.
\item Sheida Shadani, Erika Greaves, Zane B. Andrews, Claire J. Foldi (2026). \textit{Psilocybin exerts differential effects on social behavior and inflammation in mice in contexts of activity-based anorexia}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp026a.0003}{doi:10.61373/pp026a.0003}.
\item Swainson J, Brietzke E, Khullar A, McIntyre RS, Soares CN (2026). \textit{Ketamine, Psychedelics, and Psychotherapy: Reframing, Redefining, Renaming Treatment Models.}. Canadian journal of psychiatry. Revue canadienne de psychiatrie. [published; PubMed]. \href{https://doi.org/10.1177/07067437251389090}{doi:10.1177/07067437251389090}.
\item Ansari M, Elliott SI, Holmes SE, Sanacora G (2026). \textit{Placebo Effects in the Treatment of Depression-Implications for the Psychedelic Renaissance.}. Neurologic clinics. [published; PubMed]. \href{https://doi.org/10.1016/j.ncl.2025.08.009}{doi:10.1016/j.ncl.2025.08.009}.
\item Simon Halm (2026). \textit{Psychedelic- and Substance-Assisted Therapies in Global Mental Health: Bridging Cultures, Evidence, and Access}. Brain and Behavior. [published; OpenAlex]. \href{https://doi.org/10.1002/brb3.71265}{doi:10.1002/brb3.71265}.
\item Anna Maria Komarczewska, Filip Matusiak, Klaudia Brzoza, Michał Kociński, Patryk Iglewski, Michał Pietrasz (2026). \textit{Psilocybin-Induced Neuroplasticity and Sustained Antidepressant Effects}. Quality in Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/qs.2026.51.68216}{doi:10.12775/qs.2026.51.68216}.
\item Jesper L. Kristensen (2026). \textit{Regarding “The molecular mechanisms through which psilocybin prevents suicide: evidence from network pharmacology and molecular docking analyses”}. Translational Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41398-026-03844-7}{doi:10.1038/s41398-026-03844-7}.
\item Łukasz Deska, Cezary Kosmecki, Dawid Głaz, Natalia Kamińska, Wojciech Sołtys, Magdalena Stolarczyk, Maksymilian Głaz, Mateusz Stronczyński, Aleksandra Jagura-Sukiennik, Julia Wawerska (2026). \textit{PSILOCYBIN IN PSYCHIATRIC PRACTICE AND PSYCHEDELIC-ASSISTED THERAPY FOR TREATMENT-RESISTANT DEPRESSION}. International Journal of Innovative Technologies in Social Science. [published; OpenAlex]. \href{https://doi.org/10.31435/ijitss.1(49).2026.4711}{doi:10.31435/ijitss.1(49).2026.4711}.
\item Adam Wolski, Ewa Szplit, Mikołaj Franciszek Patalong, Roman Cemaga, Mateusz Kubicki, Przemysław Kołodziej, Natalia Bruska, Bartłomiej Błaszkowski, Andrii Bilyk, Katarzyna Więckowska (2026). \textit{Psychedelics in psychiatric treatment: a literature review}. Quality in Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/qs.2026.50.68013}{doi:10.12775/qs.2026.50.68013}.
\item Fernando Mora López, Johynny Solís Solís, Ekaterina Daniela Hernández Baker, Olger Herrera Barboza, David Diaz Polo, Daniela Consumi Cordero (2026). \textit{The therapeutic efficacy of psilocybin in major depressive disorder: A review of recent clinical and mechanistic evidence}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.18375715}{doi:10.5281/zenodo.18375715}.
\item Marco Banzato, Martina Colognesi, Lorena Lucatello, Stefano Comai, Gianfranco Pasut, Francesca Capolongo, Laura Orian, Lucia Biasutto, Anna Signor, Daniela Gabbia, Paolo L. Manfredi, Sara De Martin, Andrea Mattarei (2026). \textit{Design, Synthesis, and Pharmacokinetic Profiling of Fluorinated Reversible N -Alkyl Carbamate Derivatives of Psilocin for Sub-Hallucinogenic Brain Exposure}. Journal of Medicinal Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1021/acs.jmedchem.5c01797}{doi:10.1021/acs.jmedchem.5c01797}.
\item Jakub Klepacz, Radosław Swędrak, Marzena Swojnóg, Zuzanna Dobrakowska (2026). \textit{THE PSYCHEDELIC RENAISSANCE: A SYSTEMATIC REVIEW OF PSILOCYBIN AND LSD IN THE TREATMENT OF PSYCHIATRIC DISORDERS}. International Journal of Innovative Technologies in Social Science. [published; OpenAlex]. \href{https://doi.org/10.31435/ijitss.1(49).2026.4582}{doi:10.31435/ijitss.1(49).2026.4582}.
\item Ana Domi, Erika Lucente, Davide Cadeddu, Niklas Bengtsson, Erik Smedler, Louise Adermark (2026). \textit{Psilocin mediates long-term synaptic depression in the prelimbic cortex through 5-HT2A receptor-independent mechanisms}. Neuropharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neuropharm.2026.110854}{doi:10.1016/j.neuropharm.2026.110854}.
\item Martina Colognesi, Daniela Gabbia, Anna Signor, Miles Sarill, Lucia Centofanti, Andrea Rinaldi, Luciano Cascione, Sara Nunziata, Marco Banzato, Andrea Mattarei, Giovanna Finzi, Sonia Sonda, Diana Pendin, Ilaria Zanotto, Stefano Comai, Gianfranco Pasut, Abdullah Alajati, Miriam Saponaro, Loredana Bucciarelli, Maria Elena Lunati, Andrea Alimonti, et al. (2026). \textit{Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanisms}. Repository for Publications and Research Data (ETH Zurich). [published; OpenAlex]. \href{https://doi.org/10.3929/ethz-c-000793359}{doi:10.3929/ethz-c-000793359}.
\item Piotr Olejnik, Katarzyna Kamińska, Krystyna Gołembiowska, Kaja Kasarełło (2026). \textit{Effects of psilocybin and chronic mild stress on microglial activation in rat spinal cord: an ex vivo analysis}. Pharmacological Reports. [published; OpenAlex]. \href{https://doi.org/10.1007/s43440-026-00824-y}{doi:10.1007/s43440-026-00824-y}.
\item Maria Garcia Garcia, Dahbia Belahda, Carine Graux, Chris Serrand, Noe Igounenc, Felix Sergent, Thibault Mura, Amandine Luquiens (2026). \textit{Insights from the psychedelic experience integration session: Verbatims differentiate 3-month abstinence in alcohol use disorder with depressive symptoms}. Journal of Affective Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jad.2026.121215}{doi:10.1016/j.jad.2026.121215}.
\item Larsen K, Fisher PM, McCulloch DE, Olsen AS, Mueller F, Liechti M, Borgwardt S, Holze F, Vizeli P, Ley L, Klaiber A, Becker A, Ozenne B, Avram M. (2026). \textit{Psychedelics distinctly alter brain entropy and complexity compared to psychostimulants}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.64898/2026.01.15.26344193}{doi:10.64898/2026.01.15.26344193}.
\item Unknown authors (2026). \textit{Aquahenosis: A non-pharmacological altered state of consciousness induced by Floatation-REST}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/6mj8n\_v1}{source link}.
\item Hinchcliffe JK, Thomas CW, Gilmour G, Robinson ES. (2026). \textit{Psilocybin rapidly, but not immediately, reverses reward learning deficits in a durable manner in an inflammatory rat model of depressive symptoms}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.01.14.699553}{doi:10.64898/2026.01.14.699553}.
\item University of California, San Diego (2026). \textit{Behavioral and Neural Mechanisms Supporting Psilocybin-assisted Therapy for Phantom Limb Pain}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05224336}{source link}.
\item Charalampos L. Kandilakis, Costas Papatheodoropoulos (2026). \textit{Psychedelic Modulation of Excitation/Inhibition Balance: A Dual-Phase Neurodevelopmental Model}. ACS Chemical Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1021/acschemneuro.5c00892}{doi:10.1021/acschemneuro.5c00892}.
\item Talea Cornelius, Tommaso Barba (2026). \textit{Associations of Couples’ Psychedelic Use with Shared Reality and Relational Well-Being}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2025.2607729}{doi:10.1080/02791072.2025.2607729}.
\item Zuzanna Kościuk, Izabela Szpręgiel, Agnieszka Bysiek, K. Gołembiowska (2026). \textit{The effect of psilocin on neurotransmitters release in the claustrum and on rat behavior}. Pharmacological Reports. [published; OpenAlex]. \href{https://doi.org/10.1007/s43440-025-00817-3}{doi:10.1007/s43440-025-00817-3}.
\item Slot J, Bradshaw A, Dentinger B, Borovička J, Konkel Z, Rockefeller A, Bollinger I. (2026). \textit{The one that abstained: Psilocybe fuscofulva genome suggests two recent origins of the psilocybin gene cluster in Psilocybe}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2025.12.30.697041}{doi:10.64898/2025.12.30.697041}.
\item Kunal Kumar Sharma (2025). \textit{Psychedelics and neuroanesthesia: A narrative review of converging mechanisms}. Journal of Scientific Innovations in Anesthesiology. [published; OpenAlex]. \href{https://doi.org/10.65929/jsia.2026.1.2.002}{doi:10.65929/jsia.2026.1.2.002}.
\item Stefan Jerotić, Olga Čolović, Nađa Marić (2025). \textit{Psychedelic-assisted psychotherapy: Clarifying the role of the "psychotherapy"}. Medicinska istrazivanja. [published; OpenAlex]. \href{https://doi.org/10.5937/medi0-62051}{doi:10.5937/medi0-62051}.
\item Belle Buzzi (2025). \textit{Exploring Psychedelics as Novel Therapeutics for Smoking Cessation: Mechanistic Insights from Animal Studies}. VCU Scholars Compass (Virginia Commonwealth University). [published; OpenAlex]. \href{https://scholarscompass.vcu.edu/etd/8246}{source link}.
\item Aneta Petrušková (2025). \textit{Effects of Serotonergic Psychedelics on Synaptic Function and Neuroplasticity}. OPUS FAU - Online publication system of Friedrich-Alexander-Universität Erlangen-Nürnberg. [published; OpenAlex]. \href{https://doi.org/10.25593/open-fau-2619}{doi:10.25593/open-fau-2619}.
\item Maurice Lam, C. Khor, S. Hultin, J. J. Cheung, N. A. Shah (2025). \textit{‘Shroom’ for concern: a case of psychedelic mushroom-induced acute kidney injury}. Internal Medicine Journal. [published; OpenAlex]. \href{https://doi.org/10.1111/imj.70313}{doi:10.1111/imj.70313}.
\item Connor J. Maltby, Adam K. Klein, Enya Paschen, Jessica Pinto, Dino Dvořák, Joseph R. Hedde, Ashley N. Hanks, Massimiliano Bianchi, Zoe Hughes (2025). \textit{An exploration of the relationships between the effects of psilocybin on behavior, 5-HT2A receptor occupancy, and neuroplastic effects in mice}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811251395386}{doi:10.1177/02698811251395386}.
\item Hediye Moghadam, Parisa Akbari, Elmira Beirami, Samaneh Nabavifard, Akram Ameli, Neda Valian (2025). \textit{The Effect of Magic Mushroom ( Psilocybe azurescens ) on Social Interaction, Anxiety- and Depressive-Like Behaviors in Male Rats; the Role of Neuroinflammation, Oxidative Stress, and Neurotrophic Factors}. Journal of Neuroscience Research. [published; OpenAlex]. \href{https://doi.org/10.1002/jnr.70107}{doi:10.1002/jnr.70107}.
\item Ziran Huang, Xiaoyan Wei, Yihui Wang, Jin Tian, Jihui Dong, Bo Liang, Lin Lu, Wen Zhang (2025). \textit{Single-dose psilocybin promotes cell-type-specific changes of neurons in the orbitofrontal cortex}. Neurotherapeutics. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neurot.2026.e00841}{doi:10.1016/j.neurot.2026.e00841}.
\item Spiti A, Caldirola D, Perna G. (2025). \textit{New Antidepressant Development in the Treatment of Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/978-981-95-6872-7\_23}{doi:10.1007/978-981-95-6872-7\_23}.
\item Olivier B, Olivier JDA. (2025). \textit{Psychedelics: Future Therapeutics in Major Depression?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/978-981-95-6872-7\_25}{doi:10.1007/978-981-95-6872-7\_25}.
\item Xia K, Gao T. (2025). \textit{[Clinical application and mechanistic studies of psychedelics for treatment of depression: progress and future challenges].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.12122/j.issn.1673-4254.2026.01.01}{doi:10.12122/j.issn.1673-4254.2026.01.01}.
\item Thuery G, Crossen F, Mc Loone D, Hinds C, Duffy R, Jairaj C, Harkin A, Kelly JR (2025). \textit{Psychedelic therapy and postpartum depression: priorities and prospects.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/20451253251408280}{doi:10.1177/20451253251408280}.
\item Vincent J Diehl, Abigail E. Calder, Gregor Hasler (2025). \textit{The helioscope effect: A new framework for evaluating trauma-related memory processing in psychedelic experiences}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811251397306}{doi:10.1177/02698811251397306}.
\item Yale University (2025). \textit{Psilocybin in Chronic Low Back Pain: An Integrative Study of Lab-Based Mechanisms and Real-World Physical Therapy Outcomes}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07306364}{source link}.
\item Rhianna Rich, Kelsey T. Laird, Prabha Siddarth, Brittany Youssef, Grace M. Schwartz, Ashley Ramos, Karina Sergi, Micah Linton, L. Schwartzberg, Daniel F. Kelly, Keith G. Heinzerling (2025). \textit{A Nature-Themed Video Intervention Increases Nature Relatedness in Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1177/28314425251387655}{doi:10.1177/28314425251387655}.
\item Paweł Liszka, Agata Ogórek, Klaudia M Olejnik-Chlewicka, Konrad Puchalski, Marta Zasiadła, Klaudia M Patrzykąt, Jakub Perediatkiewicz, Wojciech Urbański, Paweł M Łuczak, Jakub Brodowski (2025). \textit{Psychedelics as a Therapeutic Opportunity or Threat: A Narrative Review}. Cureus. [published; OpenAlex]. \href{https://doi.org/10.7759/cureus.99942}{doi:10.7759/cureus.99942}.
\item NYU Langone Health (2025). \textit{Effects of Psilocybin on Speech Fluency, Struggle, and Brain Activity in People Who Stutter}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07296328}{source link}.
\item M. Haseeb Ul Rasool, Taha Hannan, Muhammad Imam (2025). \textit{Magic mushrooms and mood: exploring Psilocybin as a depression treatment}. Journal of the Pakistan Medical Association. [published; OpenAlex]. \href{https://doi.org/10.47391/jpma.30858}{doi:10.47391/jpma.30858}.
\item Qinqing Chen, Peiyuan Chen, Tao Wei, Sunita Chamyuang, Bai-Xiong Chen (2025). \textit{From fungi to pharmacy: Applied technologies in psilocybin production and its therapeutic applications}. Creative Science. [published; OpenAlex]. \href{https://doi.org/10.55674/cs.v18i1.264689}{doi:10.55674/cs.v18i1.264689}.
\item Matthews Nicholass K, Flis I, Hanley M, Knight M, Lane S, Littlejohn G, Thom M, Billington R, Boden R, Cummins R, Green B, Griffin C, Jones S, Salmon D, Sleep I, Smirnoff N, Ellis J. (2025). \textit{Wherefore the magic? The evolutionary role of psilocybin in nature}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2025.12.17.694186}{doi:10.64898/2025.12.17.694186}.
\item Megan Dutton, Paul Schwenn, Jules Mitchell, Per Hoffmann, Neil W. Bailey, Paul B. Fitzgerald, Jim Lagopoulos, Adem Can (2025). \textit{Psilocybin in the real world: Regulatory, ethical, and operational challenges in Australia’s clinical landscape}. Australian \& New Zealand Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1177/00048674251398677}{doi:10.1177/00048674251398677}.
\item M. H. M. Wickramasekara, G. D. M. C. Gonapaladeniya (2025). \textit{Psychedelic-Assisted Therapy (Pat): A New Frontier in Mental Health Treatment}. The journal of desk research review and analysis.. [published; OpenAlex]. \href{https://doi.org/10.4038/jdrra.v3i2.87}{doi:10.4038/jdrra.v3i2.87}.
\item Vollebregt R, Storm AEM, Lucassen PJ, Somers M. (2025). \textit{Psychedelic experiences elicited by serotonergic psychedelics: Molecular mechanisms and functional connectivity changes in the brain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2025.106529}{doi:10.1016/j.neubiorev.2025.106529}.
\item Nicole Ledwos, Jenna Baer, Muhammad Ishrat Husain, Daniel M. Blumberger, Rachel Patterson, Elizabeth Hollingdrake, Ezmond S.L. Cheung, Colin Hawco, Christoph Zrenner, Brigitte Zrenner, Jamie D. Feusner, Susan L. Rossell, David Castle, Gwyneth Zai (2025). \textit{Psilocybin-assisted psychotherapy for treatment-resistant obsessive-compulsive disorder: protocol for an open-label pilot study}. BJPsych Open. [published; OpenAlex]. \href{https://doi.org/10.1192/bjo.2025.10895}{doi:10.1192/bjo.2025.10895}.
\item Unknown authors (2025). \textit{Age and cannabis co-use are associated with differences in experience and perceived benefits of psilocybin: a retrospective study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/dczw2\_v2}{source link}.
\item T. H. W. Ching, B. Stahnke, S. Shnayder, G. Agin-Liebes, T. G. Adams, L. Amoroso, O. Baiz, A. Belser, C. Bohner, M. Burke, E. D’Amico, G. DePalmer, J. Eilbott, G. Fram, R. Grazioplene, J. Hokanson, A. Jankovsky, S. A. Kichuk, B. Martins, P. Purohit, H. Schaer, Y. P. Sierra, C. Witherow, C. Pittenger, B. Kelmendi (2025). \textit{Acute and post-dosing effects of single-dose psilocybin for obsessive-compulsive disorder in a randomized, double-blind, placebo-controlled trial: an interpretative phenomenological analysis}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2025.1726818}{doi:10.3389/fpsyt.2025.1726818}.
\item Gerasimos Konstantinou, Joshua D. Rosenblat, Sarah Hales, Muhammad Ishrat Husain, Daniel M. Blumberger (2025). \textit{Psilocybin in late-life mental health: Addressing depression, loneliness, and existential anxiety}. General Hospital Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.genhosppsych.2025.12.005}{doi:10.1016/j.genhosppsych.2025.12.005}.
\item Namik Kirlić, Merve Atli, Sunil Mistry, Michael Gold, Guy M. Goodwin (2025). \textit{The Relationship Between Participant Pretreatment Clinical Presentation and the Quality of Psilocybin Experience}. Journal of Clinical Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1097/jcp.0000000000002119}{doi:10.1097/jcp.0000000000002119}.
\item Reid MR, Song J, Boehnke KF, Buchanan NT, Aday JS. (2025). \textit{Disengaged: A systematic review of community engagement in psychedelic-assisted therapy research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2025.106516}{doi:10.1016/j.neubiorev.2025.106516}.
\item Imperial College London (2025). \textit{Investigating the Effects of a Psychedelic-augmented Mental Imagery-based Intervention for Young People With Self-harm Behaviour: an Experimental Medicine Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06798636}{source link}.
\item Taslim Uddin, Suma Akter, Kanak Yadab Ghosh (2025). \textit{Psychedelics as neuroplasticity enhancers: Mechanisms, therapeutic applications, and translational challenges}. Advanced Neurology. [published; OpenAlex]. \href{https://doi.org/10.36922/an025410095}{doi:10.36922/an025410095}.
\item University of British Columbia (2025). \textit{Standardized Natural Psilocybin-assisted Psychotherapy for Tapering of Opioid Medication in Patients With Chronic Pain: an Open-label Feasibility Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05585229}{source link}.
\item NYU Langone Health (2025). \textit{A Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Effects of Psilocybin-assisted Psychotherapy on Psychiatric and Existential Distress in Advanced Cancer}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05398484}{source link}.
\item Dodds C, Dawson R, Lim A, Tye S, Nasrallah F. (2025). \textit{Novel psychedelic interventions for post-traumatic stress disorder and their promise for precision medicine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/20451253251396255}{doi:10.1177/20451253251396255}.
\item Morris Lintong Barimbing, Dian Pritasari Jeger, Made Edwin Sridana (2025). \textit{Efficacy of psilocybin on death anxiety in terminal patients: a narrative review}. Progress in Palliative Care. [published; OpenAlex]. \href{https://doi.org/10.1080/09699260.2026.2657096}{doi:10.1080/09699260.2026.2657096}.
\item S. Fereydouni (2025). \textit{Psilocybin and Neuroplasticity: Mechanisms, Therapeutic Potential, and Future Directions}. Emerging Trends in Drugs Addictions and Health. [published; OpenAlex]. \href{https://doi.org/10.1016/j.etdah.2025.100215}{doi:10.1016/j.etdah.2025.100215}.
\item Nadav Liam Modlin, Victoria Williamson, Guy M. Goodwin, Ekaterina Malievskaia, Merve Atli, Zsofia Elek, Alice Gaillard, Don Koelpin, Anthony J. Cleare, Manish Agrawal, Rachel Yehuda, Namik Kirlić, James Rucker (2025). \textit{Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatment}. EClinicalMedicine. [published; OpenAlex]. \href{https://doi.org/10.1016/j.eclinm.2025.103692}{doi:10.1016/j.eclinm.2025.103692}.
\item Julian Kiverstein, Hüseyin Beyköylü, Michiel van Elk (2025). \textit{A causal pluralist theory of the interaction of substance, set and setting in psychedelic experience}. Philosophical Psychology. [published; OpenAlex]. \href{https://doi.org/10.1080/09515089.2025.2590741}{doi:10.1080/09515089.2025.2590741}.
\item University College, London (2025). \textit{Digital Intervention for Psychedelic Preparation (DIPP): A Randomised Controlled Feasibility Trial Comparing Meditation and Music-Based Programs in Healthy Volunteers.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06815653}{source link}.
\item Van Ameringen M, Patel V, Patterson B, Hopkinson P, Rahat M. (2025). \textit{New treatments for OCD? Evidence for cannabinoids and psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jpsychires.2025.11.021}{doi:10.1016/j.jpsychires.2025.11.021}.
\item Sana Rasheed, Rida Arif, Ahmed Asad Raza, Abedin Samadi (2025). \textit{Advancing treatment paradigms: the role of psilocybin in managing major depressive disorder}. Annals of Medicine and Surgery. [published; OpenAlex]. \href{https://doi.org/10.1097/ms9.0000000000004349}{doi:10.1097/ms9.0000000000004349}.
\item Alaina M. Jaster, Thomas M Hadlock, Belle Buzzi, Jessica L. Maltman, Gabriella Silva, Somdatta Saha, Eda Köşeli, Abby M Pondelick, Nikita Thakur, Xin Zhang, Gaoshan Li, Sandra Ledesma-Corvi, K. Moore, Hannah R. Peterson, Barbara Fujita, Alexia L. Zylko, Melissa J. Lewis, Justin L. Poklis, Matthew S. Halquist, Jennifer T. Wolstenholme, Dana E. Selley, Peter J. Hamilton, Chang Lu, M. Imad Damaj, Javier González-Maeso (2025). \textit{Sex-specific role of the 5-HT2A receptor in psilocybin-induced extinction of opioid reward}. Nature Communications. [published; OpenAlex]. \href{https://doi.org/10.1038/s41467-025-64887-w}{doi:10.1038/s41467-025-64887-w}.
\item Silvia Natoli, Arturo Cuomo, Maurizio Marchesini, Livio Luongo, Giuliano Lo Bianco, Vittorio Guardamagna, Shigeki Yamaguchi (2025). \textit{Psilocybin and Chronic Pain: A New Perspective for Future Pain Therapists?}. Medical Sciences. [published; OpenAlex]. \href{https://doi.org/10.3390/medsci13040277}{doi:10.3390/medsci13040277}.
\item Beersheva Mental Health Center (2025). \textit{Open Label, Phase 2 Study for Evaluating the Feasibility, Safety and Efficacy of Psychotherapy Assisted Psilocybin for Treatment of Severe Obsessive Compulsive Disorder (OCD) in Drug and/or Psychotherapy Resistant Patients.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04882839}{source link}.
\item Tony R. Montgomery, DeMond M. Grant (2025). \textit{Psychedelic Rejuvenation Hypothesis: A Framework for Cellular and Psychological Restoration}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.31124/advance.175630073.36585408/v2}{doi:10.31124/advance.175630073.36585408/v2}.
\item Marieke Martens, Bruna Giribaldi Cunha, David Erritzøe, David Nutt, Robin Carhart-Harris, Catherine J. Harmer (2025). \textit{Negative affective bias in depression following treatment with psilocybin or escitalopram - a secondary analysis from a randomized trial}. Translational Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41398-025-03693-w}{doi:10.1038/s41398-025-03693-w}.
\item Hannah M. Kramer, Meghan Hibicke, Jason W. Middleton, Alaina M. Jaster, Jesper L. Kristensen, Charles D. Nichols (2025). \textit{Psychedelics produce enduring behavioral effects and functional plasticity through mechanisms independent of structural plasticity}. Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1038/s41386-025-02272-3}{doi:10.1038/s41386-025-02272-3}.
\item Sian Lewis (2025). \textit{‘Magic’ mechanisms underlie psilocybin’s effects in chronic pain}. Nature reviews. Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1038/s41583-025-00999-y}{doi:10.1038/s41583-025-00999-y}.
\item Nicky J. Mehtani, Maha N. Mian, Gabrielle Agin-Liebes, Allison R. Coker, Christopher Huebner, B. Anderson, Jennifer Mitchell (2025). \textit{Psychedelic Augmentation of 12-Step Engagement: A Novel, Accessible Approach to Enhance Community-Based Recovery from Substance Use Disorders}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2025.2583960}{doi:10.1080/02791072.2025.2583960}.
\item Sarah N. Magee, Allison C. Sereno, Maria Echeveste-Sanchez, Elizabeth G. Shannon, Abir Mohsin, Sarah E. Mott, Sara Faccidomo, Clyde W. Hodge, Melissa A. Herman (2025). \textit{The Psychedelic Psilocin Suppresses Activity of Central Amygdala Corticotropin-Releasing Factor Receptor 1 Neurons and Decreases Ethanol Drinking in Female Mice}. Journal of Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1523/jneurosci.0652-25.2025}{doi:10.1523/jneurosci.0652-25.2025}.
\item Zech JM, Richard J, Jones GM (2025). \textit{The Relationship Between Psychedelic Use and Alcohol Use Disorder in a Nationally Representative Sample.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2025.2583967}{doi:10.1080/02791072.2025.2583967}.
\item Allohverdi SG, Soltanzadeh M, Schmidt A, Charlton CE, Hauke DJ, Karvelis P, Vollenweider FX, Diaconescu AO. (2025). \textit{Ketamine and Psilocybin Differentially Impact Sensory Learning During the Mismatch Negativity}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.11.06.687023}{doi:10.1101/2025.11.06.687023}.
\item Mennenga S, Hanson T, Semple M, Lifshitz D, Flores B, Balducci J, Harker S, Ford A, Lewis C. (2025). \textit{Psilocybin reduces depressive-like behavior and improves cognition in healthy aging mice via epigenetic regulation of plasticity- and immune-related genes}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-7890051/v1}{doi:10.21203/rs.3.rs-7890051/v1}.
\item Cui Guo, Nguyen N T Luu, Maryem M Adwer, Hamed Hosseinzadeh, Venkatesh Balan, Yajun Yan, Yuheng Lin (2025). \textit{Engineering artificial biosynthetic pathways for efficient microbial production of psilocybin and psilocin}. Metabolic Engineering. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ymben.2025.11.002}{doi:10.1016/j.ymben.2025.11.002}.
\item Richard Drexler, Belgin Yalçın, Rebecca Mancusi, Abigail Rogers, Kiarash Shamardani, Pamelyn J. Woo, Alexandre Ravel, Yahaya A Yabo, Carlos Alberto Oliveira de Biagi-Junior, Costanza Lo Cascio, Robert C. Malenka, Boris D. Heifets, Mariella G. Filbin, Dieter Henrik Heiland, Karl Deisseroth, Michelle Monje (2025). \textit{CNSC-36. PSILOCYBIN INDUCES SUSTAINED GLIOMA GROWTH THROUGH SEROTONERGIC AND TRKB PATHWAYS}. Neuro-Oncology. [published; OpenAlex]. \href{https://doi.org/10.1093/neuonc/noaf201.0244}{doi:10.1093/neuonc/noaf201.0244}.
\item Moujaes F, Rieser NM, Belinger L, Herdener M, Zahid Z, Preller KH (2025). \textit{The emotional architecture of the psychedelic brain.}. Trends in cognitive sciences. [published; PubMed]. \href{https://doi.org/10.1016/j.tics.2025.07.006}{doi:10.1016/j.tics.2025.07.006}.
\item Rahmani S, Crupi R, Riley AL, Davidson T (2025). \textit{The therapeutic use of psychedelic drugs: Legal, policy, and neuroscientific perspectives.}. Pharmacology, biochemistry, and behavior. [published; PubMed]. \href{https://doi.org/10.1016/j.pbb.2025.174087}{doi:10.1016/j.pbb.2025.174087}.
\item Washington University School of Medicine (2025). \textit{Precision Functional Brain Mapping to Understand the Mechanisms of Psilocybin}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04501653}{source link}.
\item d'Andrea G, Chiappini S, Ciavoni L, Tucci R, Martino F, Semeraro FM, Di Battista D, Mosca A, Miuli A, Di Carlo F, Russo M, Di Petta G, Fornaro M, Pettorruso M, Sensi SL, Martinotti G. (2025). \textit{Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changes.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-025-03654-3}{doi:10.1038/s41398-025-03654-3}.
\item Ohio State University (2025). \textit{A Randomized, Double-Blind, Placebo-Controlled Mechanistic Study to Assess a Single Oral Dose of CYB003 in Participants With Major Depressive Disorder (MDD) and Moderate to Severe Anxiety}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06820723}{source link}.
\item Pu Jiang, Cong Lin, Xiaohui Wang (2025). \textit{Psychedelics and time: Exploring altered temporal perception and its implications for consciousness, neuroscience, and therapy}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp025p.0041}{doi:10.61373/pp025p.0041}.
\item Martin HM, Cofre R, Destexhe A. (2025). \textit{Simulated 5-HT2A receptor activation accounts for the high complexity of brain activity during psychedelic states}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.10.20.683366}{doi:10.1101/2025.10.20.683366}.
\item de Oliveira AL, de Oliveira DP, Dos Santos RG, Hallak JEC. (2025). \textit{Psychedelic-induced behavioral and developmental effects on zebrafish: a systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111534}{doi:10.1016/j.pnpbp.2025.111534}.
\item Gabriele M. König, Li-Ming Hsu, Yi-Ting Chiu, Gavin P. Schmitz, Martin MacKinnon, Yen-Yu I. Shih, Bryan L. Roth, Sarah N. Magee, Evi Kostenis, Melissa A. Herman, Mia L. Foglesong (2025). \textit{Psychedelic compounds directly excite 5-HT2A layer V medial prefrontal cortex neurons through 5-HT2A Gq activation}. UNC Libraries. [published; OpenAlex]. \href{https://doi.org/10.17615/ce6e-4888}{doi:10.17615/ce6e-4888}.
\item Wong S, Jones BDM, Thiyagarajah MT, Sabbah SG, Thompson C, Solmi M, Umer M, Zrenner C, Voineskos D, Rosenblat JD, Mulsant BH, Blumberger DM, Husain MI. (2025). \textit{Biological markers of treatment response to serotonergic psychedelic therapies: a systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/20451253251384513}{doi:10.1177/20451253251384513}.
\item David J. Heal, Jane Gosden, Sharon L. Smith (2025). \textit{Mind the gap! Addressing unresolved aspects of abuse potential evaluation and scheduling of classic and novel psychedelic drugs}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811251382147}{doi:10.1177/02698811251382147}.
\item Shadani S, Greaves E, Andrews ZB, Foldi CJ. (2025). \textit{Psilocybin exerts differential effects on social behaviour and inflammation in mice in contexts of activity-based anorexia (ABA)}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.10.14.682467}{doi:10.1101/2025.10.14.682467}.
\item Sha Jin, H.Y. Wang, Xiaohui Wang (2025). \textit{Psychedelics in the context of stress and psychiatric disorders: A new horizon in mental health treatment}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp025v.0038}{doi:10.61373/pp025v.0038}.
\item Johns Hopkins University (2025). \textit{Psilocybin and Affective Function in Chronic Lower Back Pain Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06355414}{source link}.
\item Renee Ireland (2025). \textit{Psychedelics in Practice: Science, Safety, and the Future of Healing}. The proceedings of sliit international conference on advancements in science and humanities. [published; OpenAlex]. \href{https://doi.org/10.54389/epsd8792}{doi:10.54389/epsd8792}.
\item Johansen A, Plavén-Sigray P, Madsen MK, Søndergaard A, Messel C, Geisler M, Nasser A, McCulloch DE, Beliveau V, Vassilieva A, Lund A, Lehel S, Ozenne B, Stenbæk DS, Fisher PM, Svarer C, Knudsen GM. (2025). \textit{Psilocybin’s effect on human brain synaptic plasticity}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-7469144/v1}{doi:10.21203/rs.3.rs-7469144/v1}.
\item Renner AC, Kargbo RB. (2025). \textit{Stabilizing Psilocybin Pharmacology and Tuning Safety with Atypical Antipsychotic Cotherapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.5c00595}{doi:10.1021/acsmedchemlett.5c00595}.
\item M Loganathan, A Saravanakumar, P. Parthiban, G Anandharaj, S Gobika, D Dharshana, Mohamed Safir Ali (2025). \textit{Neurobiological and Therapeutic Potential of Psilocybin in Psychiatric Disorders}. Journal of Pharma Insights and Research.. [published; OpenAlex]. \href{https://doi.org/10.69613/thv1dn30}{doi:10.69613/thv1dn30}.
\item Ahmad Hammo, Stephen Wisser, Joseph Cichon (2025). \textit{Single-dose psilocybin rapidly and sustainably relieves allodynia and anxiodepressive-like behaviors in mouse models of chronic pain}. Nature Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1038/s41593-025-02068-0}{doi:10.1038/s41593-025-02068-0}.
\item Anneliese McConnell, Wei He, Harry McConnell, Sandro Sprendei, Paul F. Sowman (2025). \textit{3642 Down the rabbit hole: case reports of a hallucinogen-induced disorder of neuroperception}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.1136/bmjno-2025-anzan.170}{doi:10.1136/bmjno-2025-anzan.170}.
\item Courtney Y, Anderson JM, Lagares-Linares C, Wenthur CJ, Lehtinen MK. (2025). \textit{Gestational LSD exposure in mouse rapidly reaches embryonic CSF and is associated with altered choroid plexus signaling, cerebral cortical development, and offspring behavior}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.09.30.677638}{doi:10.1101/2025.09.30.677638}.
\item Egger, Klemens, Meling, Daniel, Polat, Firuze, Seifritz, Erich, Avram, Mihai, Scheidegger, Milan (2025). \textit{Meditation, psychedelics, and brain connectivity: A randomized controlled resting-state fMRI study of N,N-dimethyltryptamine and harmine in a meditation retreat}. Universität Zürich, ZORA. [published; OpenAlex]. \href{https://doi.org/10.5167/uzh-280470}{doi:10.5167/uzh-280470}.
\item University of Southern California (2025). \textit{An Exploratory Study of Feasibility, Efficacy, and Mechanisms of Mindfulness-Assisted Psychedelic Therapy}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06233344}{source link}.
\item Dorczok MC, Mittmann G, Ettl T, Steiner-Hofbauer V. (2025). \textit{Psilocybin-assisted psychotherapy in adults with depression - A literature review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111508}{doi:10.1016/j.pnpbp.2025.111508}.
\item Hunt T. (2025). \textit{Electrodynamics of the Psychedelic Experience}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202509.1813.v1}{doi:10.20944/preprints202509.1813.v1}.
\item Tim Schäfer, Fabian Haun, Bernhard Rupp, Dirk Hoffmeister (2025). \textit{Dissimilar Reactions and Enzymes for Psilocybin Biosynthesis in Inocybe and Psilocybe Mushrooms}. Angewandte Chemie International Edition. [published; OpenAlex]. \href{https://doi.org/10.1002/anie.202512017}{doi:10.1002/anie.202512017}.
\item Delgado-Sallent C, Ahmed SA, Khawaja-Lopez A, Lee BS, Senne R, Scott BB, Ramirez S. (2025). \textit{Psychedelics Relax Priors and Reshape Orbitofrontal Dynamics}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.09.18.677110}{doi:10.1101/2025.09.18.677110}.
\item Anastasia Calin, Ana Flavia Burlec, Cornelia Mircea, Irina Macovei, Monica Hăncianu, Andreia Corciovă (2025). \textit{Evolution and Comparative Analysis of Clinical Trials on Psilocybin in the Treatment of Psychopathologies: Trends in the EU and the US}. Journal of Clinical Medicine. [published; OpenAlex]. \href{https://doi.org/10.3390/jcm14186613}{doi:10.3390/jcm14186613}.
\item Askey T, Allen-Ross D, Luzyanin D, Lasrado R, Gilmour G, Hunt SP, Tamagnini F, Ahmed M, Stephens GJ, Maiarú M. (2025). \textit{Psilocybin ameliorates neuropathic pain-like behaviour in mice and facilitates gabapentin-mediated analgesia}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.09.15.676273}{doi:10.1101/2025.09.15.676273}.
\item Sonda S, Pendin D, Comai S, De Martin S, Manfredi P, Mattarei A. (2025). \textit{Emerging mechanisms of psilocybin-induced neuroplasticity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.tips.2025.08.012}{doi:10.1016/j.tips.2025.08.012}.
\item Sabbah SG, Li S, Wong S, Le GH, Badulescu S, Hawco C, Rosenblat JD, McIntyre RS. (2025). \textit{Temporal dynamics in neuroimaging as correlates of therapeutic response to psilocybin in major depressive disorder: A systematic review and critical appraisal.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2025.120335}{doi:10.1016/j.jad.2025.120335}.
\item Emma M. Bonniwell (14267047), Rana Alabdali (22241286), Joseph J. Hennessey (22241289), John L. McKee (22179170), Natalie G. Cavalco (20388684), Josie C. Lammers (22241292), Ethan J. Moore (22241295), Luca Franchini (10578054), Cesare Orlandi (204175), John D. McCorvy (1416910) (2025). \textit{Serotonin 5-HT2C Receptor SignalingAnalysis Reveals Psychedelic Biased Agonism}. Figshare. [published; OpenAlex]. \href{https://doi.org/10.1021/acschemneuro.5c00647.s001}{doi:10.1021/acschemneuro.5c00647.s001}.
\item Bonniwell EM, Alabdali R, Hennessey JJ, McKee JL, Cavalco NG, Lammers JC, Moore EJ, Franchini L, Orlandi C, McCorvy JD. (2025). \textit{Serotonin 5-HT2C Receptor Signaling Analysis Reveals Psychedelic Biased Agonism.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.5c00647}{doi:10.1021/acschemneuro.5c00647}.
\item Masjedi NS, Razi A. (2025). \textit{Effective connectivity of the human claustrum: Triple networks, subcortical circuits, and psychedelic modulation}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.09.07.674759}{doi:10.1101/2025.09.07.674759}.
\item Chwyl C, Spata A, Lucas W, Luoma JB. (2025). \textit{Mindset Over Molecule: Comparing Self-Transcendent and Mystical Experiences Across Recreational Psilocybin, MDMA, and Cannabis Use}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-7266162/v1}{doi:10.21203/rs.3.rs-7266162/v1}.
\item Jakub Vohryzek, Andrea I. Luppi, Selen Atasoy, Gustavo Deco, Robin Carhart-Harris, Christopher Timmermann, Morten L. Kringelbach (2025). \textit{N,N-dimethyltryptamine effects on connectome harmonics, subjective experience and comparative psychedelic experiences}. Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1038/s41386-025-02190-4}{doi:10.1038/s41386-025-02190-4}.
\item Tereza Dleštíková (2025). \textit{The Legal Perspective on Psilocybin for Medical Use in Czechia: A Key Milestone and the Case for Broader Consideration Beyond the Clinical Setting}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4030034}{doi:10.3390/psychoactives4030034}.
\item John A. Razidlo, Noelle Cataldo, Cody J. Wenthur (2025). \textit{Psilocybin Enhances Cued Fear Extinction and Extinction Recall in Stress-Naïve, Acutely Stressed, and Chronically Stressed Mice}. ACS Pharmacology \& Translational Science. [published; OpenAlex]. \href{https://doi.org/10.1021/acsptsci.5c00462}{doi:10.1021/acsptsci.5c00462}.
\item Alan K. Davis, Meghan DellaCrosse, Nathan D. Sepeda, Adam W. Levin, Mary P Cosimano, Hillary Shaub, Washington Taylor, Peter M. Gooch, Shoval Gilead, Skylar J. Gaughan, Stacey B. Armstrong, Frederick S. Barrett (2025). \textit{Five-year outcomes of psilocybin-assisted therapy for Major Depressive Disorder}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2025.00461}{doi:10.1556/2054.2025.00461}.
\item Andrade FRT, Buchborn T, Thalheimer G, Meinhardt MW, Joca S, de Almeida RMM. (2025). \textit{Therapeutic Use of Psilocybin in Depression: a Systematic Review of Clinical Evidence.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/neu.2025.10039}{doi:10.1017/neu.2025.10039}.
\item Georgios Mikellides, Marios Kyriazis (2025). \textit{Psychedelics and mental health: reimagining care through science, insight, and compassion}. Frontiers in Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.3389/fphar.2025.1649929}{doi:10.3389/fphar.2025.1649929}.
\item Gregor Hasler (2025). \textit{Gregor Hasler: Three Guiding Questions - How do psychedelics shape the brain? How can they heal psychiatric disorders such as depression and PTSD? How can we ensure their safe and responsible use?}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp025k.0032}{doi:10.61373/pp025k.0032}.
\item M Mercier, Cédric Mabilais, Vasileios Chytas, Leonice Furtado, Federico Seragnoli, Albert Buchard, Tatiana Aboulafia Brakha, Gabriel Thorens, Daniele Zullino, Louise Penzenstadler (2025). \textit{Psilocybin-Assisted Psychotherapy for Chronic Somatoform Pain Disorder: A Case Report}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4030030}{doi:10.3390/psychoactives4030030}.
\item Anna Blazhkova, Magdalena Czaja, Hanna Sitka, Sven Solisch, Anna Susłow, Ewa Szczęsna (2025). \textit{PSYCHEDELICS IN PSYCHIATRY - OVERVIEW OF PSILOCYBIN RESEARCH}. International Journal of Innovative Technologies in Social Science. [published; OpenAlex]. \href{https://doi.org/10.31435/ijitss.3(47).2025.3650}{doi:10.31435/ijitss.3(47).2025.3650}.
\item Sudhakaran G, Chakraborty S, Aung San, Bharti SAK, Csaba V, Valan Arasu M, Namasivayam SKR, Arockiaraj J. (2025). \textit{Biochemical Insights into Diverse Psilocybe Mushrooms and Their Metabolites as Sources of Neuroactive Agents: A Review}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/AGR/IND609227368}{source link}.
\item McCoy K, Reed F, Conn K, Foldi CJ. (2025). \textit{Separate or inseparable? Serotonin and dopamine system interactions may underlie the therapeutic potential of psilocybin for anorexia nervosa}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/AGR/IND609297819}{source link}.
\item Tony Montgomery, DeMond M. Grant (2025). \textit{Psychedelic Rejuvenation Hypothesis: A Framework for Cellular and Psychological Rejuvenation}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.31124/advance.175630073.36585408/v1}{doi:10.31124/advance.175630073.36585408/v1}.
\item Drewko AJ, Habets RLP, Brunt TM. (2025). \textit{Above the threshold, beyond the trip: the role of the 5-HT2A receptor in psychedelic-induced neuroplasticity and antidepressant effects.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-025-03169-9}{doi:10.1038/s41380-025-03169-9}.
\item Greaves MD, Barta T, Novelli L, Stoliker D, Razi A. (2025). \textit{Context-dependent structurally informed effective connectivity under psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.08.18.671000}{doi:10.1101/2025.08.18.671000}.
\item Bilenker D, Avena NM. (2025). \textit{Psychedelics and the Serotonin Hypothesis of Eating Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/brainsci15080893}{doi:10.3390/brainsci15080893}.
\item James J Gattuso, Geraldine Kong, Bilgenur Bezcioglu, Da Lu, Millicent N. Ekwudo, Carey Wilson, Carolina Gubert, Anthony J. Hannan, Thibault Renoir (2025). \textit{Chronic psilocybin administration increases sociability and alters the gut microbiome in male wild-type mice but not in a preclinical model of obsessive-compulsive disorder}. Neuropharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neuropharm.2025.110648}{doi:10.1016/j.neuropharm.2025.110648}.
\item Centre Hospitalier Universitaire de Nīmes (2025). \textit{Effect of Psilocybin on the Positive Valence System in Treatment-resistant Depression: a Pilot Clinical Neuroimaging Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06650800}{source link}.
\item Maxwell B. Madden, Chloe Schaefgen, Binita Vedak, Jian Kwon, Kiara S. Dresp Pedra, Samuel H. Sheats, Adam C. Puché, Steffen B. E. Wolff, Brian N. Mathur (2025). \textit{Serotonin and psilocybin activate 5-HT1B receptors to suppress cortical signaling through the claustrum}. Nature Communications. [published; OpenAlex]. \href{https://doi.org/10.1038/s41467-025-62980-8}{doi:10.1038/s41467-025-62980-8}.
\item Garcia ACM, Maia LO. (2025). \textit{Psychedelic-assisted therapies for existential and spiritual suffering in palliative care.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.pbr.2025.07.002}{doi:10.1016/bs.pbr.2025.07.002}.
\item Hughes B, Mirza S, Ponamala M, Sagaser J, Paredes R, Hematillake N, Tailor C, Khan R, Pemminati S. (2025). \textit{Exploring the Therapeutic Potential of Ketamine and Psilocybin in Comparison to Current Treatment Regimens for Treatment-Resistant Depression, Mood Disorders, and Post-traumatic Stress Disorder in the Pediatric Population: A Narrative Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.90425}{doi:10.7759/cureus.90425}.
\item Silczuk A, Madejek RJ, Koweszko T, Mularczyk-Tomczewska P, Adamska E, Gujski M, Szulc A. (2025). \textit{Psychedelic-Assisted Therapy: Potential Benefits and Challenges in Mental Health Treatment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.12659/msm.948302}{doi:10.12659/msm.948302}.
\item Harsha S. Krishna (2025). \textit{Intersecting Psychedelic Pharmacology and Gut-Brain Axis Signaling in Neurodegenerative Disorders}. JUNIOR RESEARCHERS. [published; OpenAlex]. \href{https://doi.org/10.52340/jr.2025.03.03.09}{doi:10.52340/jr.2025.03.03.09}.
\item Rebolledo-Pérez L, Hernández-Bello J, Martínez-Ramos A, Castañeda-Arellano R, Fernández-Quezada D, Sandoval-García F, Aguilar-García IG. (2025). \textit{Substance Abuse and Cognitive Decline: The Critical Role of Tau Protein as a Potential Biomarker.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms26157638}{doi:10.3390/ijms26157638}.
\item Wang X, Jun F, Lin C, Wang X (2025). \textit{Psychedelics and the Gut Microbiome: Unraveling the Interplay and Therapeutic Implications.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.5c00418}{doi:10.1021/acschemneuro.5c00418}.
\item Dotun Adeleye Adeyinka, Dayna Forsyth, Suzanne Currie, Nicoletta Faraone (2025). \textit{Neurobiology of psilocybin: a comprehensive overview and comparative analysis of experimental models}. Frontiers in Systems Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.3389/fnsys.2025.1585367}{doi:10.3389/fnsys.2025.1585367}.
\item Unknown authors (2025). \textit{Response to emotional stimuli weaker in SSRI users compared with psilocybin}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.31349}{doi:10.1002/pu.31349}.
\item Małgorzata Wierzbicka, Renata Kopczyk, Aleksandra Gerlach, Joanna Rymaszewska (2025). \textit{Therapeutic and legal aspects of psilocybin in cancer-related depression}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2025.1591864}{doi:10.3389/fpsyt.2025.1591864}.
\item Hiroe Tani (2025). \textit{577. CLINICAL EVIDENCE AND APPLICATIONS OF PSYCHEDELICS FOR MENTAL ILLNESSES}. The International Journal of Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1093/ijnp/pyaf052.377}{doi:10.1093/ijnp/pyaf052.377}.
\item Argel Aguilar-Valles, Dhiral Kot, Victor Lewis, Gianfilippo Coppola (2025). \textit{544. MOLECULAR AND CELLULAR MECHANISMS OF THE LONG-LASTING EFFECTS OF PSYCHEDELICS AND THEIR NON-HALLUCINOGENIC DERIVATIVES}. The International Journal of Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1093/ijnp/pyaf052.363}{doi:10.1093/ijnp/pyaf052.363}.
\item Unknown authors (2025). \textit{564. TOWARD AN UNDERSTANDING OF THE THERAPEUTICALLY RELEVANT MECHANISMS OF PSILOCYBIN FOR ANOREXIA NERVOSA}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359394}{source link}.
\item Adebo M, Bonnet M, Laouej O, Defaix C, McGowan JC, Butlen-Ducuing F, David DJ, Poupon E, Tritschler L, Gardier AM. (2025). \textit{Psilocybin as Transformative Fast-Acting Antidepressant: Pharmacological Properties and Molecular Mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/fcp.70038}{doi:10.1111/fcp.70038}.
\item Zirkel RT, Isaacson M, Liao C, Yi M, Yamaguchi K, Rivera D, Kuceyeski A, Nishimura N, Kwan AC, Schaffer CB. (2025). \textit{Psilocybin Prolongs the Neurovascular Coupling Response in Mouse Visual Cortex}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.07.25.666803}{doi:10.1101/2025.07.25.666803}.
\item Heidi Allen, B. Stott (2025). \textit{Preparing Social Work for Psychedelic-Assisted Therapy}. Social Work. [published; OpenAlex]. \href{https://doi.org/10.1093/sw/swaf031}{doi:10.1093/sw/swaf031}.
\item Egger K, Meling D, Polat F, Seifritz E, Avram M, Scheidegger M. (2025). \textit{Meditation, Psychedelics, and Brain Connectivity: A Randomised Controlled Resting-State fMRI Study of N,N-Dimethyltryptamine and Harmine in a Meditation Retreat}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2025.07.30.25332422}{doi:10.1101/2025.07.30.25332422}.
\item King's College London (2025). \textit{Modulation of Serotonin Pathways Using Psilocybin in Adults With and Without Autism Spectrum Disorder (ASD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05651126}{source link}.
\item Rudy LM, Godlewski MM. (2025). \textit{Molecular Pathways Potentially Involved in Hallucinatory Experiences During Sleep Paralysis: The Emerging Role of β-Arrestin-2.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms26157233}{doi:10.3390/ijms26157233}.
\item Askariyan K, Joghataei MT, Dehghan S, Nohesara S, Riahi Pour L, Mohammadi MH, Ahmadirad N. (2025). \textit{An overview of psilocybin, LSD, MDMA, and ketamine in revitalizing psychedelic-assisted therapy: Insights, limitations and future directions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111461}{doi:10.1016/j.pnpbp.2025.111461}.
\item Urban MM, Zillich L, Rieser NM, Herdener M, Vollenweider FX, Spanagel R, Preller KH, Meinhardt MW. (2025). \textit{Epigenome-wide Association Study of Psilocybin-Induced Methylome Changes in Alcohol Use Disorder}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.07.18.664368}{doi:10.1101/2025.07.18.664368}.
\item Kittur ME, Burgos M LA, Jones BDM, Blumberger DM, Mulsant BH, Rosenblat JD, Husain MI. (2025). \textit{Mapping psilocybin therapy: A systematic review of therapeutic frameworks, adaptations, and standardization across contemporary clinical trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2025.119952}{doi:10.1016/j.jad.2025.119952}.
\item Heller NH, Barrett FS, Buchborn T, Collerton D, Dupuis D, Halberstadt AL, Jardri R, Noorani TN, Preller KH, Taylor J, Waters F, Winston B, Leptourgos P. (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/7x8q4\_v3}{doi:10.31234/osf.io/7x8q4\_v3}.
\item Sudhakaran G, Chakraborty S, Kumar A, Bharti SAK, Csaba V, Valan Arasu M, Namasivayam SKR, Arockiaraj J. (2025). \textit{Biochemical Insights into Diverse Psilocybe Mushrooms and Their Metabolites as Sources of Neuroactive Agents: A Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00284-025-04379-8}{doi:10.1007/s00284-025-04379-8}.
\item Unknown authors (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/7x8q4\_v3}{source link}.
\item Plummer Z, Allen J, Brand J, Mayo LM, Shultz SR, Christie BR. (2025). \textit{Examining the potential of psilocybin and 5-MeO-DMT as therapeutics for traumatic brain injury.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111448}{doi:10.1016/j.pnpbp.2025.111448}.
\item Glenn DL, Choi SH, Zimmerman RS. (2025). \textit{A systematic review and narrative summary of the therapeutic potential of classic serotonergic psychedelics for smoking cessation and reduction.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811251353251}{doi:10.1177/02698811251353251}.
\item Miller EA, Capone C, Eaton E, Swift RM, Haass-Koffler CL. (2025). \textit{Psychedelics for Alcohol Use Disorder: A Narrative Review with Candidate Mechanisms of Action.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40263-025-01199-z}{doi:10.1007/s40263-025-01199-z}.
\item Miyuan Zhang (21677016), Haojiang Zhai (21677019), Longwei Yang (21677022), Haohong Li (5164970), Xiaohui Wang (19899) (2025). \textit{The Medial PrefrontalCortex Modulates Psychedelic-likeEffects of Psilocin}. Figshare. [published; OpenAlex]. \href{https://doi.org/10.1021/acsptsci.5c00324.s001}{doi:10.1021/acsptsci.5c00324.s001}.
\item Kosuke Kato, Jennifer Kleinhenz, Yoon-Joo Shin, Cristian Coarfa, Ali John Zarrabi, Louise Hecker (2025). \textit{Psilocybin treatment extends cellular lifespan and improves survival of aged mice}. npj Aging. [published; OpenAlex]. \href{https://doi.org/10.1038/s41514-025-00244-x}{doi:10.1038/s41514-025-00244-x}.
\item Miyuan Zhang, Haiyan Zhai, Longwei Yang, Haohong Li, Xiaohui Wang (2025). \textit{The Medial Prefrontal Cortex Modulates Psychedelic-like Effects of Psilocin}. ACS Pharmacology \& Translational Science. [published; OpenAlex]. \href{https://doi.org/10.1021/acsptsci.5c00324}{doi:10.1021/acsptsci.5c00324}.
\item Park D, Lee G, Lee WG, Kim B, Lee Y, Kim JW. (2025). \textit{The therapeutic potential of psilocybin beyond psychedelia through shared mechanisms with ketamine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-025-03100-2}{doi:10.1038/s41380-025-03100-2}.
\item Tolle HM, Luppi AI, Lawn T, Roseman L, Nutt D, Carhart-Harris RL, Mediano PAM. (2025). \textit{Accurate and Interpretable Prediction of Antidepressant Treatment Response from Receptor-informed Neuroimaging}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.07.02.662710}{doi:10.1101/2025.07.02.662710}.
\item Luca Pellegrini, Naomi Fineberg, Sorcha O'Connor, Ana Maria Frota Lisbôa Pereira de Souza, Kate Godfrey, Sara Reed, Joseph Peill, Mairead Healy, Cyrus Rohani-Shukla, Hakjun Lee, Robin Carhart-Harris, Trevor W. Robbins, David Nutt, David Erritzøe (2025). \textit{Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study}. Comprehensive Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.comppsych.2025.152619}{doi:10.1016/j.comppsych.2025.152619}.
\item Carrithers BM, Roberts DE, Weiss BM, King JD, Carhart-Harris RL, Gordon AR, Pagni BA, Moreau M, Ross S, Zeifman RJ (2025). \textit{Exploring serotonergic psychedelics as a treatment for personality disorders.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2025.110413}{doi:10.1016/j.neuropharm.2025.110413}.
\item Beneš M, Páleníček T, Horáček J. (2025). \textit{What fMRI studies say about the nature of the psychedelic effect: a scoping review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fnins.2025.1606798}{doi:10.3389/fnins.2025.1606798}.
\item Ciszowski K, Ziaja A, Niedzielska-Andres E, Pomierny-Chamioło L. (2025). \textit{Natural hallucinogens of fungal and animal origin: action and potentialapplications - a narrative review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.24425/fmc.2025.156119}{doi:10.24425/fmc.2025.156119}.
\item Ryan M. Brudner, Erica Kaczmarek, Marc G. Blainey, Christian Schulz, Shakila Meshkat, Zoe Doyle, Orly Lipsitz, Hilary Offman, Rickinder Sethi, Geneva Weiglein, Roger S. McIntyre, Joshua D. Rosenblat (2025). \textit{Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depression}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811251346697}{doi:10.1177/02698811251346697}.
\item University of Minnesota (2025). \textit{Visual Surround Suppression and Perceptual Expectation Under Psilocybin}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04424225}{source link}.
\item Daroui D, Mastrostefano A, Davini F, Giuseppe G, Terracina S. (2025). \textit{The Emerging Use of Psilocybin in Adult Populations with Alcohol Use Disorder: A Scoping Review}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202506.1536.v1}{doi:10.20944/preprints202506.1536.v1}.
\item McCulloch DE, Larsen K, Johansen A, Reveles Jensen KH, Nykjaer CH, Holze F, Falck N, Neufeld VAB, Steenstrup E, Skov-Andersen PM, Spangaard A, Geisler M, Randrup PP, Jensen PS, Shulganov V, Johansen SS, Nielsen MKK, Andersen TL, Stenbaek DS, Svarer C, Fisher PM, Knudsen GM. (2025). \textit{Molecular, haemodynamic and functional effects of LSD in the human brain}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2025.06.17.25329677}{doi:10.1101/2025.06.17.25329677}.
\item Kyle T. Greenway, Nicolas Garel, Lê-Anh Dinh-Williams, Julien Thibault Lévesque, Mendel Kaelen, Vincent Dagenais-Beaulé, Sara de la Salle, David Erritzøe, Karl Looper, Gustavo Turecki, Soham Rej, Stéphane Richard-Devantoy (2025). \textit{The Music for Subanesthetic Infusions of Ketamine randomised clinical trial: ketamine as a psychedelic treatment for highly refractory depression}. The British Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/bjp.2025.102}{doi:10.1192/bjp.2025.102}.
\item Ying Zhang, Lei Yang, Qiuyu Zhang, Chao Li, Fuqiang Mao, Chuanjun Zhuo (2025). \textit{The molecular mechanisms through which psilocybin prevents suicide: evidence from network pharmacology and molecular docking analyses}. Translational Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41398-025-03410-7}{doi:10.1038/s41398-025-03410-7}.
\item Ines Erkizia-Santamaría, Igor Horrillo, Nerea Martínez-Álvarez, Daniel Pérez-Martínez, Guadalupe Rivero, Amaia M. Erdozain, J. Javier Meana, Jorge E. Ortega (2025). \textit{Evaluation of behavioural and neurochemical effects of psilocybin in mice subjected to chronic unpredictable mild stress}. Translational Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41398-025-03421-4}{doi:10.1038/s41398-025-03421-4}.
\item Luke Lanham, Alistair R. McTaggart, James R. Falconer (2025). \textit{Is there mush-room to improve the environmental sustainability of psilocybin production?}. Journal of CO2 Utilization. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jcou.2025.103137}{doi:10.1016/j.jcou.2025.103137}.
\item Modlin NL, Williamson V, Maggio C, Stubley J, Kirlic N, Cleare A, Rucker J. (2025). \textit{Clinical conceptualisation of PTSD in psilocybin treatment: disrupting a pre-determined and over-determined maladaptive interpretive framework.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/20451253251342319}{doi:10.1177/20451253251342319}.
\item William Roseby, Hannes Kettner, Leor Roseman, Meg J. Spriggs, Taylor Lyons, Joe Peill, Bruna Giribaldi, David Erritzøe, David Nutt, Robin Carhart-Harris (2025). \textit{Enhanced meaning in life following psychedelic use: converging evidence from controlled and naturalistic studies}. Frontiers in Psychology. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyg.2025.1580663}{doi:10.3389/fpsyg.2025.1580663}.
\item Czopek A, Jończyk J, Fryc M, Kluzik D, Zagórska A. (2025). \textit{Classic Psychedelics in Pain Modulation: Mechanisms, Clinical Evidence, and Future Perspectives.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.5c00152}{doi:10.1021/acschemneuro.5c00152}.
\item Matthew Hicks (2025). \textit{Low-Income Group Psilocybin Assisted Therapy for Depression: A Feasibility Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06372197}{source link}.
\item Brian M. Ross (2025). \textit{Leveraging psychedelic neuroscience to boost human creativity using artificial intelligence}. Frontiers in Artificial Intelligence. [published; OpenAlex]. \href{https://doi.org/10.3389/frai.2025.1589086}{doi:10.3389/frai.2025.1589086}.
\item Lashgari NA, Khalaji M, Rana P, Badrabadi F, Rahnama M, Nasoori H, Momeni Roudsari N, Khosravi Nia MM, Shafaroodi H. (2025). \textit{Psychedelics in the Treatment of Neurologic and Psychiatric Disorders: Coincidence or a New Point of View.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s12035-025-05097-9}{doi:10.1007/s12035-025-05097-9}.
\item Erin E. Mauney (2025). \textit{Erin Mauney: Psychedelics as modulators of the gut-brain interaction}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp025k.0020}{doi:10.61373/pp025k.0020}.
\item Berkovitch L, Fauvel B, Preller KH, Gaillard R. (2025). \textit{Neurocognitive effects of psilocybin: A systematic and comprehensive review of neuroimaging studies in humans.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2025.106239}{doi:10.1016/j.neubiorev.2025.106239}.
\item Joseph K, Collins J, Genovese T, Maxwell M, Lieberman JA, Osten P. (2025). \textit{Converging pathways: shared brain circuitry engaged by monoaminergic antidepressants, ketamine and psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.05.26.655791}{doi:10.1101/2025.05.26.655791}.
\item Vella Y, Syrová K, Petrušková A, Koutrouli I, Kútna V, Pala J, Šíchová K, Nikolič M, Mazoch V, Jurok R, Kuchař M, Bendová Z, Páleníček T. (2025). \textit{Effects of serotonergic psychedelics on synaptogenesis and immediate early genes expression - comparison with ketamine, fluoxetine and lithium.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811251338232}{doi:10.1177/02698811251338232}.
\item Salma Laabi, Claire LeMmon, Callie Vogel, M. Chacón, Víctor M. Jiménez (2025). \textit{Psilocybin and psilocin regulate microglial immunomodulation and support neuroplasticity via serotonergic and AhR signaling}. International Immunopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.intimp.2025.114940}{doi:10.1016/j.intimp.2025.114940}.
\item Nida Paracha (2025). \textit{Navigating Intentional and Attentional Practices for Healing Across Psychedelic and Biofield Settings: A Comparative Ethnographic Study}. Journal of Integrative and Complementary Medicine. [published; OpenAlex]. \href{https://doi.org/10.1089/jicm.2024.0713}{doi:10.1089/jicm.2024.0713}.
\item Stéphanie Knatz Peck, Timothy D. Brewerton, Hannah M. Fisher, Julie Trim, Samantha Shao, Nadav Liam Modlin, Jessie Kim, Daphna M. Finn, Walter H. Kaye (2025). \textit{Therapeutic emergence of dissociated traumatic memories during psilocybin treatment for anorexia nervosa}. Journal of Eating Disorders. [published; OpenAlex]. \href{https://doi.org/10.1186/s40337-025-01274-2}{doi:10.1186/s40337-025-01274-2}.
\item Johns Hopkins University (2025). \textit{Psilocybin-facilitated Smoking Cessation Treatment: A Pilot Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT01943994}{source link}.
\item Ines Erkizia-Santamaría, Nerea Martínez-Álvarez, Leyre Salinas-Novoa, J. Javier Meana, Jorge E. Ortega (2025). \textit{Role of endogenous serotonin in psychedelic-like effects of psilocybin in mice}. The International Journal of Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1093/ijnp/pyaf035}{doi:10.1093/ijnp/pyaf035}.
\item Vogt SB, Liechti ME. (2025). \textit{Clinical pharmacology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.irn.2025.02.003}{doi:10.1016/bs.irn.2025.02.003}.
\item Hooper J, Williams S, Mueller R, Hutchison K. (2025). \textit{Age and cannabis co-use moderate experience and perceived benefits of psilocybin}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/dczw2\_v1}{doi:10.31234/osf.io/dczw2\_v1}.
\item Unknown authors (2025). \textit{Age and cannabis co-use moderate experience and perceived benefits of psilocybin}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/dczw2\_v1}{source link}.
\item McCoy K, Reed F, Conn K, Foldi CJ. (2025). \textit{Separate or inseparable? Serotonin and dopamine system interactions may underlie the therapeutic potential of psilocybin for anorexia nervosa.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.physbeh.2025.114957}{doi:10.1016/j.physbeh.2025.114957}.
\item Kit A, Conway K, Makarowski S, O'Regan G, Allen J, Shultz SR, Bodnar TS, Christie BR. (2025). \textit{Can the gut-brain axis provide insight into psilocybin's therapeutic value in reducing stress?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.ynstr.2025.100732}{doi:10.1016/j.ynstr.2025.100732}.
\item Jake F. Hooper, Emily Gyongyosi, Kent E. Hutchison, Raeghan L. Mueller (2025). \textit{Aesthetic quality of psychedelic experience is linked to insight and psychological outcomes}. Frontiers in Psychology. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyg.2025.1533055}{doi:10.3389/fpsyg.2025.1533055}.
\item Abrahms ZN, Sen AK, Jones JA. (2025). \textit{Pathway engineering for the biosynthesis of psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.copbio.2025.103314}{doi:10.1016/j.copbio.2025.103314}.
\item Icahn School of Medicine at Mount Sinai (2025). \textit{Investigating the Role of Serotonin in the Mechanism of Action of Psilocybin in Patients With Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06592833}{source link}.
\item Wingert AM, Agnorelli C, Peill J, Reed S, Nutt DJ, Erritzoe D. (2025). \textit{Serotonergic psychedelics for depression: A comprehensive overview.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.irn.2025.04.009}{doi:10.1016/bs.irn.2025.04.009}.
\item Michael A. Wheeler (2025). \textit{Michael A. Wheeler: Psychedelics and neuroimmune circuits-what a strange trip, indeed}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp025k.0011}{doi:10.61373/pp025k.0011}.
\item Wang Z, Robbins B, Zhuang R, Bruggen Rv, Sandini T, Li X, Zhang Y. (2025). \textit{Psilocybin Mitigates Behavioral Despair and Cognitive Impairment in Treatment-resistant Depression Model using Wistar Kyoto Rats}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-5493661/v1}{doi:10.21203/rs.3.rs-5493661/v1}.
\item Kratina S, Strike C, Schwartz R, Nayfeh A, Jopling S, Lo C, Rush B. (2025). \textit{A protocol for a scoping review of variations among psychedelic interventions for psychological suffering associated with the end-of-life.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1371/journal.pone.0318343}{doi:10.1371/journal.pone.0318343}.
\item Hannes Kettner (2025). \textit{Psychedelic therapy as relational medicine: psychosocial mechanisms in clinical and naturalistic contexts}. Open MIND. [published; OpenAlex]. \href{https://doi.org/10.25560/125300}{doi:10.25560/125300}.
\item Logan Neitzke-Spruill, Caroline Beit, Jill O. Robinson, Nikita Singh, Srijith Kambala, Rishi Ramesh, Amy L. McGuire (2025). \textit{A landscape analysis of psychedelic retreat organizations advertising online}. PLoS ONE. [published; OpenAlex]. \href{https://doi.org/10.1371/journal.pone.0321648}{doi:10.1371/journal.pone.0321648}.
\item Vejmola Č, Šíchová K, Syrová K, Janečková L, Koudelka V, Tesař M, Nikolič M, Viktorinová M, Tylš F, Korčák J, Viktorin V, Kelemen E, Nekovářová T, Brunovský M, Horáček J, Kuchař M, Páleníček T. (2025). \textit{Cross-Species Evidence for Psilocin-Induced Visual Distortions: Apparent Motion Is Perceived by Both Humans and Rats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.bpsgos.2025.100524}{doi:10.1016/j.bpsgos.2025.100524}.
\item Denise C. Vidot, Amrit Baral, Bria-Necole Diggs, Ranya Marrakchi El Fellah, Kylee Krivijanski, Albert Garcia-Romeu, Winston De La Haye, Clarence Locklear, Girardin Jean-Louis (2025). \textit{0391 Racial/Ethnic Differences in Psychedelic Use and Sleep Satisfaction: Preliminary Findings from the Herbal Heart Study}. SLEEP. [published; OpenAlex]. \href{https://doi.org/10.1093/sleep/zsaf090.0391}{doi:10.1093/sleep/zsaf090.0391}.
\item Acero VP, Flatt TA, Gooch PM, Gaughan SJ, Levin AW, Davis AK (2025). \textit{From molecules to meaning: unpacking the antidepressant mechanisms of psychedelic drugs.}. Expert review of clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1080/17512433.2025.2515866}{doi:10.1080/17512433.2025.2515866}.
\item Rebecca Harding, Neomi Singer, Matthew B. Wall, Talma Hendler, David Erritzøe, David Nutt, Robin Carhart-Harris, Leor Roseman (2025). \textit{Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises}. Molecular Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41380-025-03035-8}{doi:10.1038/s41380-025-03035-8}.
\item Cummins BR, Billac GB, Nichols DE, Nichols CD. (2025). \textit{5-HT2A receptors: Pharmacology and functional selectivity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pharmr.2025.100059}{doi:10.1016/j.pharmr.2025.100059}.
\item Borgogna NC, Owen T, Petrovitch D, Vaughn J, Johnson DAL, Pagano LA, Aita SL, Hill BD. (2025). \textit{Incremental efficacy systematic review and meta-analysis of psilocybin-for-depression RCTs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-025-06788-w}{doi:10.1007/s00213-025-06788-w}.
\item Butler M, Bird C, Maggio C, Durden A, Modlin N, Campbell-Coker K, Edwards M, Pick S, Millman LM, Lowery E, Bhagavan C, Kanaan R, Golder D, Mildon B, Mehta M, Rucker J, Nicholson TR. (2025). \textit{Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol}. Wellcome Open Res. [preprint; Europe PMC]. \href{https://doi.org/10.12688/wellcomeopenres.22543.2}{doi:10.12688/wellcomeopenres.22543.2}.
\item Sean M. Viña (2025). \textit{Race and Gender Differences in the Moderating Relationship of Psychedelics on Stigma and Distress}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1089/psymed.2024.0021}{doi:10.1089/psymed.2024.0021}.
\item Godfrey K, Luan LX, Timmermann C. (2025). \textit{Effects of psychedelics on human oscillatory brain activity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.irn.2025.04.012}{doi:10.1016/bs.irn.2025.04.012}.
\item Artur Pałasz, Marta Pukowiec, Katarzyna Bogus, Aleksandra Suszka-Świtek, Łukasz Filipczyk, Kinga Mordecka-Chamera, John J. Worthington, Maria Sygidus, Adam Wojtas, Agnieszka Bysiek, Krystyna Gołembiowska (2025). \textit{Psilocybin and ketamine affect novel neuropeptides gene expression in the rat hypothalamus}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811251330783}{doi:10.1177/02698811251330783}.
\item Damian Świeczkowski, Aleksander Kwaśny, Michał Pruc, Zuzanna Gaca, Łukasz Szarpak, Wiesław Jerzy Cubała (2025). \textit{Regulatory Alignment of Psilocybin Clinical Trials in Major Depressive Disorder on ClinicalTrials.gov: A Cross-Sectional Analysis}. Pharmacopsychiatry. [published; OpenAlex]. \href{https://doi.org/10.1055/a-2529-7029}{doi:10.1055/a-2529-7029}.
\item Kevin Boehnke (2025). \textit{A Phase 2a, Open-label, Pilot Study to Assess the Safety and Efficacy of Psilocybin Administration in Concert With Psychotherapy Among Adult Patients With Fibromyalgia}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05128162}{source link}.
\item Arya Afrooghe, Elham Ahmadi, Ali Lesani, Mahya Soleymani Mehranjani, Mohammad Elahi, Mohammadreza Babaei, Maryam Shayan, Hamed Shafaroodi, Razieh Mohammad Jafari, Alireza Foroumadi, Mohammad Amin Manavi, Ahmad Reza Dehpour (2025). \textit{Psilocin alleviates acute itch in mice: possible involvement of 5-HT2A receptors and kynurenine pathway}. Naunyn-Schmiedeberg s Archives of Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00210-025-04152-5}{doi:10.1007/s00210-025-04152-5}.
\item Umbacia MA, Leon MX, Quintero JM, Castro LM, Paez V, Dodd S, Bustos RH. (2025). \textit{Exploring psilocybin's role in mental health and palliative medicine: a path to improved well-being.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/14728214.2025.2488786}{doi:10.1080/14728214.2025.2488786}.
\item Omidian H, Omidian A. (2025). \textit{The Emergence of Psilocybin in Psychiatry and Neuroscience.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ph18040555}{doi:10.3390/ph18040555}.
\item Jennifer Jones (2025). \textit{Harnessing neuroplasticity with psychoplastogens: the essential role of psychotherapy in psychedelic treatment optimization}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2025.1565852}{doi:10.3389/fpsyt.2025.1565852}.
\item Ammineni D, Park R. (2025). \textit{The compulsive eating paradigm: can psychedelics help in treating obesity?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s40337-024-01186-7}{doi:10.1186/s40337-024-01186-7}.
\item Agnorelli C, Spriggs M, Godfrey K, Sawicka G, Bohl B, Douglass H, Fagiolini A, Parastoo H, Carhart-Harris R, Nutt D, Erritzoe D. (2025). \textit{Neuroplasticity and psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical models.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2025.106132}{doi:10.1016/j.neubiorev.2025.106132}.
\item A. Oliveira-Maia (2025). \textit{Reporting of psychotherapeutic methods in psychedelic treatments: on the road to ethical, professional and regulatory oversight}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/j.eurpsy.2025.64}{doi:10.1192/j.eurpsy.2025.64}.
\item Zhangrao Huang, Yongpeng Yao, Rong Di, Jianchao Zhang, Yuanyuan Pan, Gang Liu (2025). \textit{De Novo Biosynthesis of Antidepressant Psilocybin in Escherichia coli}. Microbial Biotechnology. [published; OpenAlex]. \href{https://doi.org/10.1111/1751-7915.70135}{doi:10.1111/1751-7915.70135}.
\item Keenan R, Haque R, Jin X, Mustafa T, Homman-Ludiye J, Elysee K, Wee ZS, Simonds S, Foldi C, Cowley M. (2025). \textit{Effects of a single dose of psilocybin on diet-induced weight loss in obese mice}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-6225000/v1}{doi:10.21203/rs.3.rs-6225000/v1}.
\item Unity Health Toronto (2025). \textit{Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06731335}{source link}.
\item Unknown authors (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.1093/schbul/sbaf068}{doi:10.1093/schbul/sbaf068}.
\item Heller NH, Barrett FS, Buchborn T, Collerton D, Dupuis D, Halberstadt AL, Jardri R, Noorani TN, Preller KH, Taylor J, Waters F, Winston B, Leptourgos P. (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/7x8q4\_v2}{doi:10.31234/osf.io/7x8q4\_v2}.
\item Gregory Ian Robinson, Marta Gerasymchuk, Timur Zanikov, Esmaeel Ghasemi Gojani, Shima Asghari, Alyssa Groves, Lucie Haselhorst, Sanjana Nandakumar, Cora Stahl, Ceejay Cruz, Mackenzie Cameron, Yeva Zahoruiko, Dongping Li, Rocio Rodriguez-Juarez, Alex Snelling, Darryl Hudson, Anna Fiselier, Olga Kovalchuk, Igor Kovalchuk (2025). \textit{LPS-Induced Liver Inflammation Is Inhibited by Psilocybin and Eugenol in Mice}. Pharmaceuticals. [published; OpenAlex]. \href{https://doi.org/10.3390/ph18040451}{doi:10.3390/ph18040451}.
\item Chunyan Meng, Wenting Guo, Xiao Chuan, Yan Wen, Xudong Zhu, Qingrong Zhang, Yuxuan Liang, Hongwei Li, Sha Xu, Yuntan Qiu, Haitao Chen, Wei-Jye Lin, Baixing Wu (2025). \textit{Structural basis for psilocybin biosynthesis}. Nature Communications. [published; OpenAlex]. \href{https://doi.org/10.1038/s41467-025-58239-x}{doi:10.1038/s41467-025-58239-x}.
\item Kim SH, Yang S, Jung J, Choi J, Kang M, Joo JY. (2025). \textit{Psychedelic Drugs in Mental Disorders: Current Clinical Scope and Deep Learning-Based Advanced Perspectives.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/advs.202413786}{doi:10.1002/advs.202413786}.
\item Centre Hospitalier Universitaire de Nīmes (2025). \textit{Psilocybin in Alcohol Use Disorder With Comorbid Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06235411}{source link}.
\item Ram Harari, Dmitriy Getselter, Evan Elliott (2025). \textit{The psychedelic psilocybin and light exposure have similar and synergistic effects on gene expression patterns in the visual cortex}. Molecular Brain. [published; OpenAlex]. \href{https://doi.org/10.1186/s13041-025-01191-0}{doi:10.1186/s13041-025-01191-0}.
\item Thomas Hesslow (2025). \textit{Interview with Allen Kalpin and Reiko Ikemoto-Joseph: psychedelics and ISTDP}. Journal of Contemporary ISTDP. [published; OpenAlex]. \href{https://doi.org/10.70839/jejtzv59}{doi:10.70839/jejtzv59}.
\item Dr Hafiz Shafique Ahmad, Muhammad Waqar Ali, Usman Ul Haq (2025). \textit{PSYCHEDELIC PHARMACOLOGY IN PSYCHIATRY: THE MECHANISMS AND THERAPEUTIC POTENTIAL OF PSILOCYBIN, MDMA, AND LSD IN MENTAL HEALTH DISORDERS}. Journal of medical \& health sciences review.. [published; OpenAlex]. \href{https://doi.org/10.62019/r713mw08}{doi:10.62019/r713mw08}.
\item Quah S, Glick C, Roseman L, Pasquini L, Carhart-Harris R, Saggar M. (2025). \textit{Revealing Changes in Linear and Nonlinear Functional Connectivity After Psilocybin and Escitalopram Treatment in Patients with Depression}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.03.05.641592}{doi:10.1101/2025.03.05.641592}.
\item Repple J, Bayas M, Möser C, Kobayashi NF, Reif A. (2025). \textit{Current Evidence for the Role of Rapid-Acting Antidepressants in Bipolar Depression: A Perspective and Plan for Action.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.biopsych.2025.02.903}{doi:10.1016/j.biopsych.2025.02.903}.
\item Craig, Danny R, Blalock, Eric M. (2025). \textit{Could psilocin rescue chronic, stress-accelerated, transcriptional aging in brain?}. UKnowledge (University of Kentucky). [published; OpenAlex]. \href{https://uknowledge.uky.edu/jpns/vol2/iss1/1}{source link}.
\item Guy M. Goodwin, Ania Nowakowska, Merve Atli, Boadie W. Dunlop, David Feifel, David J. Hellerstein, Lindsey Marwood, Zainib Shabir, Sunil Mistry, S. C. Stansfield, Emma Teoh, Joyce Tsai, Matthew B. Young, Ekaterina Malievskaia (2025). \textit{Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive Disorder}. The Journal of Clinical Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.4088/jcp.24m15449}{doi:10.4088/jcp.24m15449}.
\item Alexsandra Kovacevich, Ian Dorney, Lukas Bobak, David C. Kaelber, Brian S. Barnett (2025). \textit{Therapeutic Potential of Psychedelics for Treating Anosmia: An Investigation of Online Accounts}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2025.2474239}{doi:10.1080/02791072.2025.2474239}.
\item Hodge A, Forsyth A, Noorani T, Muthukumaraswamy S, Rolleston A, McHugh P. (2025). \textit{Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/93x5h\_v3}{doi:10.31234/osf.io/93x5h\_v3}.
\item Hodge A, Forsyth A, Noorani T, Muthukumaraswamy S, Rolleston A, McHugh P. (2025). \textit{Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/93x5h\_v2}{doi:10.31234/osf.io/93x5h\_v2}.
\item Unknown authors (2025). \textit{Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/93x5h\_v3}{source link}.
\item Aneta Petrušková, Debarpan Guhathakurta, Enes Yağız Akdaş, Bartomeu Perelló-Amorós, Renato Frischknecht, Eva-Maria Weiss, Tomáš Páleníček, Anna Fejtová (2025). \textit{Serotonergic Psychedelics Rapidly Modulate Evoked Glutamate Release in Cultured Cortical Neurons}. Journal of Neurochemistry. [published; OpenAlex]. \href{https://doi.org/10.1111/jnc.70020}{doi:10.1111/jnc.70020}.
\item Mohammad Balabandian, Mohammad Amin Manavi, Ali Lesani, Razieh Mohammad Jafari, Hamed Shafaroodi, Neda Heidari, Javad Mirnajafi-Zadeh, Alireza Foroumadi, Arya Afrooghe, Ahmad Reza Dehpour (2025). \textit{Psilocin, A Psychedelic Drug, Exerts Anticonvulsant Effects Against PTZ- and MES-Induced Seizures in Mice via 5-HT1A and CB1 Receptors: Involvement of Nitrergic, Opioidergic, and Kynurenine Pathways}. Pharmacology Research \& Perspectives. [published; OpenAlex]. \href{https://doi.org/10.1002/prp2.70079}{doi:10.1002/prp2.70079}.
\item Meshkat S, Malik T, Zeifman R, Swainson J, Zhang Y, Burback L, Winkler O, Greenshaw AJ, Claire Reichelt A, Vermetten E, Erritzoe D, Jha MK, Dunn W, Jetly R, Husain MI, Bhat V. (2025). \textit{Psychedelics and Suicide-Related Outcomes: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/jcm14051416}{doi:10.3390/jcm14051416}.
\item Mauney E, King F, Burton-Murray H, Kuo B. (2025). \textit{Psychedelic-assisted Therapy as a Promising Treatment for Irritable Bowel Syndrome.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/mcg.0000000000002149}{doi:10.1097/mcg.0000000000002149}.
\item Heller NH, Barrett FS, Buchborn T, Collerton D, Dupuis D, Halberstadt AL, Jardri R, Noorani TN, Preller KH, Taylor J, Waters F, Winston B, Leptourgos P. (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/7x8q4\_v1}{doi:10.31234/osf.io/7x8q4\_v1}.
\item Xue Wang, Cong Lin, Xiaohui Wang (2025). \textit{Psychedelics and Pro-Social Behaviors: A Perspective on Autism Spectrum Disorders}. ACS Pharmacology \& Translational Science. [published; OpenAlex]. \href{https://doi.org/10.1021/acsptsci.5c00034}{doi:10.1021/acsptsci.5c00034}.
\item Lucido MJ, Dunlop BW. (2025). \textit{Emerging Medications for Treatment-Resistant Depression: A Review with Perspective on Mechanisms and Challenges.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/brainsci15020161}{doi:10.3390/brainsci15020161}.
\item Hogea L, Tabugan DC, Costea I, Albai O, Nussbaum L, Cojocaru A, Corsaro L, Anghel T. (2025). \textit{The Therapeutic Potential of Psychedelics in Treating Substance Use Disorders: A Review of Clinical Trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/medicina61020278}{doi:10.3390/medicina61020278}.
\item Brengel EK, Axe B, Maheswari A, Abeer MI, Ortiz RJ, Woodward TJ, Walhof R, Utama R, Sawada C, Balaji S, Kulkarni PP, Bradshaw HB, Gitcho MA, Ferris CF. (2025). \textit{Psilocybin as a Treatment for Repetitive Mild Head Injury: Evidence from Neuroradiology and Molecular Biology}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.02.03.636248}{doi:10.1101/2025.02.03.636248}.
\item de Miranda AS, C B Toscano E, Venna VR, Graeff FG, Teixeira AL. (2025). \textit{Investigating novel pharmacological strategies for treatment-resistant depression: focus on new mechanisms and approaches.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/17460441.2025.2460674}{doi:10.1080/17460441.2025.2460674}.
\item Unknown authors (2025). \textit{PSILOCYBIN MITIGATES BEHAVIORAL DESPAIR AND COGNITIVE RECOGNITION IMPAIRMENTS BY REGULATING THE HYPOTHALAMIC- PITUITARY-ADRENAL (HPA) AXIS VIA THE BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) SIGNALING PATHWAY MEDIATED BY THE ENDOCANNABINOID SYSTEM (ECS)}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC11814968}{source link}.
\item de Deus JL, Maia JM, Soriano RN, Amorim MR, Branco LGS. (2025). \textit{Psychedelics in neuroinflammation: Mechanisms and therapeutic potential.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111278}{doi:10.1016/j.pnpbp.2025.111278}.
\item Sorcha O'Connor, Kate Godfrey, Sara Reed, Joseph Peill, Cyrus Rohani-Shukla, Mairead Healy, Trevor W. Robbins, Ana Frota Lisboa Pereira de Souza, Robin J. Tyacke, Maria Papasyrou, Dea Siggaard Stenbæk, Pedro Castro-Rodrigues, Martina Chiera, Hakjun Lee, Jonny Martell, Robin Carhart-Harris, Luca Pellegrini, Naomi Fineberg, David Nutt, David Erritzøe (2025). \textit{Study Protocol for ‘PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity’}. Cureus. [published; OpenAlex]. \href{https://doi.org/10.7759/cureus.78171}{doi:10.7759/cureus.78171}.
\item Paloma C. Frautschi, Ajay Paul Singh, Nicholas A. Stowe, Sean M. Grady, Zarmeen Zahid, Matthew I. Banks, John-Paul J. Yu (2025). \textit{Effects of Psilocybin on Mouse Brain Microstructure}. American Journal of Neuroradiology. [published; OpenAlex]. \href{https://doi.org/10.3174/ajnr.a8634}{doi:10.3174/ajnr.a8634}.
\item Niklas Viohl, Ali Asghar Hakami Zanjani, Himanshu Khandelia (2025). \textit{Molecular insights into the modulation of the 5 HT2 A receptor by serotonin, psilocin, and the G protein subunit Gqα}. FEBS Letters. [published; OpenAlex]. \href{https://doi.org/10.1002/1873-3468.15099}{doi:10.1002/1873-3468.15099}.
\item Yousefi P, Lietz MP, O'Higgins FJ, Rippe RCA, Hasler G, van Elk M, Enriquez-Geppert S. (2025). \textit{Acute effects of psilocybin on attention and executive functioning in healthy volunteers: a systematic review and multilevel meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-024-06742-2}{doi:10.1007/s00213-024-06742-2}.
\item Liebnau J, Betzler F, Kerber A. (2025). \textit{Catalyst for change: Psilocybin's antidepressant mechanisms-A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811241312866}{doi:10.1177/02698811241312866}.
\item Melani A, Bonaso M, Biso L, Zucchini B, Conversano C, Scarselli M. (2025). \textit{Uncovering Psychedelics: From Neural Circuits to Therapeutic Applications.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ph18010130}{doi:10.3390/ph18010130}.
\item Shakila Meshkat, Richard J. Zeifman, Kathleen E. Stewart, Reinhard Janssen-Aguilar, Wendy Lou, Rakesh Jetly, Candice M. Monson, Venkat Bhat (2025). \textit{Psilocybin-assisted massed cognitive processing therapy for chronic posttraumatic stress disorder: Protocol for an open-label pilot feasibility trial}. PLoS ONE. [published; OpenAlex]. \href{https://doi.org/10.1371/journal.pone.0313741}{doi:10.1371/journal.pone.0313741}.
\item Henderson I, Elsaadany R, Chan G, Bajaj V, Duarte D, Goodman S, Grunstein M, Vadhan NP, Duarte RA. (2025). \textit{Exploring the Potential of Psychedelics in the Treatment of Headache Disorders: Clinical Considerations and Exploratory Insights.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11916-024-01321-8}{doi:10.1007/s11916-024-01321-8}.
\item Krawczyk N, Miller M, Gu EY, Irvine N, Ramirez E, Santaella-Tenorio J, Lippincott T, Bogenschutz M, Bunting AM, Meacham MC (2025). \textit{Self-reported experiences and perspectives on using psychedelics to manage opioid use among participants of two Reddit communities.}. Addiction (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1111/add.16767}{doi:10.1111/add.16767}.
\item Brooks BM, Cordero FJ, Alchermes SL, Brooks BM. (2025). \textit{Social pain: A systematic review on interventions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.12688/f1000research.159561.1}{doi:10.12688/f1000research.159561.1}.
\item Schuler H, Zhou D, Savignac C, Cvetkovska V, Tse Y, Meccia J, Lopez J, Harutyunyan AS, Ragoussis J, Bzdok D, Bagot RC. (2025). \textit{Cell-type specific transcriptional modulation by psilocybin induces sustained plasticity in mouse medial prefrontal cortex}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.01.08.631940}{doi:10.1101/2025.01.08.631940}.
\item Strand NH, Whitney M, Johnson B, Dunn T, Attanti S, Maloney J, Misra L, Gomez D, Viswanath O, Emami E, Leathem J. (2025). \textit{Pain and Perception: Exploring Psychedelics as Novel Therapeutic Agents in Chronic Pain Management.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11916-024-01353-0}{doi:10.1007/s11916-024-01353-0}.
\item Constantino JL, van Dalfsen JH, Massetti S, Kamphuis J, Schoevers RA. (2025). \textit{Neurobiological mechanisms of antidepressant properties of psilocybin: A systematic review of blood biomarkers.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111251}{doi:10.1016/j.pnpbp.2025.111251}.
\item Erkizia-Santamaría I, Horrillo I, Meana JJ, Ortega JE. (2025). \textit{Clinical and preclinical evidence of psilocybin as antidepressant. A narrative review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111249}{doi:10.1016/j.pnpbp.2025.111249}.
\item Chen J, Wang Z, Yong CY, Goh EML, Moy HY, Chan ECY. (2025). \textit{Elucidating the Phase I metabolism of psilocin in vitro.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00204-024-03952-7}{doi:10.1007/s00204-024-03952-7}.
\item Tuğcan MO, Akpınar AA. (2025). \textit{Mushroom poisoning: An updated review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.4103/tjem.tjem\_129\_24}{doi:10.4103/tjem.tjem\_129\_24}.
\item Caitlyn S. Greenspun (2024). \textit{The Right to 'Trip:' Navigating Psilocybin-Assisted Psychotherapy Under the Right to Try Pathway}. eYLS (Yale Law School). [published; OpenAlex]. \href{https://lawecommons.luc.edu/luclj/vol56/iss3/6}{source link}.
\item Muniz, John Marco D.F. (2024). \textit{Comparative Efficacy of Hallucinogens in Treating Mood Disorders Through a Meta-Analysis of Symptom Reduction, Dosage, and Duration}. Journal of International Crisis and Risk Communication Research. [published; OpenAlex]. \href{https://stars.library.ucf.edu/hut2024/268}{source link}.
\item Henrique Tofoli Vieira Machado, GEOVANA MENDES DE SEIXAS, L. Silva, Mariana Duarte Garcia Brito, Gabriella Assink de Castro (2024). \textit{Alternative therapy for neurological and psychiatric disorders using psilocybin}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.5327/1516-3180.cpn.1123}{doi:10.5327/1516-3180.cpn.1123}.
\item Marina D. Kostić, Jana Nedić, Jovana S. Dragojević, Vera M. Divac (2024). \textit{In Silico Evaluation of Tryptamine-Derived Schiff Bases as Modulators of the Serotonin 5-HT₂A Receptor}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.46793/iccbikg25.477k}{doi:10.46793/iccbikg25.477k}.
\item Andreia Machado Brito da Costa, Ricardo Jorge Dinis-Oliveira, Áurea Madureira-Carvalho, Diana Dias-da-Silva (2024). \textit{Neurotoxic and Neuroprotective Effects of Psychedelics in a Human Neuroblastoma Cell Model}. RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia. [published; OpenAlex]. \href{https://doi.org/10.51126/revsalus.v7isup.1031}{doi:10.51126/revsalus.v7isup.1031}.
\item Mile Jevtić (2024). \textit{The effects of psychedelics on neuroplasticity: A review of current research and the possibility of therapeutic application in psychiatry}. Engrami. [published; OpenAlex]. \href{https://doi.org/10.5937/engrami47-57385}{doi:10.5937/engrami47-57385}.
\item Fonzo GA, Wolfgang AS, Barksdale BR, Krystal JH, Carpenter LL, Kraguljac NV, Grzenda A, McDonald WM, Widge AS, Rodriguez CI, Nemeroff CB. (2024). \textit{Psilocybin: From Psychiatric Pariah to Perceived Panacea.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.ajp.20230682}{doi:10.1176/appi.ajp.20230682}.
\item Bostoen T, Tap S, Breeksema J, Schoevers R (2024). \textit{Post-traumatic stress disorder in psychedelic research.}. International review of neurobiology. [published; PubMed]. \href{https://doi.org/10.1016/bs.irn.2025.02.004}{doi:10.1016/bs.irn.2025.02.004}.
\item Zitong Wang, Brett Robbins, Ryan Zhuang, Thaísa Meira Sandini, Rebekah van Bruggen, Xin-Min Li, Yanbo Zhang (2024). \textit{Early psilocybin intervention alleviates behavioral despair and cognitive impairment in stressed Wistar rats}. Progress in Neuro-Psychopharmacology and Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.pnpbp.2024.111243}{doi:10.1016/j.pnpbp.2024.111243}.
\item Marianne Destoop, Pavel Mohr, Florence Butlen-Ducuing, Péter Kéri, Jerzy Samochowiec, Livia De Picker, Andrea Fiorillo, Kim P. C. Kuypers, Geert Dom (2024). \textit{Use of psychedelic treatments in psychiatric clinical practice: an EPA policy paper}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/j.eurpsy.2024.1806}{doi:10.1192/j.eurpsy.2024.1806}.
\item Khalaud Naseeb Alhajry, Zahra Mohammed Sukairi, Hamidah Abdullah Lajami, Safiah Anber Bin Ali Ibrahim, Nawal Obaid Alanazi, Eman Ali Alsafwani, Ashwag Saad Hnif Albishi, Nada Naser Alomi, Zahrh Ahmed Ali Al-Hamadah, Anwar Mehdaf Akash Alrowaly (2024). \textit{Psychedelic-Assisted Therapy: The Emerging Role of the Psychiatric-Mental Health Nurse}. Saudi Journal of Medicine and Public Health. [published; OpenAlex]. \href{https://doi.org/10.64483/20251153}{doi:10.64483/20251153}.
\item Koning E, Chaves C, Kirkpatrick RH, Brietzke E. (2024). \textit{Exploring the neurobiological correlates of psilocybin-assisted psychotherapy in eating disorders: a review of potential methodologies and implications for the psychedelic study design.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s40337-024-01185-8}{doi:10.1186/s40337-024-01185-8}.
\item Bakshi B, Yerraguntla S, Armon C, Barkhaus P, Bertorini T, Bowser R, Breevoort S, Bromberg M, Brown A, Carter GT, Chang V, Crayle J, Fullam T, Greene M, Heiman-Patterson T, Jackson C, Jhooty S, Mallon E, Cadavid JM, Mcdermott CJ, Pattee G, Pierce K, Ratner D, Sun Y, Wang O, Wicks P, Wiedau M, Bedlack R. (2024). \textit{ALSUntangled \#77: Psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/21678421.2024.2441274}{doi:10.1080/21678421.2024.2441274}.
\item Johannes Jungwirth, Robin von Rotz, Isabel Dziobek, Franz X. Vollenweider, Katrin H. Preller (2024). \textit{Psilocybin increases emotional empathy in patients with major depression}. Molecular Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41380-024-02875-0}{doi:10.1038/s41380-024-02875-0}.
\item Barnett JH, Todd KT, Benetatos J, Rabichow BE, Gibson KA, Olney KC, Fryer JD. (2024). \textit{Psilocybin causes sex, time, and dose dependent alterations in brain signaling pathways}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.12.16.628764}{doi:10.1101/2024.12.16.628764}.
\item Ferreira AE, Reis-Pina P. (2024). \textit{Exploring the role of psychedelic-assisted therapy in enhancing spirituality and mystical experiences in patients with life-threatening illnesses: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jpsychores.2024.112020}{doi:10.1016/j.jpsychores.2024.112020}.
\item Gitte Moos Knudsen (2024). \textit{The Neurobiological Effect of 5-HT2AR Modulation}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03289949}{source link}.
\item Christopher L. Robinson, Pawan Solanki, S Snyder, Adam Amir, Antje M. Barreveld, Rory Vu Mather, Ivo H. Cerda, Michael Motoc, Harman Chopra, R. Jason Yong, Joel Castellanos, Timothy Furnish, Alan D. Kaye, Vwaire Orhurhu, Trent Emerick (2024). \textit{Chronic pain education: past, present, and future of psychedelics for the management of chronic pain}. Pain Medicine. [published; OpenAlex]. \href{https://doi.org/10.1093/pm/pnae124}{doi:10.1093/pm/pnae124}.
\item Marchi M, Farina R, Rachedi K, Laonigro F, Žuljević MF, Pingani L, Ferrari S, Somers M, Boks MPM, Galeazzi GM. (2024). \textit{Psychedelics as an intervention for psychological, existential distress in terminally ill patients: A systematic review and network meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811241303594}{doi:10.1177/02698811241303594}.
\item Humphreys K, Todd Korthuis P, Stjepanović D, Hall W. (2024). \textit{Therapeutic Potential of Psychedelic Drugs: Navigating High Hopes, Strong Claims, Weak Evidence, and Big Money.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1146/annurev-psych-020124-023532}{doi:10.1146/annurev-psych-020124-023532}.
\item Shabir Kanwal (2024). \textit{Psilocybin Microdosing for Anxiety Relief in Young Adults: A Comparative Review of Emerging Evidence}. Premier Journal of Science. [published; Crossref]. \href{https://doi.org/10.70389/pjs.100036}{doi:10.70389/pjs.100036}.
\item Eline Pottie, G.C. Glatfelter, M.H. Baumann, Christophe P. Stove (2024). \textit{Differential in Vitro Activation Profiles for Psychedelic versus Non-psychedelic Ergolines at the 5-HT2A Receptor}. Emerging Trends in Drugs Addictions and Health. [published; OpenAlex]. \href{https://doi.org/10.1016/j.etdah.2023.100109}{doi:10.1016/j.etdah.2023.100109}.
\item Jitendra Kumar Sinha, Shampa Ghosh, Krishna Kumar Singh, M. P. Singh, Manchala Raghunath (2024). \textit{Exploring Therapeutic Potentials and Pathways of Psychedelics in Alzheimer’s Disease-Related Dementia}. Alzheimer s \& Dementia. [published; OpenAlex]. \href{https://doi.org/10.1002/alz.084413}{doi:10.1002/alz.084413}.
\item Collins HM. (2024). \textit{Psychedelics for the Treatment of Obsessive-Compulsive Disorder: Efficacy and Proposed Mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/ijnp/pyae057}{doi:10.1093/ijnp/pyae057}.
\item Spangemacher M, Mertens LJ, Färber LV, Jungaberle A, Jungaberle H, Gründer G. (2024). \textit{Psilocybin as a Disease-Modifying Drug-A Salutogenic Approach in Psychiatry.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3238/arztebl.m2024.0224}{doi:10.3238/arztebl.m2024.0224}.
\item Miller CE, Zoladz PR. (2024). \textit{Evaluating the potential for psilocybin as a treatment for post-traumatic stress disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1124/jpet.124.002237}{doi:10.1124/jpet.124.002237}.
\item Maximillian J. Wood, Rosalind McAlpine, Sunjeev K. Kamboj (2024). \textit{Strategies for resolving challenging psychedelic experiences: insights from a mixed-methods study}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-024-79931-w}{doi:10.1038/s41598-024-79931-w}.
\item Raj Nashikkar, Kavita Mane, Rajendra Patil (2024). \textit{Psilocybin Fungi Unveiled: Morphological Characteristics and Pharmacological Potentials}. International Journal for Research in Applied Science and Engineering Technology. [published; OpenAlex]. \href{https://doi.org/10.22214/ijraset.2024.65160}{doi:10.22214/ijraset.2024.65160}.
\item Reid MJ, Kettner H, Blanken TF, Weiss B, Carhart-Harris R. (2024). \textit{Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic Action.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11920-024-01539-8}{doi:10.1007/s11920-024-01539-8}.
\item Hodge A, Forsyth A, Noorani T, Muthukumaraswamy S, Rolleston A, McHugh P. (2024). \textit{Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/93x5h}{doi:10.31234/osf.io/93x5h}.
\item Hodge A, Forsyth A, Noorani T, Muthukumaraswamy S, Rolleston A, McHugh P. (2024). \textit{Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/93x5h\_v1}{doi:10.31234/osf.io/93x5h\_v1}.
\item Pasquini L, Vohryzek J, Escrichs A, Sanz Perl Y, Ponce-Alvarez A, Idesis S, Girn M, Roseman L, Mitchell JM, Gazzaley A, Kringelbach M, Nutt DJ, Lyons T, Carhart-Harris RL, Deco G. (2024). \textit{Long-term effects of psilocybin on dynamic and effectivity connectivity of fronto-striatal-thalamic circuits}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.11.06.622302}{doi:10.1101/2024.11.06.622302}.
\item Cristiano Chaves, Rafael G. dos Santos, Serdar Dursun, Massimo Tusconi, Mauro Giovanni Carta, Elisa Brietzke, Jaime E. C. Hallak (2024). \textit{Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2024.1485337}{doi:10.3389/fpsyt.2024.1485337}.
\item Link Swanson, Sophia Jungers, Ranji Varghese, Kathryn R. Cullen, Michael D. Evans, Jessica L. Nielson, Michael-Paul Schallmo (2024). \textit{Enhanced visual contrast suppression during peak psilocybin effects: Psychophysical results from a pilot randomized controlled trial}. Journal of Vision. [published; OpenAlex]. \href{https://doi.org/10.1167/jov.24.12.5}{doi:10.1167/jov.24.12.5}.
\item Min H, Park SY, Park J, Na S, Lee HS, Kim T, Ham J, Park YT. (2024). \textit{A narrative exploration of psilocybin's potential in mental health.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2024.1429373}{doi:10.3389/fpsyt.2024.1429373}.
\item Imperial College London (2024). \textit{Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative Mechanisms}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03429075}{source link}.
\item Perez Rosal SR, La Torre JT, Birnkammer S, Chernoloz O, Williams MT, Faber SC. (2024). \textit{Expert recommendations for Germany's integration of psychedelic-assisted therapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s12909-024-06141-3}{doi:10.1186/s12909-024-06141-3}.
\item Stefanie Enriquez-Geppert, Jaroslav Krc, Fiachra O'Higgins, Morten Peter Lietz (2024). \textit{Psilocybin-assisted neurofeedback for the improvement of executive functions: a randomized semi-naturalistic-lab feasibility study}. Philosophical Transactions of the Royal Society B Biological Sciences. [published; OpenAlex]. \href{https://doi.org/10.1098/rstb.2023.0095}{doi:10.1098/rstb.2023.0095}.
\item University Health Network, Toronto (2024). \textit{Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06506019}{source link}.
\item Danielle R. Adams, Heidi Allen, Ginger E. Nicol, Leopoldo J. Cabassa (2024). \textit{Moving psychedelic-assisted therapies from promising research into routine clinical practice: Lessons from the field of implementation science}. Translational Behavioral Medicine. [published; OpenAlex]. \href{https://doi.org/10.1093/tbm/ibae053}{doi:10.1093/tbm/ibae053}.
\item Szpręgiel I, Bysiek A. (2024). \textit{Psilocybin and the glutamatergic pathway: implications for the treatment of neuropsychiatric diseases.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s43440-024-00660-y}{doi:10.1007/s43440-024-00660-y}.
\item de la Fuente Revenga M, González-Maeso J. (2024). \textit{Snapshot of 5-HT2A receptor activation in the mouse brain via IP1 detection}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.10.11.617861}{doi:10.1101/2024.10.11.617861}.
\item Hannah Douglass (2024). \textit{The therapeutic potential and mechanisms of action of psilocybin-assisted therapy in anorexia nervosa treatment}. Open MIND. [published; OpenAlex]. \href{https://doi.org/10.25560/118978}{doi:10.25560/118978}.
\item James Rucker, Matthew Butler, Sadie Hambleton, Catherine Bird, Mathieu Seynaeve, Sanjay Cheema, Kete Campbell-Coker, Carolina Maggio, Fiona Dunbar, Giorgio Lambru, Manjit Matharu (2024). \textit{Plain Language Summary Publication: Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: Results from an open-label phase Ib ascending dose study}. Headache The Journal of Head and Face Pain. [published; OpenAlex]. \href{https://doi.org/10.1111/head.14846}{doi:10.1111/head.14846}.
\item Seong-Jin Yu, Kuo-Jen Wu, Yu-Syuan Wang, Eun-Kyung Bae, Fabio Chianelli, Nicholas C. Bambakidis, Yun Wang (2024). \textit{Neuroprotective effects of psilocybin in a rat model of stroke}. BMC Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1186/s12868-024-00903-x}{doi:10.1186/s12868-024-00903-x}.
\item Victorita E. Ivan, David P. Tomàs-Cuesta, Ingrid M. Esteves, Artur Luczak, Majid H. Mohajerani, Bruce L. McNaughton, Aaron J. Gruber (2024). \textit{Psilocybin reduces functional correlation and the encoding of spatial information by neurons in mouse retrosplenial cortex}. European Journal of Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1111/ejn.16558}{doi:10.1111/ejn.16558}.
\item Junges LH, Müller-Santos M. (2024). \textit{Exploring the biocatalysis of psilocybin and other tryptamines: Enzymatic pathways, synthetic strategies, and industrial implications.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/btpr.3513}{doi:10.1002/btpr.3513}.
\item Choi C, Johnson DE, Chen-Li D, Rosenblat J. (2024). \textit{Mechanisms of psilocybin on the treatment of posttraumatic stress disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811241286771}{doi:10.1177/02698811241286771}.
\item Elizabeth L. Fisher, Ryan Smith, Kyna-Anne Conn, Andrew W. Corcoran, Laura K Milton, Jakob Hohwy, Claire J. Foldi (2024). \textit{Psilocybin increases optimistic engagement over time: computational modelling of behaviour in rats}. Translational Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41398-024-03103-7}{doi:10.1038/s41398-024-03103-7}.
\item Ordovich-Clarkson RD, Jabbour M, Pelayo DA, Lara D, La Croix S, Mumman M, Stukas S, Anderson R, Meraz D, Bangura A, Anderson B, Bamrud L, Blake C. (2024). \textit{Comparing psilocybin to metformin as neuroprotective agents against Parkinson's dementia: A systematic review of evidence and efficacy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2024.111155}{doi:10.1016/j.pnpbp.2024.111155}.
\item Lee J, Tantillo DJ, Wang LP, Fiehn O. (2024). \textit{Impact of Protonation Sites on Collision-Induced Dissociation-MS/MS Using CIDMD Quantum Chemistry Modeling.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acs.jcim.4c00761}{doi:10.1021/acs.jcim.4c00761}.
\item Allohverdi S, Soltanzadeh M, Schmidt A, Charlton C, Hauke D, Karvelis P, Vollenweider F, Diaconescu A. (2024). \textit{Ketamine and Psilocybin Differentially Impact Sensory Learning During the Mismatch Negativity}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-4492873/v1}{doi:10.21203/rs.3.rs-4492873/v1}.
\item Vamvakopoulou IA, Nutt DJ. (2024). \textit{Psychedelics: From Cave Art to 21st-Century Medicine for Addiction.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1159/000540062}{doi:10.1159/000540062}.
\item Bushra Yasin, Shivani Mehta, George Tewfik, Alex Bekker (2024). \textit{Psychedelics as novel therapeutic agents for chronic pain: mechanisms and future perspectives}. Exploration of neuroscience. [published; OpenAlex]. \href{https://doi.org/10.37349/en.2024.00058}{doi:10.37349/en.2024.00058}.
\item Abe Y, Sugiura Y, Maeda R, Taira S, Yoshida K, Ibi D, Moritoh S, Hashimoto K, Yagishita S, Tanaka KF. (2024). \textit{Distinct classes of antidepressants commonly act to shape pallidal structure and function in mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.09.23.614626}{doi:10.1101/2024.09.23.614626}.
\item Gobbi G. (2024). \textit{CCNP Innovations in Neuropsychopharmacology Award: The psychopharmacology of psychedelics: where the brain meets spirituality.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1503/jpn.240037}{doi:10.1503/jpn.240037}.
\item Behera HK, Joga R, Yerram S, Karnati P, Mergu T, Gandhi K, M S, Nathiya D, Singh RP, Srivastava S, Kumar S. (2024). \textit{Exploring the regulatory framework of psychedelics in the US \& Europe.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.ajp.2024.104242}{doi:10.1016/j.ajp.2024.104242}.
\item Li G, Facchini PJ. (2024). \textit{New frontiers in the biosynthesis of psychoactive specialized metabolites.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pbi.2024.102626}{doi:10.1016/j.pbi.2024.102626}.
\item Zhen Z, Sun X, Yuan S, Zhang J. (2024). \textit{Psychoactive substances for the treatment of neuropsychiatric disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.ajp.2024.104193}{doi:10.1016/j.ajp.2024.104193}.
\item Amany E. Ayad (2024). \textit{G33 Psychedelic drugs for the treatment of chronic pain: is ketamine included?}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.1136/rapm-2024-esra.582}{doi:10.1136/rapm-2024-esra.582}.
\item Caspani G, Ruffell SGD, Tsang W, Netzband N, Rohani-Shukla C, Swann JR, Jefferies WA (2024). \textit{Mind over matter: the microbial mindscapes of psychedelics and the gut-brain axis.}. Pharmacological research. [published; PubMed]. \href{https://doi.org/10.1016/j.phrs.2024.107338}{doi:10.1016/j.phrs.2024.107338}.
\item Loizaga-Velder A, Loizaga Pazzi A. (2024). \textit{Traditional Medicine, Culture, and Psychedelic Science: New Pathways for Recovery From Substance Use Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.15288/jsad.23-00011}{doi:10.15288/jsad.23-00011}.
\item David S. Jevotovsky, Harman Chopra, Court Wing, Carlton J. Spotswood, Joel Castellanos (2024). \textit{Refractory CRPS pain treated with psilocybin: A case report}. Clinical Case Reports. [published; OpenAlex]. \href{https://doi.org/10.1002/ccr3.9421}{doi:10.1002/ccr3.9421}.
\item University of Arizona (2024). \textit{Psilocybin for Treatment of Obsessive Compulsive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03300947}{source link}.
\item Kargbo RB. (2024). \textit{Exploring the Therapeutic Potential of Entheogens in Postoperative Cognitive Decline and Psychological Resilience.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.4c00412}{doi:10.1021/acsmedchemlett.4c00412}.
\item Kargbo RB. (2024). \textit{Current Trends in Psychedelic Science: Integrating Modified Lysergic Acid Derivatives and Psilocybin in Modern Medicine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.4c00414}{doi:10.1021/acsmedchemlett.4c00414}.
\item William M. Campo, Ann Marie Yali (2024). \textit{Psychedelic use and psychological flexibility: The role of meaningful intention and decentering}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2024.00350}{doi:10.1556/2054.2024.00350}.
\item Frederick A. Bagdasarian, Hanne D. Hansen, Chi-Hyeon Yoo, Michael S. Placzek, Jacob M. Hooker, Hsiao-Ying Wey (2024). \textit{Acute Effects of Psilocybin and Salvinorin-A on Functional Connectivity}. Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition. [published; OpenAlex]. \href{https://doi.org/10.58530/2023/3494}{doi:10.58530/2023/3494}.
\item Marinho EAV, Serra YA, Oliveira-Lima AJ, Marcourakis T, Berro LF. (2024). \textit{Ayahuasca for the treatment of alcohol use disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.irn.2024.07.007}{doi:10.1016/bs.irn.2024.07.007}.
\item Vella Y, Syrova K, Petruskova A, Koutrouli I, Kutna V, Pala J, Nikolic M, Sichova K, Mazoch V, Jurok R, Kuchar M, Bendova Z, Palenicek T. (2024). \textit{Effects of serotonergic psychedelics on synaptogenesis and immediate early genes expression - comparison with ketamine, fluoxetine and lithium}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.08.07.606965}{doi:10.1101/2024.08.07.606965}.
\item Brugmann University Hospital (2024). \textit{Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Feasibility, Clinical Efficacy \& (Neuro)Cognitive Mechanisms}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06160232}{source link}.
\item Gustavo Deco, Yonatan Sanz Perl, Samuel Johnson, Niamh Bourke, Robin Carhart-Harris, Morten L. Kringelbach (2024). \textit{Different hierarchical reconfigurations in the brain by psilocybin and escitalopram for depression}. Nature Mental Health. [published; OpenAlex]. \href{https://doi.org/10.1038/s44220-024-00298-y}{doi:10.1038/s44220-024-00298-y}.
\item Aday JS, Horton D, Fernandes-Osterhold G, O'Donovan A, Bradley ER, Rosen RC, Woolley JD (2024). \textit{Psychedelic-assisted psychotherapy: where is the psychotherapy research?}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06620-x}{doi:10.1007/s00213-024-06620-x}.
\item Mograbi DC, Rodrigues R, Bienemann B, Huntley J (2024). \textit{Brain Networks, Neurotransmitters and Psychedelics: Towards a Neurochemistry of Self-Awareness.}. Current neurology and neuroscience reports. [published; PubMed]. \href{https://doi.org/10.1007/s11910-024-01353-y}{doi:10.1007/s11910-024-01353-y}.
\item david J, Berkovich-Ohana A, Dor-Ziderman Y. (2024). \textit{Embracing Change: Impermanence Acceptance Mediates Differences in Death Processing Between Ayahuasca Users and Non-users}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/tmeb3}{doi:10.31234/osf.io/tmeb3}.
\item Unknown authors (2024). \textit{Embracing Change: Impermanence Acceptance Mediates Differences in Death Processing Between Ayahuasca Users and Non-users}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/tmeb3\_v1}{source link}.
\item Washington University School of Medicine (2024). \textit{Psilocybin for the Treatment of Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05675800}{source link}.
\item Butler M, Bird C, Maggio C, Durden A, Modlin N, Campbell-Coker K, Edwards M, Pick S, Millman LM, Lowery E, Bhagavan C, Kanaan R, Golder D, Mildon B, Mehta M, Rucker J, Nicholson TR. (2024). \textit{Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol}. Wellcome Open Res. [preprint; Europe PMC]. \href{https://doi.org/10.12688/wellcomeopenres.22543.1}{doi:10.12688/wellcomeopenres.22543.1}.
\item Sara de la Salle, Hannes Kettner, Julien Thibault Lévesque, Nicolas Garel, Shannon Dames, Ryan Patchett-Marble, Soham Rej, Sara G. Gloeckler, David Erritzøe, Robin Carhart-Harris, Kyle T. Greenway (2024). \textit{Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-024-66817-0}{doi:10.1038/s41598-024-66817-0}.
\item Kristoffer Andreas Aamodt Andersen, Bjørn Holmøy, Lowan H. Stewart (2024). \textit{Assessment of psychedelic--induced states: Norwegian translation and adaptation of the revised Mystical Experience Questionnaire (MEQ-30)}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2024.00346}{doi:10.1556/2054.2024.00346}.
\item Ari Brouwer, Charles L. Raison, F. LeRon Shults (2024). \textit{The trajectory of psychedelic, spiritual, and psychotic experiences: implications for cognitive scientific perspectives on religion}. Religion Brain \& Behavior. [published; OpenAlex]. \href{https://doi.org/10.1080/2153599x.2024.2349151}{doi:10.1080/2153599x.2024.2349151}.
\item Zheng S, Ma R, Yang Y, Li G. (2024). \textit{Psilocybin for the treatment of Alzheimer's disease.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fnins.2024.1420601}{doi:10.3389/fnins.2024.1420601}.
\item Magdalena Kolasa, Agnieszka Nikiforuk, Agata Korlatowicz, Joanna Solich, Agnieszka Potasiewicz, Marta Dziedzicka-Wasylewska, Ryszard Bugno, Adam S. Hogendorf, Andrzej J. Bojarski, Agata Faron-Górecka (2024). \textit{Unraveling psilocybin’s therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-024-06644-3}{doi:10.1007/s00213-024-06644-3}.
\item Joshua M. Poulin, Gregory E. Bigford, Krista L. Lanctôt, Peter Giacobbe, Ayal Schaffer, Mark Sinyor, Jennifer S. Rabin, Mario Masellis, Amit Singnurkar, Christopher B. Pople, Nir Lipsman, Muhammad Ishrat Husain, Joshua D. Rosenblat, Xingshan Cao, Bradley J. MacIntosh, Sean M. Nestor (2024). \textit{Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depression}. Trials. [published; OpenAlex]. \href{https://doi.org/10.1186/s13063-024-08268-6}{doi:10.1186/s13063-024-08268-6}.
\item Shadani S, Conn K, Andrews ZB, Foldi CJ (2024). \textit{Potential Differences in Psychedelic Actions Based on Biological Sex.}. Endocrinology. [published; PubMed]. \href{https://doi.org/10.1210/endocr/bqae083}{doi:10.1210/endocr/bqae083}.
\item Nauman Ashraf (2024). \textit{IS PSYCHEDELIC TREATMENT OF MENTAL HEALTH DISORDERS READY FOR PRIME TIME?}. Journal of Pakistan Psychiatric Society. [published; OpenAlex]. \href{https://doi.org/10.63050/jpps.21.02.935}{doi:10.63050/jpps.21.02.935}.
\item Brownstien M, Lazar M, Botvinnik A, Shevakh C, Blakolmer K, Lerer L, Lifschytz T, Lerer B. (2024). \textit{Striking Long Term Beneficial Effects of Single Dose Psilocybin and Psychedelic Mushroom Extract in the SAPAP3 Rodent Model of OCD-Like Excessive Self-Grooming}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.06.25.600634}{doi:10.1101/2024.06.25.600634}.
\item Bennett Lange, Luke Morgan, Christopher Mattox, Suhrud Pathak, Keyi Liu, Rishi Nadar, Jun Ren, Jeyaram Bharathi Jeyabalan, Timothy Moore, Muralikrishnan Dhanasekaran (2024). \textit{Historical Perspectives and Pharmacodynamic Actions of the Magic Mushroom (Psilocybin) for Future Global Healthcare}. Trends in Medical Research. [published; OpenAlex]. \href{https://doi.org/10.3923/tmr.2024.245.273}{doi:10.3923/tmr.2024.245.273}.
\item Frederick A. Bagdasarian, Hanne D. Hansen, Jingyuan Chen, Chi-Hyeon Yoo, Michael S. Placzek, Jacob M. Hooker, Hsiao-Ying Wey (2024). \textit{Acute Effects of Hallucinogens on Functional Connectivity: Psilocybin and Salvinorin-A}. ACS Chemical Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1021/acschemneuro.4c00245}{doi:10.1021/acschemneuro.4c00245}.
\item P. Todd Korthuis, Adrianne R. Wilson-Poe, Joshua C. Black, Andrew A. Monte (2024). \textit{Commentary on Darkeet al.: Expanded psychedelic access requires new safety monitoring systems}. Addiction. [published; OpenAlex]. \href{https://doi.org/10.1111/add.16589}{doi:10.1111/add.16589}.
\item Ippolito A, Vasudevan S, Hurley S, Gilmour G, Westhorpe F, Churchill G, Sharp T. (2024). \textit{Increased 5-HT2A receptor signalling efficacy differentiates serotonergic psychedelics from non-psychedelics}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.06.13.594677}{doi:10.1101/2024.06.13.594677}.
\item Linda M. Richmond (2024). \textit{Psychedelics’ Use as Medicine Hits Significant Roadblock}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2024.07.7.54}{doi:10.1176/appi.pn.2024.07.7.54}.
\item Sandra Szafoni, Piotr Gręblowski, Klaudia Grabowska, Gniewko Więckiewicz (2024). \textit{Unlocking the healing power of psilocybin: an overview of the role of psilocybin therapy in major depressive disorder, obsessive-compulsive disorder and substance use disorder}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2024.1406888}{doi:10.3389/fpsyt.2024.1406888}.
\item Linda Nguyen, Sona Regonda, Adam Gaisinsky (2024). \textit{Therapeutic Potential of Fungally Derived Psilocybin Extract in Morphine-Dependent Mice: A Research Protocol}. Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal. [published; OpenAlex]. \href{https://doi.org/10.26685/urncst.588}{doi:10.26685/urncst.588}.
\item Ramos L, Vicente SG. (2024). \textit{The effects of psilocybin on cognition and emotional processing in healthy adults and adults with depression: a systematic literature review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/13803395.2024.2363343}{doi:10.1080/13803395.2024.2363343}.
\item Julia Bornemann, James B. Close, Kirran Ahmad, Tommaso Barba, Kate Godfrey, Lauren Macdonald, David Erritzøe, David Nutt, Robin Carhart-Harris (2024). \textit{Study protocol for “Psilocybin in patients with fibromyalgia: brain biomarkers of action”}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2024.1320780}{doi:10.3389/fpsyt.2024.1320780}.
\item Mengyang Xu, Andor J. Kiss, J. Andrew Jones, Matthew S. McMurray, Haifei Shi (2024). \textit{Effect of oral tryptamines on the gut microbiome of rats-a preliminary study}. PeerJ. [published; OpenAlex]. \href{https://doi.org/10.7717/peerj.17517}{doi:10.7717/peerj.17517}.
\item Haniff Z, Bocharova M, Mantingh T, Rucker J, Velayudhan L, Taylor D, Young A, Aarsland D, Vernon A, Thuret S. (2024). \textit{Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC11847495}{source link}.
\item Floris G, Dabrowski KR, Zanda MT, Daws SE. (2024). \textit{Psilocybin reduces heroin seeking behavior and modulates inflammatory gene expression in the nucleus accumbens and prefrontal cortex of male rats}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.05.28.596205}{doi:10.1101/2024.05.28.596205}.
\item Vohryzek J, Luppi A, Atasoy S, Deco G, Timmermann C, Carhart-Harris RL, Kringelbach ML. (2024). \textit{Time-resolved coupling between connectome harmonics and subjective experience under the psychedelic DMT}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.05.30.596410}{doi:10.1101/2024.05.30.596410}.
\item McGovern H, Wellman N, Hutchinson B, Oestreich LKL, Cooper SE, Fonzo G, Doss M. (2024). \textit{Resetting the Hippocampal Buffer: A Neurocognitive Account of Psychedelic Therapy for Anxiety-Related Psychopathology}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/y8sb7}{doi:10.31234/osf.io/y8sb7}.
\item Unknown authors (2024). \textit{Resetting the Hippocampal Buffer: A Neurocognitive Account of Psychedelic Therapy for Anxiety-Related Psychopathology}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/y8sb7\_v1}{source link}.
\item Andrea Casanova, Andres Ort, John W Smallridge, Katrin H. Preller, Erich Seifritz, Franz X. Vollenweider (2024). \textit{The influence of psilocybin on subconscious and conscious emotional learning}. iScience. [published; OpenAlex]. \href{https://doi.org/10.1016/j.isci.2024.110034}{doi:10.1016/j.isci.2024.110034}.
\item Fisher EL, Smith R, Corcoran AW, Milton LK, Conn K, Hohwy J, Foldi CJ. (2024). \textit{Psilocybin increases optimistic engagement over time: computational modelling of behavior in rats}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.05.16.594614}{doi:10.1101/2024.05.16.594614}.
\item University of Calgary (2024). \textit{Mechanisms Supporting Psilocybin-assisted Psychotherapy for Alcohol Use Disorder: A Randomized, Controlled Clinical Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05995769}{source link}.
\item Jérôme Jeanblanc, Romain Bordy, Grégory Fouquet, Virginie Jeanblanc, Mickaël Naassïla (2024). \textit{Psilocybin reduces alcohol self-administration via selective left nucleus accumbens activation in rats}. Brain. [published; OpenAlex]. \href{https://doi.org/10.1093/brain/awae136}{doi:10.1093/brain/awae136}.
\item Prince Patel, Samrat Gollapudi, Brian Joseph Mathew, Bhaumik B. Patel (2024). \textit{Brain Connectivity Pattern Changes Associated With Psychedelic-Assisted Psychotherapy}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.31986/issn.2689-0690\_rdw.stratford\_research\_day.179\_2024}{doi:10.31986/issn.2689-0690\_rdw.stratford\_research\_day.179\_2024}.
\item Claire Parker, Bethany Wood (2024). \textit{At the Forefront: Social Workers’ Role in Psilocybin Treatment for Depression and Substance Misuse}. Social Work. [published; OpenAlex]. \href{https://doi.org/10.1093/sw/swae019}{doi:10.1093/sw/swae019}.
\item Nicholas A Kerna, Kevin D. Pruitt, N.D. Victor Carsrud, Kyle Kadivi, Dabeluchi C. Ngwu, Hilary M. Holets, John V. Flores, Ijeoma Nnake, Cornelius I. Azi, Joseph Anderson, Fatimah A. Olunlade, Uzoamaka Nwokorie (2024). \textit{From Venerable Cultural Practices to Modern Psychological Solutions: Enter Entheogens into Mainstream Medicine}. European Journal of Arts Humanities and Social Sciences. [published; OpenAlex]. \href{https://doi.org/10.59324/ejahss.2024.1(3).10}{doi:10.59324/ejahss.2024.1(3).10}.
\item Schmid Y, Bershad AK (2024). \textit{Altered States and Social Bonds: Effects of MDMA and Serotonergic Psychedelics on Social Behavior as a Mechanism Underlying Substance-Assisted Therapy.}. Biological psychiatry. Cognitive neuroscience and neuroimaging. [published; PubMed]. \href{https://doi.org/10.1016/j.bpsc.2024.02.001}{doi:10.1016/j.bpsc.2024.02.001}.
\item Shafiee A, Arabzadeh Bahri R, Rafiei MA, Esmaeilpur Abianeh F, Razmara P, Jafarabady K, Amini MJ (2024). \textit{The effect of psychedelics on the level of brain-derived neurotrophic factor: A systematic review and meta-analysis.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811241234247}{doi:10.1177/02698811241234247}.
\item Jan Thomann, Karolina E. Kolaczynska, Oliver V Stoeckmann, Deborah Rudin, Patrick Vizeli, Marius C. Hoener, Christopher R. Pryce, Franz X. Vollenweider, Matthias E. Liechti, Urs Duthaler (2024). \textit{In vitro and in vivo metabolism of psilocybin’s active metabolite psilocin}. Frontiers in Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.3389/fphar.2024.1391689}{doi:10.3389/fphar.2024.1391689}.
\item Xiangting Zhao, Yingjie Du, Yishan Yao, Wei Dai, Yong-Yu Yin, Guyan Wang, Yunfeng Li, Liming Zhang (2024). \textit{Psilocybin promotes neuroplasticity and induces rapid and sustained antidepressant-like effects in mice}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811241249436}{doi:10.1177/02698811241249436}.
\item Kyna-Anne Conn, Laura K Milton, Kaixin Huang, Hermany Munguba, Janika Ruuska, M. B. Lemus, Erin Greaves, Jihane Homman-Ludiye, Brian J. Oldfield, Claire J. Foldi (2024). \textit{Psilocybin restrains activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms}. Molecular Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41380-024-02575-9}{doi:10.1038/s41380-024-02575-9}.
\item Tobias P. Whelan, Eileen Daly, Nicolaas A.J. Puts, Paula Smith, Carrie Allison, Simon Baron-Cohen, Ekaterina Malievskaia, Declan Murphy, Gráinne McAlonan (2024). \textit{The ‘PSILAUT’ protocol: an experimental medicine study of autistic differences in the function of brain serotonin targets of psilocybin}. BMC Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1186/s12888-024-05768-2}{doi:10.1186/s12888-024-05768-2}.
\item Paula Sophie Seibold, Sebastian Dörner, Janis Fricke, Tim Schäfer, Christine Beemelmanns, Dirk Hoffmeister (2024). \textit{Genetic regulation of l-tryptophan metabolism in Psilocybe mexicana supports psilocybin biosynthesis}. Fungal Biology and Biotechnology. [published; OpenAlex]. \href{https://doi.org/10.1186/s40694-024-00173-6}{doi:10.1186/s40694-024-00173-6}.
\item Terri D’Arrigo (2024). \textit{MedCheck: Psilocybin for Depression, LSD for Anxiety, Donanemab, LSD, and More}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2024.05.5.1}{doi:10.1176/appi.pn.2024.05.5.1}.
\item Ivan V, Tomas-Cuesta D, Esteves I, Luczak A, Mohajerani M, McNaughton B, Gruber A. (2024). \textit{Psilocybin reduces functional connectivity and the encoding of spatial information by neurons in mouse retrosplenial cortex}. Authorea Preprints. [preprint; Europe PMC]. \href{https://doi.org/10.22541/au.171378690.00112411/v1}{doi:10.22541/au.171378690.00112411/v1}.
\item Tipado Z, Kuypers KPC, Sorger B, Ramaekers JG. (2024). \textit{Visual hallucinations originating in the retinofugal pathway under clinical and psychedelic conditions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2024.04.011}{doi:10.1016/j.euroneuro.2024.04.011}.
\item Jordan Sloshower, Richard J. Zeifman, Jeffrey Guss, Robert Krause, Hamideh Safi-Aghdam, Surbhi Pathania, Brian Pittman, Deepak Cyril D’Souza (2024). \textit{Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-024-58318-x}{doi:10.1038/s41598-024-58318-x}.
\item Juliani A, Chelu V, Graesser L, Safron A. (2024). \textit{A dual-receptor model of serotonergic psychedelics}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.04.12.589282}{doi:10.1101/2024.04.12.589282}.
\item Joseph Peill, M. Marguilho, David Erritzøe, Tommaso Barba, Kyle T. Greenway, Fernando E. Rosas, Christopher Timmermann, Robin Carhart-Harris (2024). \textit{Psychedelics and the ‘inner healer’: Myth or mechanism?}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811241239206}{doi:10.1177/02698811241239206}.
\item Ram Harari, Ipsita Chatterjee, Dmitriy Getselter, Evan Elliott (2024). \textit{Psilocybin induces acute anxiety and changes in amygdalar phosphopeptides independently from the 5-HT2A receptor}. iScience. [published; OpenAlex]. \href{https://doi.org/10.1016/j.isci.2024.109686}{doi:10.1016/j.isci.2024.109686}.
\item Gayle Maloney, Terence H. W. Ching, Stephen A. Kichuk, Christopher Pittenger, Benjamin Kelmendi (2024). \textit{Mechanisms of therapeutic change after psychedelic treatment in OCD}. Psychiatry Research. [published; OpenAlex]. \href{https://doi.org/10.1016/j.psychres.2024.115907}{doi:10.1016/j.psychres.2024.115907}.
\item Haniff ZR, Bocharova M, Mantingh T, Rucker JJ, Velayudhan L, Taylor DM, Young AH, Aarsland D, Vernon AC, Thuret S. (2024). \textit{Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pharmthera.2024.108641}{doi:10.1016/j.pharmthera.2024.108641}.
\item M. Imad Damaj, Eda Köşeli, Belle Buzzi, Yogesh Rakholia, Melissa J. Lewis, Javier González-Maeso (2024). \textit{Pharmacology of Classical Psychedelic in Mouse Models of Chronic Pain}. Journal of Pain. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jpain.2024.01.093}{doi:10.1016/j.jpain.2024.01.093}.
\item Le GH, Wong S, Badulescu S, Au H, Di Vincenzo JD, Gill H, Phan L, Rhee TG, Ho R, Teopiz KM, Kwan ATH, Rosenblat JD, Mansur RB, McIntyre RS. (2024). \textit{Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2024.03.165}{doi:10.1016/j.jad.2024.03.165}.
\item Jesse Hudspeth, Kai Rogge, Sebastian Dörner, Maximilian Müll, Dirk Hoffmeister, Bernhard Rupp, Sebastiaan Werten (2024). \textit{Methyl transfer in psilocybin biosynthesis}. Nature Communications. [published; OpenAlex]. \href{https://doi.org/10.1038/s41467-024-46997-z}{doi:10.1038/s41467-024-46997-z}.
\item Natalie Ertl, Matthew B. Wall (2024). \textit{Scanning the new frontier of mental health: psychedelic brain imaging}. The Biochemist. [published; OpenAlex]. \href{https://doi.org/10.1042/bio\_2023\_171}{doi:10.1042/bio\_2023\_171}.
\item Ben Seal (2024). \textit{Psychedelic drugs and the law: What’s next?}. Knowable Magazine. [published; OpenAlex]. \href{https://doi.org/10.1146/knowable-031424-2}{doi:10.1146/knowable-031424-2}.
\item Brandon Weiss, Leor Roseman, Bruna Giribaldi, David Nutt, Robin Carhart-Harris, David Erritzøe (2024). \textit{Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive Disorder}. International Journal of Mental Health and Addiction. [published; OpenAlex]. \href{https://doi.org/10.1007/s11469-024-01253-9}{doi:10.1007/s11469-024-01253-9}.
\item Norred MA, Zuschlag ZD, Hamner MB. (2024). \textit{A Neuroanatomic and Pathophysiologic Framework for Novel Pharmacological Approaches to the Treatment of Post-traumatic Stress Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40265-023-01983-5}{doi:10.1007/s40265-023-01983-5}.
\item Habelt B, Afanasenkau D, Schwarz C, Domanegg K, Kuchar M, Werner C, Minev IR, Spanagel R, Meinhardt MW, Bernhardt N. (2024). \textit{Prefrontal Electrophysiological Biomarkers and Mechanism-Based Drug Effects in a Rat Model of Alcohol Addiction}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3905152/v1}{doi:10.21203/rs.3.rs-3905152/v1}.
\item Orr Shahar, Alexander Botvinnik, Amit Shwartz, Elad Lerer, Peretz Golding, Alex Buko, Ethan Hamid, Dani Kahn, Miles Guralnick, Karin Blakolmer, Gilly Wolf, Amit Lotan, Leonard Lerer, Bernard Lerer, Tzuri Lifschytz (2024). \textit{Effect of chemically synthesized psilocybin and psychedelic mushroom extract on molecular and metabolic profiles in mouse brain}. Molecular Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41380-024-02477-w}{doi:10.1038/s41380-024-02477-w}.
\item Frautschi PC, Singh AP, Stowe NA, Yu JJ. (2024). \textit{Multimodal Neuroimaging of the Effect of Serotonergic Psychedelics on the Brain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3174/ajnr.a8118}{doi:10.3174/ajnr.a8118}.
\item Hatzipantelis CJ, Olson DE (2024). \textit{The Effects of Psychedelics on Neuronal Physiology.}. Annual review of physiology. [published; PubMed]. \href{https://doi.org/10.1146/annurev-physiol-042022-020923}{doi:10.1146/annurev-physiol-042022-020923}.
\item Broc A. Pagni, Petros Petridis, Samantha K. Podrebarac, Jack Grinband, Eric D. Claus, Michael P. Bogenschutz (2024). \textit{Psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder: an fMRI pilot study}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-024-52967-8}{doi:10.1038/s41598-024-52967-8}.
\item Jitendra Kumar Sinha, Anchal Trisal, Shampa Ghosh, Saurabh Gupta, Krishna Kumar Singh, Sung Soo Han, Madhumita Mahapatra, Mosleh Mohammad Abomughaid, Ali M. Abomughayedh, Abdulmajeed G. Almutary, Danish Iqbal, Rakesh Bhaskar, Prabhu Chandra Mishra, Saurabh Kumar Jha, Niraj Kumar Jha, Abhishek Kumar Singh (2024). \textit{Psychedelics for alzheimer's disease-related dementia: Unveiling therapeutic possibilities and pathways}. Ageing Research Reviews. [published; OpenAlex]. \href{https://doi.org/10.1016/j.arr.2024.102211}{doi:10.1016/j.arr.2024.102211}.
\item Esmaeel Ghasemi Gojani, Bo Wang, Dongping Li, Olga Kovalchuk, Igor Kovalchuk (2024). \textit{The Effects of Psilocybin on Lipopolysaccharide-Induced Inflammation in THP-1 Human Macrophages}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives3010004}{doi:10.3390/psychoactives3010004}.
\item Timur Zanikov, Marta Gerasymchuk, Gregory Ian Robinson, Esmaeel Ghasemi Gojani, Shima Asghari, Alyssa Groves, Mackenzie Cameron, Rocio Rodriguez-Juarez, Alexandra Snelling, Darryl Hudson, Anna Fiselier, Olga Kovalchuk, Igor Kovalchuk (2024). \textit{Psilocybin and eugenol prevent DSS-induced neuroinflammation in mice}. Biocatalysis and Agricultural Biotechnology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.bcab.2024.103033}{doi:10.1016/j.bcab.2024.103033}.
\item Modlin NL, Creed M, Sarang M, Maggio C, Rucker JJ, Williamson V. (2024). \textit{Trauma-Informed Care in Psychedelic Therapy Research: A Qualitative Literature Review of Evidence-Based Psychotherapy Interventions in PTSD and Psychedelic Therapy Across Conditions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2147/ndt.s432537}{doi:10.2147/ndt.s432537}.
\item Roberto De Filippo, Dietmar Schmitz (2024). \textit{Synthetic surprise as the foundation of the psychedelic experience}. Neuroscience \& Biobehavioral Reviews. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neubiorev.2024.105538}{doi:10.1016/j.neubiorev.2024.105538}.
\item Swanson L, Jungers S, Varghese R, Cullen KR, Evans MD, Nielson J, Schallmo M. (2024). \textit{Enhanced visual contrast suppression during peak psilocybin effects: A psychophysical study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/5rm62}{doi:10.31234/osf.io/5rm62}.
\item Unknown authors (2024). \textit{Enhanced visual contrast suppression during peak psilocybin effects: A psychophysical study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/5rm62\_v1}{source link}.
\item Mehdi Sekssaoui, Joël Bockaert, Philippe Marin, Carine Bécamel (2024). \textit{Antidepressant-like effects of psychedelics in a chronic despair mouse model: is the 5-HT2A receptor the unique player?}. Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1038/s41386-024-01794-6}{doi:10.1038/s41386-024-01794-6}.
\item Terence H. W. Ching, Lucia Amoroso, Calvin Bohner, Elizabeth J. D’Amico, Jeffrey Eilbott, Tara Entezar, Madison Fitzpatrick, Geena Fram, Rachael Grazioplene, Jamila Hokanson, Anastasia Jankovsky, Stephen A. Kichuk, Bradford Martins, Prerana Patel, Henry Schaer, Sarah Shnayder, Chelsea Witherow, Christopher Pittenger, Benjamin Kelmendi (2024). \textit{Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2023.1278823}{doi:10.3389/fpsyt.2023.1278823}.
\item N. Jones, Laura M. Wagner, Molly C. Pellitteri Hahn, Cameron O. Scarlett, Cody J. Wenthur (2024). \textit{In vivo validation of psilacetin as a prodrug yielding modestly lower peripheral psilocin exposure than psilocybin}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2023.1303365}{doi:10.3389/fpsyt.2023.1303365}.
\item Alexander M. Sherwood, Elise K. Burkhartzmeyer, Samuel E. Williamson, Michael H. Baumann, Grant C. Glatfelter (2024). \textit{Psychedelic-like Activity of Norpsilocin Analogues}. ACS Chemical Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1021/acschemneuro.3c00610}{doi:10.1021/acschemneuro.3c00610}.
\item Huang Z, Wei X, Wang Y, Tian J, Dong J, Liang B, Lu L, Zhang W. (2024). \textit{Psilocybin Promotes Cell-Type-Specific Changes in the Orbitofrontal Cortex Revealed by Single-Nucleus RNA-seq}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.01.07.573163}{doi:10.1101/2024.01.07.573163}.
\item Shore R, Dobson K, Thomson N, Barnim N, Bergman H, Rideout K, McKeown S, Olmstead MC, Goldie C, Dumont E. (2024). \textit{Behavioural Investigations of Psilocybin in Animals 1962-2021: A Scoping Review}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.01.04.574146}{doi:10.1101/2024.01.04.574146}.
\item Devon Stoliker, Leonardo Novelli, Franz X. Vollenweider, Gary F. Egan, Katrin H. Preller, Adeel Razi (2024). \textit{Neural Mechanisms of Resting-State Networks and the Amygdala Underlying the Cognitive and Emotional Effects of Psilocybin}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2024.01.002}{doi:10.1016/j.biopsych.2024.01.002}.
\item Vanderijst L, Hever F, Buot A, Dauré C, Benoit J, Hanak C, Veeser J, Morgiève M, Campanella S, Kornreich C, Mallet L, Leys C, Noël X. (2024). \textit{Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Protocol for a Double-Blind, Randomized, Placebo-Controlled, 7-month Parallel-Group Phase II Superiority Trial}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3829237/v1}{doi:10.21203/rs.3.rs-3829237/v1}.
\item Kyna-Anne Conn, Laura K Milton, Kaixin Huang, Hermany Munguba, Jaana Ruuska, Mónica Lemus, Erin Greaves, Jihane Homman-Ludiye, Brian J. Oldfield, Claire J. Foldi (2023). \textit{Insights into the serotonergic mechanisms of psilocybin-induced improvements in anorexia-like behaviour in female rats}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2024.104774}{doi:10.1016/j.nsa.2024.104774}.
\item Prosenjit Ghosh, Avinash Desousa (2023). \textit{Psychedelics: The New Kid on the Block}. Annals of Indian Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.4103/aip.aip\_195\_23}{doi:10.4103/aip.aip\_195\_23}.
\item Dominic Sisti (2023). \textit{Introduction to the Special Section on Psychedelics Research and Treatment}. Perspectives in biology and medicine. [published; OpenAlex]. \href{https://doi.org/10.1353/pbm.2024.a919714}{doi:10.1353/pbm.2024.a919714}.
\item Gukasyan N, Narayan SK (2023). \textit{Menstrual Changes and Reversal of Amenorrhea Induced by Classic Psychedelics: A Case Series.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2022.2157350}{doi:10.1080/02791072.2022.2157350}.
\item Nutt DJ, Peill JM, Weiss B, Godfrey K, Carhart-Harris RL, Erritzoe D. (2023). \textit{Psilocybin and Other Classic Psychedelics in Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2023\_451}{doi:10.1007/7854\_2023\_451}.
\item M. Madsen, Anja Sofie Petersen, Dea Siggaard Stenbæk, Inger Marie Sørensen, Harald Schiønning, Tobias Fjeld, Charlotte H. Nykjær, Sara Marie Ulv Larsen, Maria Zofia Grzywacz, Tobias Mathiesen, Ida L. Klausen, Oliver Overgaard-Hansen, Kristoffer Brendstrup-Brix, Kristían Línnet, Sys Stybe Johansen, Patrick M. Fisher, Rigmor Jensen, Gitte M. Knudsen (2023). \textit{CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity}. Headache The Journal of Head and Face Pain. [published; OpenAlex]. \href{https://doi.org/10.1111/head.14656}{doi:10.1111/head.14656}.
\item Zaretsky TG, Jagodnik KM, Barsic R, Antonio JH, Bonanno PA, MacLeod C, Pierce C, Carney H, Morrison MT, Saylor C, Danias G, Lepow L, Yehuda R. (2023). \textit{The Psychedelic Future of Post-Traumatic Stress Disorder Treatment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/1570159x22666231027111147}{doi:10.2174/1570159x22666231027111147}.
\item Olivier B, Olivier JDA. (2023). \textit{Efficacy, Safety, and Tolerability of Psychedelics in Treatment-Resistant Depression (TRD).}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/978-981-97-4402-2\_3}{doi:10.1007/978-981-97-4402-2\_3}.
\item Martire G, Sipple D, Baron D, Gold MS, Lewandowski KU, Dennen CA, Sharafshah A, Elman I, Thanos PK, Modestino EJ, Badgaiyan RD, Pinhasov A, Bowirrat A, Makale M, Roy AK, Sunder K, Murphy KT, Mahajan S, Mahajan Y, Levin C, Blum K (2023). \textit{Theorizing that Psychedelic Assisted Therapy May Play a Role in the Treatment of Trauma-Induced Personality Disorders.}. Journal of addiction psychiatry. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/39634920/}{source link}.
\item Verheijen Marcha C.T. (2023). \textit{Psilocybin Therapy for Depression: A Review of Current Molecular Knowledge}. Journal of the Netherlands Society of Toxicology. [published; Crossref]. \href{https://doi.org/10.61833/jnst.2024.0002}{doi:10.61833/jnst.2024.0002}.
\item Poulin JM, Bigford GE, Lanctot KL, Giacobbe P, Schaffer A, Sinyor M, Rabin JS, Masellis M, Singnurkar A, Pople CB, Lipsman N, MacIntosh BJ, Nestor SM. (2023). \textit{Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, proof-of-principle, placebo-controlled and crossover, neuroimaging trial in depression}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3474764/v1}{doi:10.21203/rs.3.rs-3474764/v1}.
\item Wojtas A, Gołembiowska K. (2023). \textit{Molecular and Medical Aspects of Psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms25010241}{doi:10.3390/ijms25010241}.
\item Jingxuan Chen (2023). \textit{Application of psilocybin in mental health disorders}. Theoretical and Natural Science. [published; OpenAlex]. \href{https://doi.org/10.54254/2753-8818/21/20230859}{doi:10.54254/2753-8818/21/20230859}.
\item Shah FI, Shehzadi S, Akram F, Haq IU, Javed B, Sabir S, Kazim Y, Ashfaq S. (2023). \textit{Unveiling the Psychedelic Journey: An Appraisal of Psilocybin as a Profound Antidepressant Therapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s12033-023-00994-7}{doi:10.1007/s12033-023-00994-7}.
\item Gregory Ian Robinson, Dongping Li, Bo Wang, Tahiat Rahman, Marta Gerasymchuk, Darryl Hudson, Olga Kovalchuk, Igor Kovalchuk (2023). \textit{Psilocybin and Eugenol Reduce Inflammation in Human 3D EpiIntestinal Tissue}. Life. [published; OpenAlex]. \href{https://doi.org/10.3390/life13122345}{doi:10.3390/life13122345}.
\item McCulloch DE, Lopez JP, Dalla C, Castrén E, Erritzoe D, Frokjaer VG, Lundberg J, Preller KH, Fisher PM, Knudsen GM. (2023). \textit{Knowledge gaps in psychedelic medicalisation: Preclinical and neuroimaging mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.nsa.2023.103929}{doi:10.1016/j.nsa.2023.103929}.
\item Conn K, Milton L, Huang K, Munguba H, Ruuska J, Lemus M, Greaves E, Homman-Ludiye J, Oldfield B, Foldi C. (2023). \textit{Psilocybin prevents activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.12.12.571374}{doi:10.1101/2023.12.12.571374}.
\item Holas P, Kamińska J (2023). \textit{Mindfulness meditation and psychedelics: potential synergies and commonalities.}. Pharmacological reports: PR. [published; PubMed]. \href{https://doi.org/10.1007/s43440-023-00551-8}{doi:10.1007/s43440-023-00551-8}.
\item Duan W, Cao D, Wang S, Cheng J. (2023). \textit{Serotonin 2A Receptor (5-HT2AR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acs.chemrev.3c00375}{doi:10.1021/acs.chemrev.3c00375}.
\item Gattuso JJ, Wilson C, Hannan AJ, Renoir T. (2023). \textit{Psilocybin as a lead candidate molecule in preclinical therapeutic studies of psychiatric disorders: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/jnc.16017}{doi:10.1111/jnc.16017}.
\item Geyer MA. (2023). \textit{A Brief Historical Overview of Psychedelic Research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.bpsc.2023.11.003}{doi:10.1016/j.bpsc.2023.11.003}.
\item Halman A, Kong G, Sarris J, Perkins D. (2023). \textit{Drug-drug interactions involving classic psychedelics: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811231211219}{doi:10.1177/02698811231211219}.
\item McTaggart A, Scarlett K, Slot J, Barlow C, Appleyard C, Gardiner D, Fechner N, Tilden J, Hass D, Voogelbreinder S, Lording W, Lloyd R, Shuey L, Drenth A, James T. (2023). \textit{Wood-loving magic mushrooms from Australia are saprotrophic invaders in the northern hemisphere}. Authorea Preprints. [preprint; Europe PMC]. \href{https://doi.org/10.22541/au.170019739.91075425/v1}{doi:10.22541/au.170019739.91075425/v1}.
\item Schoeller F, Jain A, Adrien V, Maes P, Reggente N. (2023). \textit{Aesthetic Chills Mitigate Maladaptive Cognition In Depression}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3582420/v1}{doi:10.21203/rs.3.rs-3582420/v1}.
\item Wolinsky D, Barrett FS, Vandrey R. (2023). \textit{The psychedelic effects of cannabis: A review of the literature.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811231209194}{doi:10.1177/02698811231209194}.
\item Heresco-Levy U, Lerer B. (2023). \textit{Synergistic psychedelic - NMDAR modulator treatment for neuropsychiatric disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-023-02312-8}{doi:10.1038/s41380-023-02312-8}.
\item Chruścicka-Smaga B, Machaczka A, Szewczyk B, Pilc A. (2023). \textit{Interaction of hallucinogenic rapid-acting antidepressants with mGlu2/3 receptor ligands as a window for more effective therapies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s43440-023-00547-4}{doi:10.1007/s43440-023-00547-4}.
\item Madrid-Gambin F, Fabregat-Safont D, Gomez-Gomez A, Olesti E, Mason NL, Ramaekers JG, Pozo OJ. (2023). \textit{Present and future of metabolic and metabolomics studies focused on classical psychedelics in humans.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.biopha.2023.115775}{doi:10.1016/j.biopha.2023.115775}.
\item Van Der Walt J, Parker R. (2023). \textit{LSD and psilocybin for chronic nociplastic pain: A narrative review of the literature supporting the use of classic psychedelic agents in chronic pain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7196/samj.2023.v113i11.814}{doi:10.7196/samj.2023.v113i11.814}.
\item Cameron LP, Benetatos J, Lewis V, Bonniwell EM, Jaster AM, Moliner R, Castrén E, McCorvy JD, Palner M, Aguilar-Valles A. (2023). \textit{Beyond the 5-HT2A Receptor: Classic and Nonclassic Targets in Psychedelic Drug Action.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1523/jneurosci.1384-23.2023}{doi:10.1523/jneurosci.1384-23.2023}.
\item Henry Harder, Fabian P. Steinmetz, Maja Kohek (2023). \textit{The Psychedelic Social Club: a regulatory concept for people who use psychedelics?}. Drugs Education Prevention and Policy. [published; OpenAlex]. \href{https://doi.org/10.1080/09687637.2023.2276067}{doi:10.1080/09687637.2023.2276067}.
\item Banushi B, Polito V (2023). \textit{A Comprehensive Review of the Current Status of the Cellular Neurobiology of Psychedelics.}. Biology. [published; PubMed]. \href{https://doi.org/10.3390/biology12111380}{doi:10.3390/biology12111380}.
\item Kratina S, Lo C, Schwartz R, Strike C, Jopling S, Nayfeh A, Rush B. (2023). \textit{A protocol for a scoping review of psychedelic interventions to alleviate psychological suffering in populations coping with end-of-life issues}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/4gfyd}{doi:10.31234/osf.io/4gfyd}.
\item Unknown authors (2023). \textit{A protocol for a scoping review of psychedelic interventions to alleviate psychological suffering in populations coping with end-of-life issues}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/4gfyd\_v1}{source link}.
\item Nathalie M. Rieser, Ladina P Gubser, Flora Moujaes, Patricia Duerler, Candace R. Lewis, Lars Michels, Franz X. Vollenweider, Katrin H. Preller (2023). \textit{Psilocybin-induced changes in cerebral blood flow are associated with acute and baseline inter-individual differences}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-023-44153-z}{doi:10.1038/s41598-023-44153-z}.
\item Anna Douglas, Daniel Staas, Anna Hampton, Kylie Burns, F. Suter (2023). \textit{Psilocybin, Depression, and Synaptogenesis: Insights into the Field’s Past, Present, and Future}. Georgetown Scientific Research Journal. [published; OpenAlex]. \href{https://doi.org/10.48091/gsr.v3i2.62}{doi:10.48091/gsr.v3i2.62}.
\item Robert H. Dworkin, Michael McDermott, Sandeep M. Nayak, Eric C. Strain (2023). \textit{Psychedelics and Psychotherapy: Is the Whole Greater than the Sum of its Parts?}. Clinical Pharmacology \& Therapeutics. [published; OpenAlex]. \href{https://doi.org/10.1002/cpt.3050}{doi:10.1002/cpt.3050}.
\item Chloé Galipeau, Miguel Farinha-Ferreira, Jean-Charles Mariani, Samuel Diebolt, Louis Barthe, Renata Santos, Zsolt Lenkei, Ana M. Sebastião (2023). \textit{UNRAVELLING THE ROLE OF5-HT2AR ACTIVATION IN THE LONG-LASTING BEHAVIORAL EFFECTS OF PSILOCYBIN}. IBRO Neuroscience Reports. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ibneur.2023.08.1116}{doi:10.1016/j.ibneur.2023.08.1116}.
\item Aneta Petrušková, Eva-Maria Weiss, Debarpan Guhathakurta, Enes Yağız Akdaş, Bartomeu Perelló, Renato Frischknecht, Tomáš Páleníček, Anna Fejtová (2023). \textit{MODULATION OF SYNAPTIC FUNCTION AND NEURONAL NETWORK ACTIVITY BY SEROTONERGIC PSYCHEDELICS}. IBRO Neuroscience Reports. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ibneur.2023.08.608}{doi:10.1016/j.ibneur.2023.08.608}.
\item Tomáš Páleníček, Tereza Klučková, M. Nikolič, Čestmír Vejmola, Filip Tylš, Vojtěch Viktorin, Jiřı́ Horáček, Martin Brunovský (2023). \textit{DOES THE PHENOMENOLOGY OF THE PSILOCYBIN EXPERIENCE PREDICT LONG-TERM EFFECTS ON MOOD AND WELL-BEING IN HEALTHY VOLUNTEERS?}. IBRO Neuroscience Reports. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ibneur.2023.08.1240}{doi:10.1016/j.ibneur.2023.08.1240}.
\item Gold ND, Mallard AJ, Hermann JC, Zeifman RJ, Pagni BA, Bogenschutz MP, Ross S (2023). \textit{Exploring the Potential Utility of Psychedelic Therapy for Patients With Amyotrophic Lateral Sclerosis.}. Journal of palliative medicine. [published; PubMed]. \href{https://doi.org/10.1089/jpm.2022.0604}{doi:10.1089/jpm.2022.0604}.
\item Goel A, Rai Y, Sivadas S, Diep C, Clarke H, Shanthanna H, Ladha KS. (2023). \textit{Use of Psychedelics for Pain: A Scoping Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/aln.0000000000004673}{doi:10.1097/aln.0000000000004673}.
\item University of Zurich (2023). \textit{Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy and Mechanism in Alcohol Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04141501}{source link}.
\item Richa Tyagi, Tanishka S. Saraf, Clinton E. Canal (2023). \textit{The Psychedelic N,N-Dipropyltryptamine Prevents Seizures in a Mouse Model of Fragile X Syndrome via a Mechanism that Appears Independent of Serotonin and Sigma1 Receptors}. ACS Pharmacology \& Translational Science. [published; OpenAlex]. \href{https://doi.org/10.1021/acsptsci.3c00137}{doi:10.1021/acsptsci.3c00137}.
\item Guy M. Goodwin (2023). \textit{The psychedelic experience and treatment-resistant depression}. World Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1002/wps.21140}{doi:10.1002/wps.21140}.
\item Wolfgang AS, Hoge CW. (2023). \textit{Psychedelic-Assisted Therapy in Military and Veterans Healthcare Systems: Clinical, Legal, and Implementation Considerations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11920-023-01446-4}{doi:10.1007/s11920-023-01446-4}.
\item Zhang R, Anguiano M, Aarrestad IK, Lin S, Chandra J, Vadde SS, Olson DE, Kim CK. (2023). \textit{Rapid, biochemical tagging of cellular activity history in vivo}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.09.06.556431}{doi:10.1101/2023.09.06.556431}.
\item Syed OA, Tsang B, Gerlai R. (2023). \textit{The zebrafish for preclinical psilocybin research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2023.105381}{doi:10.1016/j.neubiorev.2023.105381}.
\item Natasha L. Mason, Attila Szabó, Kim P. C. Kuypers, Pablo Mallaroni, R. de la Torre Fornell, Johannes T. Reckweg, Desmond H. Y. Tse, Nadia R. P. W. Hutten, Amanda Feilding, Johannes G. Ramaekers (2023). \textit{Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: An experimental, placebo-controlled study}. Brain Behavior and Immunity. [published; OpenAlex]. \href{https://doi.org/10.1016/j.bbi.2023.09.004}{doi:10.1016/j.bbi.2023.09.004}.
\item Marc J. Weintraub, Jessica Jeffrey, Charles S. Grob, Megan Ichinose, R. Lindsey Bergman, Ziva D. Cooper, David J. Miklowitz (2023). \textit{Psilocybin-Assisted Cognitive Behavioral Therapy for Adults with Major Depressive Disorder: Rationale and Treatment Development}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1089/psymed.2023.0018}{doi:10.1089/psymed.2023.0018}.
\item Sofia Audrey B. Gonzales, Christine Alexopoulos, Daniel G. Arkfeld (2023). \textit{Potential Benefits of Psilocybin for Lupus Pain: A Case Report}. Current Rheumatology Reviews. [published; OpenAlex]. \href{https://doi.org/10.2174/1573397119666230904150750}{doi:10.2174/1573397119666230904150750}.
\item Kalfas M, Taylor RH, Tsapekos D, Young AH. (2023). \textit{Psychedelics for treatment resistant depression: are they game changers?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/14656566.2023.2281582}{doi:10.1080/14656566.2023.2281582}.
\item Pepe M, Hesami M, de la Cerda KA, Perreault ML, Hsiang T, Jones AMP. (2023). \textit{A journey with psychedelic mushrooms: From historical relevance to biology, cultivation, medicinal uses, biotechnology, and beyond.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.biotechadv.2023.108247}{doi:10.1016/j.biotechadv.2023.108247}.
\item Emmanuelle A. D. Schindler, Peter S. Hendricks (2023). \textit{Adapting psychedelic medicine for headache and chronic pain disorders}. Expert Review of Neurotherapeutics. [published; OpenAlex]. \href{https://doi.org/10.1080/14737175.2023.2246655}{doi:10.1080/14737175.2023.2246655}.
\item Sharma P, Nguyen QA, Matthews SJ, Carpenter E, Mathews DB, Patten CA, Hammond CJ. (2023). \textit{Psilocybin history, action and reaction: A narrative clinical review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811231190858}{doi:10.1177/02698811231190858}.
\item Alexsandra Kovacevich, Jeremy Weleff, Benjamin Claytor, Brian S. Barnett (2023). \textit{Three Cases of Reported Improvement in Microsmia and Anosmia Following Naturalistic Use of Psilocybin and LSD}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2023.2253538}{doi:10.1080/02791072.2023.2253538}.
\item Natália Bernardi Videira, Vijayalekshmi Nair, Valérie Paquet, Dean Calhoun (2023). \textit{The changing outlook of psychedelic drugs: The importance of risk assessment and occupational exposure limits}. Journal of Applied Toxicology. [published; OpenAlex]. \href{https://doi.org/10.1002/jat.4533}{doi:10.1002/jat.4533}.
\item Xuehan Du (2023). \textit{Pharmacology and Therapeutic Effects of Psilocybin}. Highlights in Science Engineering and Technology. [published; OpenAlex]. \href{https://doi.org/10.54097/hset.v65i.11331}{doi:10.54097/hset.v65i.11331}.
\item Robert Gramling, Emily Bennett, Keith Curtis, William A. Richards, Donna M. Rizzo, Francesca Arnoldy, Logan P Hegg, Jon Porter, Heather Honstein, Susanna Pratt, Elise C. Tarbi, Maija Reblin, Paul Thambi, Manish Agrawal (2023). \textit{Developing a Direct Observation Measure of Therapeutic Connection in Psilocybin-Assisted Therapy: A Feasibility Study}. Journal of Palliative Medicine. [published; OpenAlex]. \href{https://doi.org/10.1089/jpm.2023.0189}{doi:10.1089/jpm.2023.0189}.
\item Nick Zagorski (2023). \textit{Australia Legalizes Psychedelics for Use in Depression, PTSD Therapy}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2023.09.9.20}{doi:10.1176/appi.pn.2023.09.9.20}.
\item Anna Jaremek, Joanna Kępa, Norbert Kandefer, Michał Wyszkowski, Aleksandra Grabarczyk, Anna Pawlak, Sylwia Grad, Małgorzata Gregorek, Paweł Gregorek (2023). \textit{Psilocybin's Emerging Role in Combating Depressive Disorder}. Journal of Education Health and Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/jehs.2023.40.01.011}{doi:10.12775/jehs.2023.40.01.011}.
\item Pilozzi A, Foster S, Mischoulon D, Fava M, Huang X (2023). \textit{A Brief Review on the Potential of Psychedelics for Treating Alzheimer's Disease and Related Depression.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms241512513}{doi:10.3390/ijms241512513}.
\item Jahanabadi S, Amiri S, Karkeh-Abadi M, Razmi A. (2023). \textit{Natural psychedelics in the treatment of depression; a review focusing on neurotransmitters.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.fitote.2023.105620}{doi:10.1016/j.fitote.2023.105620}.
\item Shahar O, Botvinnik A, Shwartz A, Lerer E, Buko A, Hamid E, Kahn D, Guralnick M, Blakolmer K, Wolf G, Lerer L, Lerer B, Lifschytz T. (2023). \textit{Distinctive Molecular and Metabolic Profiles of Chemically Synthesized Psilocybin and Psychedelic Mushroom Extract}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3146433/v1}{doi:10.21203/rs.3.rs-3146433/v1}.
\item Kuypers K. (2023). \textit{Psychedelics for depression: from neurobiology to treatment}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC10417770}{source link}.
\item Lin M, Lee H, Tsang V, Chai B, Howard A, Uy C, Elefante J. (2023). \textit{Systematic Review on the Mechanisms of Action of Psilocybin in the Treatment of Depression}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC10434693}{source link}.
\item Nicolas Garel, Julien Thibault Lévesque, Dasha A. Sandra, Justin Lessard-Wajcer, Elizaveta Solomonova, Michael Lifshitz, Stéphane Richard-Devantoy, Kyle T. Greenway (2023). \textit{Imprinting: expanding the extra-pharmacological model of psychedelic drug action to incorporate delayed influences of sets and settings}. Frontiers in Human Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.3389/fnhum.2023.1200393}{doi:10.3389/fnhum.2023.1200393}.
\item Nkadimeng SM, Hay L, Steinmann CM, Eloff JN. (2023). \textit{Administration effects of four psilocybin mushroom extracts on serotonin levels and endothelial nitric oxide synthase activity levels in vivo and in vitro after one hour}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3088850/v1}{doi:10.21203/rs.3.rs-3088850/v1}.
\item Flora Moujaes, Nathalie M. Rieser, Christophe Phillips, Nuno M.P. de Matos, Mike Brügger, P. Dürler, Lukasz Smigielski, Philipp Stämpfli, Erich Seifritz, Franz X. Vollenweider, Alan Anticevic, Katrin H. Preller (2023). \textit{Comparing Neural Correlates of Consciousness: From Psychedelics to Hypnosis and Meditation}. Biological Psychiatry Cognitive Neuroscience and Neuroimaging. [published; OpenAlex]. \href{https://doi.org/10.1016/j.bpsc.2023.07.003}{doi:10.1016/j.bpsc.2023.07.003}.
\item Kozak Z, Johnson MW, Aaronson ST. (2023). \textit{Assessing potential of psilocybin for depressive disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/13543784.2023.2273493}{doi:10.1080/13543784.2023.2273493}.
\item Patrick D. Skosnik, Jordan Sloshower, Hamideh Safi-Aghdam, Surbhi Pathania, Shariful A. Syed, Brian Pittman, Deepak Cyril D’Souza (2023). \textit{Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811231179800}{doi:10.1177/02698811231179800}.
\item Scala M, Fanelli G, De Ronchi D, Serretti A, Fabbri C. (2023). \textit{Clinical specificity profile for novel rapid acting antidepressant drugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/yic.0000000000000488}{doi:10.1097/yic.0000000000000488}.
\item Winston De La Haye, G Walcott, Jordan Eaton, Jhoelle Beckford, Janelle D. Greene (2023). \textit{Psychedelic Assisted Psychotherapy preparing your target using psychohistoriography: a Jamaican perspective}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2023.1136990}{doi:10.3389/fpsyt.2023.1136990}.
\item Lee HJ, Tsang VW, Chai BS, Lin MC, Howard A, Uy C, Elefante JO. (2023). \textit{Psilocybin's Potential Mechanisms in the Treatment of Depression: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2023.2223195}{doi:10.1080/02791072.2023.2223195}.
\item Terri D’Arrigo (2023). \textit{Experts Offer Tips on Talking With Patients About Psychedelics}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2023.07.7.51}{doi:10.1176/appi.pn.2023.07.7.51}.
\item Hecker L, kato k, Kleinhenz JMK, Shin Y, Papageorgiou J, Zarrabi A. (2023). \textit{Psilocybin decelerates cellular senescence}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-2921423/v1}{doi:10.21203/rs.3.rs-2921423/v1}.
\item Chen T, Cheng L, Ma J, Yuan J, Pi C, Xiong L, Chen J, Liu H, Tang J, Zhong Y, Zhang X, Liu Z, Zuo Y, Shen H, Wei Y, Zhao L. (2023). \textit{Molecular mechanisms of rapid-acting antidepressants: New perspectives for developing antidepressants.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.phrs.2023.106837}{doi:10.1016/j.phrs.2023.106837}.
\item Filip Tylš, Čestmír Vejmola, Vlastimil Koudelka, Václava Piorecká, L. Kadeřábek, Marcel Bochin, Tomáš Novák, Martin Kuchař, Zdeňka Bendová, Martin Brunovský, Jiřı́ Horáček, Tomáš Pálení ček (2023). \textit{Underlying pharmacological mechanisms of psilocin-induced broadband desynchronization and disconnection of EEG in rats}. Frontiers in Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.3389/fnins.2023.1152578}{doi:10.3389/fnins.2023.1152578}.
\item Calder A, Mock S, Friedli N, Pasi P, Hasler G. (2023). \textit{Psychedelics in the treatment of eating disorders: Rationale and potential mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2023.05.008}{doi:10.1016/j.euroneuro.2023.05.008}.
\item Jessica E. Flower, William J. Gibbons, Alexandra M. Adams, Xin Wang, Caroline N. Broude, J. Andrew Jones (2023). \textit{“Biosynthesis of psilocybin and its nonnatural derivatives by a promiscuous psilocybin synthesis pathway in Escherichia coli”}. Biotechnology and Bioengineering. [published; OpenAlex]. \href{https://doi.org/10.1002/bit.28480}{doi:10.1002/bit.28480}.
\item Gina Ratkovic, Mike Sosteric, Tristan Sosteric (2023). \textit{A case-study evaluation of the “Copenhagen Music Program” for psilocybin-assisted therapy}. Frontiers in Psychology. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyg.2023.1156852}{doi:10.3389/fpsyg.2023.1156852}.
\item Gabrielle Agin-Liebes, Elizabeth M. Nielson, Michael A. Zingman, Katherine Kim, Alexandra Haas, Lindsey T. Owens, Ursula Rogers, Michael P. Bogenschutz (2023). \textit{Reports of self-compassion and affect regulation in psilocybin-assisted therapy for alcohol use disorder: An interpretive phenomenological analysis.}. Psychology of Addictive Behaviors. [published; OpenAlex]. \href{https://doi.org/10.1037/adb0000935}{doi:10.1037/adb0000935}.
\item Halman A, Kong G, Sarris J, Perkins D. (2023). \textit{Drug-drug interactions between classic psychedelics and psychoactive drugs: a systematic review}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2023.06.01.23290811}{doi:10.1101/2023.06.01.23290811}.
\item Rafael Moliner, Mykhailo Girych, Cecilia A. Brunello, Vera Kovaleva, Caroline Biojone, Giray Enkavi, Lina Antenucci, Erik F. Kot, Sergey A. Goncharuk, Katja Kaurinkoski, Mirjami Kuutti, Senem Merve Fred, Lauri Elsilä, Sven Sakson, Cecilia Cannarozzo, Cassiano R.A.F. Diniz, Nina Seiffert, Anna Rubiolo, Hele Haapaniemi, Elsa Meshi, Elina Nagaeva, Tiina Öhman, Tomasz Róg, Esko Kankuri, Marçal Vilar, Markku Varjosalo, Esa R. Korpi, Perttu Permi, Константин С. Минеев, Märt Saarma, Ilpo Vattulainen, Plínio Casarotto, Eero Ċastrén (2023). \textit{Psychedelics promote plasticity by directly binding to BDNF receptor TrkB}. Nature Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1038/s41593-023-01316-5}{doi:10.1038/s41593-023-01316-5}.
\item Whelan TP, Daly E, Puts NA, Malievskaia E, Murphy DG, McAlonan GM. (2023). \textit{Bridging the translational neuroscience gap: Development of the ‘shiftability’ paradigm and an exemplar protocol to capture psilocybin-elicited ‘shift’ in neurobiological mechanisms in autism}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2023.05.25.23290521}{doi:10.1101/2023.05.25.23290521}.
\item Keramatian K, Chakrabarty T, DuBow A, Saraf G, Yatham LN. (2023). \textit{New Pharmacologic Approaches to the Treatment of Bipolar Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40265-023-01872-x}{doi:10.1007/s40265-023-01872-x}.
\item Junhong Liu, Yuanyuan Wang, Ke Xia, Jinfeng Wu, Danhao Zheng, Aoling Cai, Haitao Yan, Ruibin Su (2023). \textit{Acute psilocybin increased cortical activities in rats}. Frontiers in Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.3389/fnins.2023.1168911}{doi:10.3389/fnins.2023.1168911}.
\item Lasch A, Schweikert T, Dora E, Kolb T, Schurig HL, Walther A. (2023). \textit{[Psilocybin-Assisted Treatment of Depression, Anxiety and Substance use Disorders: Neurobiological Basis and Clinical Application].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/a-2046-5202}{doi:10.1055/a-2046-5202}.
\item Meyer M, Slot J. (2023). \textit{The evolution and ecology of psilocybin in nature.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.fgb.2023.103812}{doi:10.1016/j.fgb.2023.103812}.
\item Kargbo RB. (2023). \textit{Microbiome-Gut-Brain Axis Modulation: New Approaches in Treatment of Neuropsychological and Gastrointestinal Functional Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.3c00168}{doi:10.1021/acsmedchemlett.3c00168}.
\item Goodwin GM, Croal M, Marwood L, Malievskaia E (2023). \textit{Unblinding and demand characteristics in the treatment of depression.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2023.02.030}{doi:10.1016/j.jad.2023.02.030}.
\item Terence H. W. Ching, Rachael Grazioplene, Calvin Bohner, Stephen A. Kichuk, Giuliana DePalmer, Elizabeth J. D’Amico, Jeffrey Eilbott, Anastasia Jankovsky, Michelle Burke, Jamila Hokanson, Brad Martins, Chelsea Witherow, Prerana Patel, Lucia Amoroso, Henry Schaer, Christopher Pittenger, Benjamin Kelmendi (2023). \textit{Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2023.1178529}{doi:10.3389/fpsyt.2023.1178529}.
\item Braun D, Rosenberg A, Haruvi R, Malamud D, Barbara R, Kawashima T. (2023). \textit{High-resolution tracking of unconfined zebrafish behavior reveals stimulatory and anxiolytic effects of psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.04.13.536830}{doi:10.1101/2023.04.13.536830}.
\item Khan I, Jaura TA, Tukruna A, Arif A, Tebha SS, Nasir S, Mukherjee D, Masroor N, Yosufi A. (2023). \textit{Use of Selective Alternative Therapies for Treatment of OCD.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2147/ndt.s403997}{doi:10.2147/ndt.s403997}.
\item Zia FZ, Baumann MH, Belouin SJ, Dworkin RH, Ghauri MH, Hendricks PS, Henningfield JE, Lanier RK, Ross S, Berger A. (2023). \textit{Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2023.109528}{doi:10.1016/j.neuropharm.2023.109528}.
\item Yingjie Du, Yunfeng Li, Xiangting Zhao, Yishan Yao, Bin Wang, Liming Zhang, Guyan Wang (2023). \textit{Psilocybin facilitates fear extinction in mice by promoting hippocampal neuroplasticity}. Chinese Medical Journal. [published; OpenAlex]. \href{https://doi.org/10.1097/cm9.0000000000002647}{doi:10.1097/cm9.0000000000002647}.
\item Ibi D. (2023). \textit{[Contribution of serotonin 5-HT2A receptor to antidepressant effect of serotonergic psychedelics].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1254/fpj.22141}{doi:10.1254/fpj.22141}.
\item William Irvine, Marshall Tyler, Rupika Delgoda (2023). \textit{In silico characterization of the psilocybin biosynthesis pathway}. Computational Biology and Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.compbiolchem.2023.107854}{doi:10.1016/j.compbiolchem.2023.107854}.
\item Domanegg K, Sommer WH, Meinhardt MW. (2023). \textit{Psychedelic Targeting of Metabotropic Glutamate Receptor 2 and Its Implications for the Treatment of Alcoholism.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/cells12060963}{doi:10.3390/cells12060963}.
\item Ching THW, Grazioplene R, Pittenger C, Kelmendi B. (2023). \textit{Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin Combined with Non-Directive Support in the Treatment of OCD}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/ba42z}{doi:10.31234/osf.io/ba42z}.
\item Unknown authors (2023). \textit{Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin Combined with Non-Directive Support in the Treatment of OCD}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/ba42z\_v1}{source link}.
\item Timur Zanikov, Marta Gerasymchuk, Esmaeel Ghasemi Gojani, Gregory Ian Robinson, Shima Asghari, Alyssa Groves, Lucie Haselhorst, Sanjana Nandakumar, Cora Stahl, Mackenzie Cameron, Dongping Li, Rocio Rodriguez-Juarez, Alexandra Snelling, Darryl Hudson, Anna Fiselier, Olga Kovalchuk, Igor Kovalchuk (2023). \textit{The Effect of Combined Treatment of Psilocybin and Eugenol on Lipopolysaccharide-Induced Brain Inflammation in Mice}. Molecules. [published; OpenAlex]. \href{https://doi.org/10.3390/molecules28062624}{doi:10.3390/molecules28062624}.
\item Wulff AB, Nichols CD, Thompson SM. (2023). \textit{Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2023.109504}{doi:10.1016/j.neuropharm.2023.109504}.
\item Steven W. Cotten, Frederick G. Strathmann, Frederick S. Barrett, Laura Labay, James Mullally, Alexander M. Sherwood, Frank Wiegand (2023). \textit{Psychedelics for Medicinal Use: How Will This Alter the Collective Laboratory Consciousness?}. Clinical Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1093/clinchem/hvad016}{doi:10.1093/clinchem/hvad016}.
\item Kalkman HO (2023). \textit{Inhibition of Microglial GSK3β Activity Is Common to Different Kinds of Antidepressants: A Proposal for an In Vitro Screen to Detect Novel Antidepressant Principles.}. Biomedicines. [published; PubMed]. \href{https://doi.org/10.3390/biomedicines11030806}{doi:10.3390/biomedicines11030806}.
\item Shi En Kim (2023). \textit{How psychedelics spark neuronal growth}. C\&EN Global Enterprise. [published; OpenAlex]. \href{https://doi.org/10.1021/cen-10108-scicon1}{doi:10.1021/cen-10108-scicon1}.
\item Lazur J, Hnatyk K, Kała K, Sułkowska-Ziaja K, Muszyńska B. (2023). \textit{Discovering the Potential Mechanisms of Medicinal Mushrooms Antidepressant Activity: A Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/antiox12030623}{doi:10.3390/antiox12030623}.
\item Zohairi F, Khandelia H, Hakami Zanjani AA (2023). \textit{Interaction of psychedelic tryptamine derivatives with a lipid bilayer.}. Chemistry and physics of lipids. [published; PubMed]. \href{https://doi.org/10.1016/j.chemphyslip.2023.105279}{doi:10.1016/j.chemphyslip.2023.105279}.
\item Meghan Hibicke, Hannah M. Kramer, Charles D. Nichols (2023). \textit{A Single Administration of Psilocybin Persistently Rescues Cognitive Deficits Caused by Adolescent Chronic Restraint Stress Without Long-Term Changes in Synaptic Protein Gene Expression in a Rat Experimental System with Translational Relevance to Depression}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1089/psymed.2022.0012}{doi:10.1089/psymed.2022.0012}.
\item Gattuso JJ, Perkins D, Ruffell S, Lawrence AJ, Hoyer D, Jacobson LH, Timmermann C, Castle D, Rossell SL, Downey LA, Pagni BA, Galvão-Coelho NL, Nutt D, Sarris J. (2023). \textit{Default Mode Network Modulation by Psychedelics: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/ijnp/pyac074}{doi:10.1093/ijnp/pyac074}.
\item Jacques Ambrose, J.S. Zabinski (2023). \textit{Psychedelic Renaissance: Clinical Health Justice, Patient Safety, and Equity Need to Be Put First}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2023.03.3.43}{doi:10.1176/appi.pn.2023.03.3.43}.
\item Terri D’Arrigo (2023). \textit{Psychedelics Legislation Gains Momentum}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2023.03.3.4}{doi:10.1176/appi.pn.2023.03.3.4}.
\item Yahong Chen, Junhong Liu, Yishan Yao, Haitao Yan, Ruibin Su (2023). \textit{Rearing behaviour in the mouse behavioural pattern monitor distinguishes the effects of psychedelics from those of lisuride and TBG}. Frontiers in Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.3389/fphar.2023.1021729}{doi:10.3389/fphar.2023.1021729}.
\item Henríquez-Hernández LA, Rojas-Hernández J, Quintana-Hernández DJ, Borkel LF. (2023). \textit{Hofmann vs. Paracelsus: Do Psychedelics Defy the Basics of Toxicology?-A Systematic Review of the Main Ergolamines, Simple Tryptamines, and Phenylethylamines.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/toxics11020148}{doi:10.3390/toxics11020148}.
\item Pedicini M, Cordner ZA. (2023). \textit{Utility of preclinical models in the study of psilocybin - A comprehensive review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2023.105046}{doi:10.1016/j.neubiorev.2023.105046}.
\item White CM, Weisman N, Dalo J. (2023). \textit{Psychedelics for Patients With Cancer: A Comprehensive Literature Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/10600280221144055}{doi:10.1177/10600280221144055}.
\item Mastinu A, Anyanwu M, Carone M, Abate G, Bonini SA, Peron G, Tirelli E, Pucci M, Ribaudo G, Oselladore E, Premoli M, Gianoncelli A, Uberti DL, Memo M. (2023). \textit{The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms24021329}{doi:10.3390/ijms24021329}.
\item Jing Wang, Min Liang, Qing Shang, Hongyan Qian, Ran An, Hua Liu, Gaojie Shao, Tao Li, Xinshe Liu (2023). \textit{Psilocin suppresses methamphetamine-induced hyperlocomotion and acquisition of conditioned place preference via D2R-mediated ERK signaling}. CNS Neuroscience \& Therapeutics. [published; OpenAlex]. \href{https://doi.org/10.1111/cns.14054}{doi:10.1111/cns.14054}.
\item Eklund, Julia (2022). \textit{Psilocin esters - An investigation of synthetic feasibility, chemical, and metabolic stability}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.16912635}{doi:10.5281/zenodo.16912635}.
\item Brian S. Barnett, Noah Wiles Sweat, Peter S. Hendricks (2022). \textit{Case report: Prolonged amelioration of mild red-green color vision deficiency following psilocybin mushroom use}. Drug Science Policy and Law. [published; OpenAlex]. \href{https://doi.org/10.1177/20503245231172536}{doi:10.1177/20503245231172536}.
\item Jack E. Henningfield, Judy Ashworth, David J. Heal, Sharon L. Smith (2022). \textit{Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811221140004}{doi:10.1177/02698811221140004}.
\item Mann JJ. (2022). \textit{Is psilocybin an effective antidepressant and what is its Mechanism of action?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.xcrm.2022.100906}{doi:10.1016/j.xcrm.2022.100906}.
\item Kelly JR, Clarke G, Harkin A, Corr SC, Galvin S, Pradeep V, Cryan JF, O'Keane V, Dinan TG (2022). \textit{Seeking the Psilocybiome: Psychedelics meet the microbiota-gut-brain axis.}. International journal of clinical and health psychology: IJCHP. [published; PubMed]. \href{https://doi.org/10.1016/j.ijchp.2022.100349}{doi:10.1016/j.ijchp.2022.100349}.
\item Rankaduwa S, Owen AM (2022). \textit{Psychedelics, entropic brain theory, and the taxonomy of conscious states: a summary of debates and perspectives.}. Neuroscience of consciousness. [published; PubMed]. \href{https://doi.org/10.1093/nc/niad001}{doi:10.1093/nc/niad001}.
\item Urban MM, Stingl MR, Meinhardt MW (2022). \textit{Mini-review: The neurobiology of treating substance use disorders with classical psychedelics.}. Frontiers in neuroscience. [published; PubMed]. \href{https://doi.org/10.3389/fnins.2023.1156319}{doi:10.3389/fnins.2023.1156319}.
\item Phan AN, Terry GE (2022). \textit{Systematic review and rationale of using psychedelics in the treatment of cannabis use disorder.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1144276}{doi:10.3389/fpsyt.2023.1144276}.
\item Acero VP, Cribas ES, Browne KD, Rivellini O, Burrell JC, O'Donnell JC, Das S, Cullen DK (2022). \textit{Bedside to bench: the outlook for psychedelic research.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2023.1240295}{doi:10.3389/fphar.2023.1240295}.
\item Barnett BS, Bassir Nia A, Sackett NB, Weleff J (2022). \textit{Editorial: Psychedelics as treatments for substance use disorders: exploring therapeutic potential, risks, underlying mechanisms of action, and implementation challenges.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1305478}{doi:10.3389/fpsyt.2023.1305478}.
\item Alistair R. McTaggart, Timothy Y. James, Jason C. Slot, Caine Barlow, Nigel Fechner, Louise S. Shuey, A. Drenth (2022). \textit{Genome sequencing progenies of magic mushrooms (Psilocybe subaeruginosa) identifies tetrapolar mating and gene duplications in the psilocybin pathway}. Fungal Genetics and Biology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.fgb.2022.103769}{doi:10.1016/j.fgb.2022.103769}.
\item Carhart-Harris RL, Chandaria S, Erritzoe DE, Gazzaley A, Girn M, Kettner H, Mediano PAM, Nutt DJ, Rosas FE, Roseman L, Timmermann C, Weiss B, Zeifman RJ, Friston KJ. (2022). \textit{Canalization and plasticity in psychopathology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2022.109398}{doi:10.1016/j.neuropharm.2022.109398}.
\item Meccia J, Lopez J, Bagot RC. (2022). \textit{Probing the antidepressant potential of psilocybin: integrating insight from human research and animal models towards an understanding of neural circuit mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-022-06297-0}{doi:10.1007/s00213-022-06297-0}.
\item Kelly DF, Kelly DF, Heinzerling K, Sharma A, Gowrinathan S, Sergi K, Mallari RJ. (2022). \textit{Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1227/neu.0000000000002275}{doi:10.1227/neu.0000000000002275}.
\item Geoffrey M. Bove, David J. Mokler (2022). \textit{Effects of a single dose of psilocybin on cytokines, chemokines and leptin in rat serum}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2022.00230}{doi:10.1556/2054.2022.00230}.
\item Neşe Devenot, Aidan Seale-Feldman, Elyse Smith, Tehseen Noorani, Albert Garcia-Romeu, Matthew W. Johnson (2022). \textit{Psychedelic Identity Shift: A Critical Approach to Set And Setting}. Kennedy Institute of Ethics journal. [published; OpenAlex]. \href{https://doi.org/10.1353/ken.2022.0022}{doi:10.1353/ken.2022.0022}.
\item Gukasyan N, Schreyer CC, Griffiths RR, Guarda AS (2022). \textit{Psychedelic-Assisted Therapy for People with Eating Disorders.}. Current psychiatry reports. [published; PubMed]. \href{https://doi.org/10.1007/s11920-022-01394-5}{doi:10.1007/s11920-022-01394-5}.
\item Shukuroglou M, Roseman L, Wall M, Nutt D, Kaelen M, Carhart-Harris R. (2022). \textit{Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811221125354}{doi:10.1177/02698811221125354}.
\item NWTraumatherapies (2022). \textit{NW Trauma Therapies, Chronic Illness of Chronic Depression, PTSD, MS, HIV, and SARS-CoV-2, Long Haulers Syndrome. Treatment of Unregulaaible Trauma by the Treatment of Enhanced Micro Dosing the Levels of 0.15, Thru 0.33, With a Maintenance Dose of 1 Gram Per Month for Neural Pathway Increase of Non Synthesized Psilocybin, Using the Actual Plant to Regulate the Highjacked Nervous System.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05042466}{source link}.
\item Schmitz GP, Chiu Y, König GM, Kostenis E, Roth BL, Herman MA. (2022). \textit{Psychedelic compounds directly excite 5-HT2A Layer 5 Pyramidal Neurons in the Prefrontal Cortex through a 5-HT2A Gq -mediated activation mechanism}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.11.15.516655}{doi:10.1101/2022.11.15.516655}.
\item Jefferson SJ, Gregg I, Dibbs M, Liao C, Wu H, Davoudian PA, Sprouse JS, Sherwood AM, Kaye AP, Pittenger C, Kwan AC. (2022). \textit{5-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.11.03.515044}{doi:10.1101/2022.11.03.515044}.
\item VanderZwaag J, Halvorson T, Dolhan K, Šimončičová E, Ben-Azu B, Tremblay MÈ. (2022). \textit{The Missing Piece? A Case for Microglia's Prominent Role in the Therapeutic Action of Anesthetics, Ketamine, and Psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11064-022-03772-0}{doi:10.1007/s11064-022-03772-0}.
\item Hamna Raheel, Unaiza Naeem, Asim Shaikh, Omer Ahmed Shaikh (2022). \textit{The psychedelic renaissance: can psilocybin possibly combat depression?}. International Journal of Surgery Global Health. [published; OpenAlex]. \href{https://doi.org/10.1097/gh9.0000000000000089}{doi:10.1097/gh9.0000000000000089}.
\item Syed Rizwan A. Bokhari, Ahmad Makmom Abdullah, Zamir A. Zamir, Raquel M. Rosen (2022). \textit{A Rare Case of Magic Mushroom (Psilocybin) Related AKI and Hypertensive Emergency}. Journal of the American Society of Nephrology. [published; OpenAlex]. \href{https://doi.org/10.1681/asn.20223311s1895a}{doi:10.1681/asn.20223311s1895a}.
\item Mason N, Szabo A, Kuypers K, Mallaroni P, de la Torre Fornell R, Reckweg J, Tse D, Hutten N, Feilding A, Ramaekers J. (2022). \textit{Psilocybin induces acute and persisting alterations in immune status and the stress response in healthy volunteers}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2022.10.31.22281688}{doi:10.1101/2022.10.31.22281688}.
\item Calleja-Conde J, Morales-García JA, Echeverry-Alzate V, Bühler KM, Giné E, López-Moreno JA. (2022). \textit{Classic psychedelics and alcohol use disorders: A systematic review of human and animal studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/adb.13229}{doi:10.1111/adb.13229}.
\item Dupuis D, Veissière S. (2022). \textit{Culture, context, and ethics in the therapeutic use of hallucinogens: Psychedelics as active super-placebos?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/13634615221131465}{doi:10.1177/13634615221131465}.
\item Jensen ME, Jensen ME, Stenbæk DS, Juul TS, Fisher PM, Ekstrøm CT, Knudsen GM, Fink-Jensen A. (2022). \textit{Psilocybin-assisted therapy for reducing alcohol intake in patients with alcohol use disorder: protocol for a randomised, double-blinded, placebo-controlled 12-week clinical trial (The QUANTUM Trip Trial).}. BMJ Open. [published; Europe PMC]. \href{https://doi.org/10.1136/bmjopen-2022-066019}{doi:10.1136/bmjopen-2022-066019}.
\item Vamvakopoulou IA, Narine KAD, Campbell I, Dyck JRB, Nutt DJ. (2022). \textit{Mescaline: The forgotten psychedelic.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2022.109294}{doi:10.1016/j.neuropharm.2022.109294}.
\item Sottile RJ, Vida T. (2022). \textit{A proposed mechanism for the MDMA-mediated extinction of traumatic memories in PTSD patients treated with MDMA-assisted therapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2022.991753}{doi:10.3389/fpsyt.2022.991753}.
\item Goel DB, Zilate S. (2022). \textit{Potential Therapeutic Effects of Psilocybin: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.30214}{doi:10.7759/cureus.30214}.
\item McCartney AM, McGovern HT, De Foe A. (2022). \textit{Predictors of Psychedelic Experience: A Thematic Analysis.}. Journal of Psychoactive Drugs. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2022.2129885}{doi:10.1080/02791072.2022.2129885}.
\item Liu Y, Guo ZJ, Zhou XW (2022). \textit{Chinese Cordyceps: Bioactive Components, Antitumor Effects and Underlying Mechanism-A Review.}. Molecules (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/molecules27196576}{doi:10.3390/molecules27196576}.
\item López-Arnau R, Camarasa J, Carbó ML, Nadal-Gratacós N, Puigseslloses P, Espinosa-Velasco M, Urquizu E, Escubedo E, Pubill D. (2022). \textit{3,4-Methylenedioxy methamphetamine, synthetic cathinones and psychedelics: From recreational to novel psychotherapeutic drugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2022.990405}{doi:10.3389/fpsyt.2022.990405}.
\item Dworkin RH, Anderson BT, Andrews N, Edwards RR, Grob CS, Ross S, Satterthwaite TD, Strain EC (2022). \textit{If the Doors of Perception Were Cleansed, Would Chronic Pain be Relieved? Evaluating the Benefits and Risks of Psychedelics.}. The journal of pain. [published; PubMed]. \href{https://doi.org/10.1016/j.jpain.2022.05.003}{doi:10.1016/j.jpain.2022.05.003}.
\item Pochwat B, Krupa AJ, Siwek M, Szewczyk B (2022). \textit{New investigational agents for the treatment of major depressive disorder.}. Expert opinion on investigational drugs. [published; PubMed]. \href{https://doi.org/10.1080/13543784.2022.2113376}{doi:10.1080/13543784.2022.2113376}.
\item Gobbi G, Inserra A, Greenway KT, Lifshitz M, Kirmayer LJ (2022). \textit{Psychedelic medicine at a crossroads: Advancing an integrative approach to research and practice.}. Transcultural psychiatry. [published; PubMed]. \href{https://doi.org/10.1177/13634615221119388}{doi:10.1177/13634615221119388}.
\item Cruzat J, Perl YS, Escrichs A, Vohryzek J, Timmermann C, Roseman L, Luppi AI, Ibañez A, Nutt D, Carhart-Harris R, Tagliazucchi E, Deco G, Kringelbach ML. (2022). \textit{Effects of classic psychedelic drugs on turbulent signatures in brain dynamics.}. Network Neuroscience. [published; Europe PMC]. \href{https://doi.org/10.1162/netn\_a\_00250}{doi:10.1162/netn\_a\_00250}.
\item Dougherty RF, Clarke P, Alti M, Kuc J, Schlosser D, Dunlop BW, Hellerstein DJ, Aaronson ST, Zisook S, Young AH, Carhart-Harris R, Goodwin G, Ryslik GA. (2022). \textit{Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language Processing}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/kh3cx}{doi:10.31234/osf.io/kh3cx}.
\item Unknown authors (2022). \textit{Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language Processing}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/kh3cx\_v1}{source link}.
\item Vohryzek J, Cabral J, Lord L, Fernandes H, Roseman L, Nutt D, Carhart-Harris R, Deco G, Kringelbach M. (2022). \textit{Brain dynamics predictive of response to psilocybin for treatment-resistant depression}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-2060381/v1}{doi:10.21203/rs.3.rs-2060381/v1}.
\item Calder AE, Hasler G. (2022). \textit{Towards an understanding of psychedelic-induced neuroplasticity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41386-022-01389-z}{doi:10.1038/s41386-022-01389-z}.
\item Stoliker D, Preller KH, Novelli L, Anticevic A, Egan GF, Vollenweider FX, Razi A. (2022). \textit{Neural mechanisms of psychedelic visual imagery}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2022.09.07.22279700}{doi:10.1101/2022.09.07.22279700}.
\item Mellner C, Dahlen M, Simonsson O (2022). \textit{Association between Lifetime Classic Psychedelic Use and Sick Leave in a Population-Based Sample.}. International journal of environmental research and public health. [published; PubMed]. \href{https://doi.org/10.3390/ijerph191811353}{doi:10.3390/ijerph191811353}.
\item Barba T, Buehler S, Kettner H, Radu C, Cunha BG, Nutt DJ, Erritzoe D, Roseman L, Carhart-Harris R. (2022). \textit{Effects of psilocybin versus escitalopram on rumination and thought suppression in depression.}. BJPsych Open. [published; Europe PMC]. \href{https://doi.org/10.1192/bjo.2022.565}{doi:10.1192/bjo.2022.565}.
\item Mitch Earleywine, Zachary Herrmann (2022). \textit{Psychedelics for Psychiatric Disorders: Promise, Not Panacea}. Psychiatric Annals. [published; OpenAlex]. \href{https://doi.org/10.3928/00485713-20220810-01}{doi:10.3928/00485713-20220810-01}.
\item Brian S. Barnett, Jeremy Weleff (2022). \textit{Psychedelics in the Treatment of Substance Use Disorders}. Psychiatric Annals. [published; OpenAlex]. \href{https://doi.org/10.3928/00485713-20220804-01}{doi:10.3928/00485713-20220804-01}.
\item Rodrigues J, Nombora O, Ribeiro L. (2022). \textit{Therapeutic potential of serotoninergic psychedelic substances in the treatment of Obsessive Compulsive Disorder}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9567436}{source link}.
\item National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Forum on Neuroscience and Nervous System Disorders. (2022). \textit{Exploring Psychedelics and Entactogens as Treatments for Psychiatric Disorders: Proceedings of a Workshop}. National Academies Press (US), Washington (DC). [published; Europe PMC]. \href{https://europepmc.org/article/MED/36049038}{source link}.
\item Johannesdottir A, Sigurdsson E. (2022). \textit{[The use of psilocybin for treatment-resistant depression].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.17992/lbl.2022.09.706}{doi:10.17992/lbl.2022.09.706}.
\item Nutt D. (2022). \textit{Psychedelic Psychiatry}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9565852}{source link}.
\item Erkizia-Santamaría I, Alles-Pascual R, Horrillo I, Meana JJ, Ortega JE. (2022). \textit{Serotonin 5-HT2A, 5-HT2c and 5-HT1A receptor involvement in the acute effects of psilocybin in mice. In vitro pharmacological profile and modulation of thermoregulation and head-twich response.}. Biomedicine \& Pharmacotherapy. [published; Europe PMC]. \href{https://doi.org/10.1016/j.biopha.2022.113612}{doi:10.1016/j.biopha.2022.113612}.
\item Pilc A, Machaczka A, Kawalec P, Smith JL, Witkin JM. (2022). \textit{Where do we go next in antidepressant drug discovery? A new generation of antidepressants: a pivotal role of AMPA receptor potentiation and mGlu2/3 receptor antagonism.}. Expert Opinion on Drug Discovery. [published; Europe PMC]. \href{https://doi.org/10.1080/17460441.2022.2111415}{doi:10.1080/17460441.2022.2111415}.
\item Yao S, Wei C, Lin H, Zhang P, Liu Y, Deng Y, Huang Q, Xie B. (2022). \textit{Cystathionine Gamma-Lyase Regulate Psilocybin Biosynthesis in Gymnopilus dilepis Mushroom via Amino Acid Metabolism Pathways.}. Journal of Fungi. [published; Europe PMC]. \href{https://doi.org/10.3390/jof8080870}{doi:10.3390/jof8080870}.
\item Henningfield JE, Coe MA, Griffiths RR, Belouin SJ, Berger A, Coker AR, Comer SD, Heal DJ, Hendricks PS, Nichols CD, Sapienza F, Vocci FJ, Zia FZ. (2022). \textit{Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2022.109220}{doi:10.1016/j.neuropharm.2022.109220}.
\item Prouzeau D, Conejero I, Voyvodic PL, Becamel C, Abbar M, Lopez-Castroman J. (2022). \textit{Psilocybin Efficacy and Mechanisms of Action in Major Depressive Disorder: a Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11920-022-01361-0}{doi:10.1007/s11920-022-01361-0}.
\item Gitte Moos Knudsen (2022). \textit{Prophylactic Effects of Psilocybin on Chronic Cluster Headache: an Open-label Clinical Trial and Neuroimaging Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04280055}{source link}.
\item Jaster AM, Younkin J, Cuddy T, de la Fuente Revenga M, Poklis JL, Dozmorov MG, González-Maeso J. (2022). \textit{Differences across sexes on head-twitch behavior and 5-HT2A receptor signaling in C57BL/6J mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neulet.2022.136836}{doi:10.1016/j.neulet.2022.136836}.
\item Terri D’Arrigo (2022). \textit{Med Check: Psilocybin for OCD, Nuplazid Vote, and More}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2022.08.8.2}{doi:10.1176/appi.pn.2022.08.8.2}.
\item Gumpper RH, Fay JF, Roth BL. (2022). \textit{Molecular insights into the regulation of constitutive activity by RNA editing of 5HT2C serotonin receptors.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.celrep.2022.111211}{doi:10.1016/j.celrep.2022.111211}.
\item Golden CT, Chadderton P. (2022). \textit{Psilocybin reduces low frequency oscillatory power and neuronal phase-locking in the anterior cingulate cortex of awake rodents.}. Scientific Reports. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-022-16325-w}{doi:10.1038/s41598-022-16325-w}.
\item Dodd S, Norman TR, Eyre HA, Stahl SM, Phillips A, Carvalho AF, Berk M. (2022). \textit{Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s1092852922000888}{doi:10.1017/s1092852922000888}.
\item Madsen MK, Petersen AS, Stenbæk DS, Sørensen IM, Schiønning H, Fjeld T, Nykjær CH, Ulv Larsen SM, Grzywacz M, Mathiesen T, Klausen IL, Overgaard-Hansen O, Brendstrup-Brix K, Linnet K, Johansen SS, Fisher PM, Jensen RH, Knudsen GM. (2022). \textit{Psilocybin-induced reduction in chronic cluster headache attack frequency correlates with changes in hypothalamic functional connectivity}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2022.07.10.22277414}{doi:10.1101/2022.07.10.22277414}.
\item Zeifman R, Spriggs MJ, Kettner H, Lyons T, Rosas F, Mediano P, Erritzoe D, Carhart-Harris R. (2022). \textit{From Relaxed Beliefs Under Psychedelics (REBUS) to Revised Beliefs After Psychedelics (REBAS): Preliminary Development of the RElaxed Beliefs Questionnaire (REB-Q)}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/w8j6t}{doi:10.31234/osf.io/w8j6t}.
\item Unknown authors (2022). \textit{From Relaxed Beliefs Under Psychedelics (REBUS) to Revised Beliefs After Psychedelics (REBAS): Preliminary Development of the RElaxed Beliefs Questionnaire (REB-Q)}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/w8j6t\_v1}{source link}.
\item Kiraga MK, Kuypers KPC, Uthaug MV, Ramaekers JG, Mason NL. (2022). \textit{Decreases in State and Trait Anxiety Post-psilocybin: A Naturalistic, Observational Study Among Retreat Attendees.}. Frontiers in Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2022.883869}{doi:10.3389/fpsyt.2022.883869}.
\item Bosch OG, Halm S, Seifritz E. (2022). \textit{Psychedelics in the treatment of unipolar and bipolar depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s40345-022-00265-5}{doi:10.1186/s40345-022-00265-5}.
\item Vohryzek J, Cabral J, Lord L, Fernandes HM, Roseman L, Nutt DJ, Carhart-Harris RL, Deco G, Kringelbach ML. (2022). \textit{Brain dynamics predictive of response to psilocybin for treatment-resistant depression}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.06.30.497950}{doi:10.1101/2022.06.30.497950}.
\item Sherif MA, Khalil MZ, Shukla R, Brown JC, Carpenter LL. (2022). \textit{Synapses, predictions, and prediction errors: a neocortical computational study of MDD using the temporal memory algorithm of HTM}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.06.29.498015}{doi:10.1101/2022.06.29.498015}.
\item Gaddis A, Lidstone DE, Nebel MB, Griffiths RR, Mostofsky SH, Mejia AF, Barrett FS. (2022). \textit{Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity.}. NeuroImage. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuroimage.2022.119434}{doi:10.1016/j.neuroimage.2022.119434}.
\item McCulloch DE, Knudsen GM, Barrett FS, Doss MK, Carhart-Harris RL, Rosas FE, Deco G, Kringelbach ML, Preller KH, Ramaekers JG, Mason NL, Müller F, Fisher PM (2022). \textit{Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2022.104689}{doi:10.1016/j.neubiorev.2022.104689}.
\item Saeger HN, Olson DE (2022). \textit{Psychedelic-inspired approaches for treating neurodegenerative disorders.}. Journal of neurochemistry. [published; PubMed]. \href{https://doi.org/10.1111/jnc.15544}{doi:10.1111/jnc.15544}.
\item Wang Q, Ren Y, Cui Y, Gao B, Zhang H, Jiang Q, Loor JJ, Deng Z, Xu C. (2022). \textit{Bacillus subtilis Produces Amino Acids to Stimulate Protein Synthesis in Ruminal Tissue Explants via the Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Beta-Serine/Threonine Kinase-Mammalian Target of Rapamycin Complex 1 Pathway.}. Frontiers in Veterinary Science. [published; Europe PMC]. \href{https://doi.org/10.3389/fvets.2022.852321}{doi:10.3389/fvets.2022.852321}.
\item Wojtas A, Bysiek A, Wawrzczak-Bargiela A, Szych Z, Majcher-Maślanka I, Herian M, Maćkowiak M, Gołembiowska K. (2022). \textit{Effect of Psilocybin and Ketamine on Brain Neurotransmitters, Glutamate Receptors, DNA and Rat Behavior.}. International Journal of Molecular Sciences. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms23126713}{doi:10.3390/ijms23126713}.
\item Schindler EAD. (2022). \textit{Psychedelics as preventive treatment in headache and chronic pain disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2022.109166}{doi:10.1016/j.neuropharm.2022.109166}.
\item Felsch CL, Kuypers KPC. (2022). \textit{Don't be afraid, try to meditate- potential effects on neural activity and connectivity of psilocybin-assisted mindfulness-based intervention for social anxiety disorder: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2022.104724}{doi:10.1016/j.neubiorev.2022.104724}.
\item M Rekatsina, E Moka, A Vadalouca, G Varrassi (2022). \textit{SP56 Psychedelic drugs and pain}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.1136/rapm-2022-esra.62}{doi:10.1136/rapm-2022-esra.62}.
\item Anthony Principe (2022). \textit{Neuropharmacological analysis of the anti-addictive and therapeutic effects of psilocybin}. SURG Journal. [published; OpenAlex]. \href{https://doi.org/10.21083/surg.v14i1.6870}{doi:10.21083/surg.v14i1.6870}.
\item Malcolm B, Thomas K (2022). \textit{Serotonin toxicity of serotonergic psychedelics.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-021-05876-x}{doi:10.1007/s00213-021-05876-x}.
\item Smausz R, Neill J, Gigg J. (2022). \textit{Neural mechanisms underlying psilocybin's therapeutic potential - the need for preclinical in vivo electrophysiology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811221092508}{doi:10.1177/02698811221092508}.
\item Henner RL, Keshavan MS, Hill KP. (2022). \textit{Review of potential psychedelic treatments for PTSD.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jns.2022.120302}{doi:10.1016/j.jns.2022.120302}.
\item Doss MK, Samaha J, Barrett FS, Griffiths RR, de Wit H, Gallo DA, Koen JD. (2022). \textit{Unique Effects of Sedatives, Dissociatives, Psychedelics, Stimulants, and Cannabinoids on Episodic Memory: A Review and Reanalysis of Acute Drug Effects on Recollection, Familiarity, and Metamemory}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.05.20.492842}{doi:10.1101/2022.05.20.492842}.
\item Mahmood D, Alenezi SK, Anwar MJ, Azam F, Qureshi KA, Jaremko M. (2022). \textit{New Paradigms of Old Psychedelics in Schizophrenia.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ph15050640}{doi:10.3390/ph15050640}.
\item Elsouri KN, Kalhori S, Colunge D, Grabarczyk G, Hanna G, Carrasco C, Aleman Espino A, Francisco A, Borosky B, Bekheit B, Ighanifard M, Astudillo AA, Demory Beckler M. (2022). \textit{Psychoactive Drugs in the Management of Post Traumatic Stress Disorder: A Promising New Horizon.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.25235}{doi:10.7759/cureus.25235}.
\item University of Zurich (2022). \textit{Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy in Major Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03715127}{source link}.
\item Rossi GN, Hallak JEC, Bouso Saiz JC, Dos Santos RG. (2022). \textit{Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges.}. Expert Opinion on Drug Safety. [published; Europe PMC]. \href{https://doi.org/10.1080/14740338.2022.2066650}{doi:10.1080/14740338.2022.2066650}.
\item Raut SB, Marathe PA, van Eijk L, Eri R, Ravindran M, Benedek DM, Ursano RJ, Canales JJ, Johnson LR. (2022). \textit{Diverse therapeutic developments for post-traumatic stress disorder (PTSD) indicate common mechanisms of memory modulation.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pharmthera.2022.108195}{doi:10.1016/j.pharmthera.2022.108195}.
\item Rudzki S. (2022). \textit{Is PTSD an Evolutionary Survival Adaptation Initiated by Unrestrained Cytokine Signaling and Maintained by Epigenetic Change?}. Military Medicine. [published; Europe PMC]. \href{https://doi.org/10.1093/milmed/usac095}{doi:10.1093/milmed/usac095}.
\item Lemos Martins Sofia, Machado Brito-da-Costa Andreia, Madureira-Carvalho Áurea, Dinis-Oliveira Ricardo Jorge, Dias da Silva Diana (2022). \textit{Psylocybin and Psilocin as new tools to fight depression: an overview of the Pharmacodynamic and pharmacokinetic mechanisms}. RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia. [published; Crossref]. \href{https://doi.org/10.51126/revsalus.v4isup.271}{doi:10.51126/revsalus.v4isup.271}.
\item Michael Avissar, Adrian Jacques H. Ambrose (2022). \textit{Demystifying Psychedelic Treatments in Psychiatry: Is Ego Dissolution the Solution?}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2022.04.4.35}{doi:10.1176/appi.pn.2022.04.4.35}.
\item McClure-Begley TD, Roth BL. (2022). \textit{The promises and perils of psychedelic pharmacology for psychiatry.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41573-022-00421-7}{doi:10.1038/s41573-022-00421-7}.
\item Adams AM, Anas NA, Sen AK, Hinegardner-Hendricks JD, O'Dell PJ, Gibbons WJ, Flower JE, McMurray MS, Jones JA. (2022). \textit{Development of an E. coli-based norbaeocystin production platform and evaluation of behavioral effects in rats.}. Metabolic Engineering Communications. [published; Europe PMC]. \href{https://doi.org/10.1016/j.mec.2022.e00196}{doi:10.1016/j.mec.2022.e00196}.
\item Smedfors G, Glotfelty E, Kalani N, Hjelle CP, Horntvedt O, Wellfelt K, Brodin A, von Kieseritzky F, Olson L, Karlsson T. (2022). \textit{Psilocybin Combines Rapid Synaptogenic And Anti-Inflammatory Effects In Vitro}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-1321542/v1}{doi:10.21203/rs.3.rs-1321542/v1}.
\item Kiraga M, Kuypers KPC, Uthaug MV, Ramaekers J, Mason NL. (2022). \textit{Persisting decreases in state and trait anxiety post-psilocybin: A naturalistic, observational study among retreat attendees}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2022.03.02.22271743}{doi:10.1101/2022.03.02.22271743}.
\item Wolff M, Mertens LJ, Walter M, Enge S, Evens R. (2022). \textit{The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs' effects on psychological flexibility.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811211073758}{doi:10.1177/02698811211073758}.
\item Thomas CW, Blanco-Duque C, Bréant BJ, Goodwin GM, Sharp T, Bannerman DM, Vyazovskiy VV. (2022). \textit{Psilocin acutely alters sleep-wake architecture and cortical brain activity in laboratory mice.}. Translational Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-022-01846-9}{doi:10.1038/s41398-022-01846-9}.
\item Van Court RC, Wiseman MS, Meyer KW, Ballhorn DJ, Amses KR, Slot JC, Dentinger BTM, Garibay-Orijel R, Uehling JK. (2022). \textit{Diversity, biology, and history of psilocybin-containing fungi: Suggestions for research and technological development.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.funbio.2022.01.003}{doi:10.1016/j.funbio.2022.01.003}.
\item Ziff S, Stern B, Lewis G, Majeed M, Gorantla VR. (2022). \textit{Analysis of Psilocybin-Assisted Therapy in Medicine: A Narrative Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.21944}{doi:10.7759/cureus.21944}.
\item Markopoulos A, Inserra A, De Gregorio D, Gobbi G. (2022). \textit{Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2021.749068}{doi:10.3389/fphar.2021.749068}.
\item Sakurai H, Yonezawa K, Tani H, Mimura M, Bauer M, Uchida H. (2022). \textit{Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/a-1714-9097}{doi:10.1055/a-1714-9097}.
\item Daisuke Ibi (2021). \textit{Investigation of the neural network responsible for antidepressant effect of serotonergic psychedelics}. Proceedings for Annual Meeting of The Japanese Pharmacological Society. [published; OpenAlex]. \href{https://doi.org/10.1254/jpssuppl.96.0\_4-b-s43-2}{doi:10.1254/jpssuppl.96.0\_4-b-s43-2}.
\item Daisuke Ibi (2021). \textit{Investigation of neuronal basis underlying antidepressant effect of serotonergic psychedelics}. Proceedings for Annual Meeting of The Japanese Pharmacological Society. [published; OpenAlex]. \href{https://doi.org/10.1254/jpssuppl.95.0\_3-s35-1}{doi:10.1254/jpssuppl.95.0\_3-s35-1}.
\item Garcia-Romeu A, Darcy S, Jackson H, White T, Rosenberg P (2021). \textit{Psychedelics as Novel Therapeutics in Alzheimer's Disease: Rationale and Potential Mechanisms.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2021\_267}{doi:10.1007/7854\_2021\_267}.
\item Ehrmann K, Allen JJB, Moreno FA. (2021). \textit{Psilocybin for the Treatment of Obsessive-Compulsive Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2021\_279}{doi:10.1007/7854\_2021\_279}.
\item Sousa TR, Rema J, Machado S, Novais F. (2021). \textit{Psychedelics and Hallucinogens in Psychiatry: Finding New Pharmacological Targets.}. Current Topics in Medicinal Chemistry. [published; Europe PMC]. \href{https://doi.org/10.2174/1568026621666211201145800}{doi:10.2174/1568026621666211201145800}.
\item Sarris J, Pinzon Rubiano D, Day K, Galvão-Coelho NL, Perkins D. (2021). \textit{Psychedelic medicines for mood disorders: current evidence and clinical considerations.}. PubMed. [published; Europe PMC]. \href{https://doi.org/10.1097/yco.0000000000000759}{doi:10.1097/yco.0000000000000759}.
\item Rieser NM, Herdener M, Preller KH (2021). \textit{Psychedelic-Assisted Therapy for Substance Use Disorders and Potential Mechanisms of Action.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2021\_284}{doi:10.1007/7854\_2021\_284}.
\item Khan AJ, Bradley E, O'Donovan A, Woolley J. (2021). \textit{Psilocybin for Trauma-Related Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2022\_366}{doi:10.1007/7854\_2022\_366}.
\item Kuburi S, Di Passa AM, Tassone VK, Mahmood R, Lalovic A, Ladha KS, Dunlop K, Rizvi S, Demchenko I, Bhat V. (2021). \textit{Neuroimaging Correlates of Treatment Response with Psychedelics in Major Depressive Disorder: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/24705470221115342}{doi:10.1177/24705470221115342}.
\item Husain MI, Ledwos N, Fellows E, Baer J, Rosenblat JD, Blumberger DM, Mulsant BH, Castle DJ (2021). \textit{Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2022.1076459}{doi:10.3389/fpsyt.2022.1076459}.
\item McCartney A, McGovern H, De Foe A. (2021). \textit{Predictors of Psychedelic Experience: A Thematic Analysis}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/5d7fc}{doi:10.31234/osf.io/5d7fc}.
\item Unknown authors (2021). \textit{Predictors of Psychedelic Experience: A Thematic Analysis}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/5d7fc\_v1}{source link}.
\item McKernan K, Kane L, Helbert Y, Zhang L, Houde N, McLaughlin S. (2021). \textit{A whole genome atlas of 81 Psilocybe genomes as a resource for psilocybin production.}. F1000Res. [preprint; Europe PMC]. \href{https://doi.org/10.12688/f1000research.55301.2}{doi:10.12688/f1000research.55301.2}.
\item Marschall J, Fejer G, Lempe P, Prochazkova L, Kuchar M, Hajkova K, van Elk M. (2021). \textit{Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811211050556}{doi:10.1177/02698811211050556}.
\item National Council of Scientific and Technical Research, Argentina (2021). \textit{Double-blind Placebo-controlled Naturalistic Study of Microdosing With Psilocybin: Effects on Brain Activity, Behavior, Cognition, Creativity, and Mental Health}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05160220}{source link}.
\item Elman I, Pustilnik A, Borsook D. (2021). \textit{Beating pain with psychedelics: Matter over mind?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2021.12.005}{doi:10.1016/j.neubiorev.2021.12.005}.
\item Louk J. M. J. Vanderschuren, Paul Willner, Emily M. Jutkiewicz, Bart Ellenbroek (2021). \textit{Announcement of two special issues: behavioural pharmacology of synaptopathies and psychedelic drugs}. Behavioural Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.1097/fbp.0000000000000662}{doi:10.1097/fbp.0000000000000662}.
\item Vilca-Melendez S, Uthaug MV, Griffin JL. (2021). \textit{1H Nuclear Magnetic Resonance: A Future Approach to the Metabolic Profiling of Psychedelics in Human Biofluids?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2021.742856}{doi:10.3389/fpsyt.2021.742856}.
\item Whitfield HJ. (2021). \textit{A Spectrum of Selves Reinforced in Multilevel Coherence: A Contextual Behavioural Response to the Challenges of Psychedelic-Assisted Therapy Development.}. Frontiers in Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2021.727572}{doi:10.3389/fpsyt.2021.727572}.
\item Ines Erkizia-Santamaría, R. Alles-Pascual, Igor Horrillo, J. Javier Meana, Jorge E. Ortega (2021). \textit{P.0298 Evaluation of the acute mechanism of action of psilocybin in mice}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.282}{doi:10.1016/j.euroneuro.2021.10.282}.
\item Slocum ST, DiBerto JF, Roth BL. (2021). \textit{Molecular insights into psychedelic drug action.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/jnc.15540}{doi:10.1111/jnc.15540}.
\item Strumila R, Nobile B, Korsakova L, Lengvenyte A, Olie E, Lopez-Castroman J, Guillaume S, Courtet P. (2021). \textit{Psilocybin, a Naturally Occurring Indoleamine Compound, Could Be Useful to Prevent Suicidal Behaviors.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ph14121213}{doi:10.3390/ph14121213}.
\item Meinhardt MW, Pfarr S, Fouquet G, Rohleder C, Meinhardt ML, Barroso-Flores J, Hoffmann R, Jeanblanc J, Paul E, Wagner K, Hansson AC, Köhr G, Meier N, von Bohlen Und Halbach O, Bell RL, Endepols H, Neumaier B, Schönig K, Bartsch D, Naassila M, Spanagel R, Sommer WH. (2021). \textit{Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism.}. Science Advances. [published; Europe PMC]. \href{https://doi.org/10.1126/sciadv.abh2399}{doi:10.1126/sciadv.abh2399}.
\item Ling S, Ceban F, Lui LMW, Lee Y, Teopiz KM, Rodrigues NB, Lipsitz O, Gill H, Subramaniapillai M, Mansur RB, Lin K, Ho R, Rosenblat JD, Castle D, McIntyre RS. (2021). \textit{Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40263-021-00877-y}{doi:10.1007/s40263-021-00877-y}.
\item Strickland JC, Johnson MW. (2021). \textit{Human behavioral pharmacology of psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.apha.2021.10.003}{doi:10.1016/bs.apha.2021.10.003}.
\item Gass P, Vasilescu AN, Inta D. (2021). \textit{[Rapid-acting antidepressants-neurobiological mechanisms of action].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00115-021-01225-7}{doi:10.1007/s00115-021-01225-7}.
\item Doss MK, Považan M, Rosenberg MD, Sepeda ND, Davis AK, Finan PH, Smith GS, Pekar JJ, Barker PB, Griffiths RR, Barrett FS. (2021). \textit{Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder.}. Translational Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-021-01706-y}{doi:10.1038/s41398-021-01706-y}.
\item Kozlowska U, Nichols C, Wiatr K, Figiel M. (2021). \textit{From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/jnc.15509}{doi:10.1111/jnc.15509}.
\item Spriggs MJ, Douglass HM, Park RJ, Read T, Danby JL, de Magalhães FJC, Alderton KL, Williams TM, Blemings A, Lafrance A, Nicholls DE, Erritzoe D, Nutt DJ, Carhart-Harris RL. (2021). \textit{Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study".}. Frontiers in Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2021.735523}{doi:10.3389/fpsyt.2021.735523}.
\item Fitzgerald PJ (2021). \textit{Many Drugs of Abuse May Be Acutely Transformed to Dopamine, Norepinephrine and Epinephrine In Vivo.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms221910706}{doi:10.3390/ijms221910706}.
\item Gonda X, Dome P, Neill JC, Tarazi FI. (2021). \textit{Novel antidepressant drugs: Beyond monoamine targets.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s1092852921000791}{doi:10.1017/s1092852921000791}.
\item Rodríguez Arce JM, Winkelman MJ. (2021). \textit{Psychedelics, Sociality, and Human Evolution.}. Frontiers in Psychology. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyg.2021.729425}{doi:10.3389/fpsyg.2021.729425}.
\item Zeiss R, Gahr M, Graf H. (2021). \textit{Rediscovering Psilocybin as an Antidepressive Treatment Strategy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ph14100985}{doi:10.3390/ph14100985}.
\item Aleksandrova LR, Phillips AG. (2021). \textit{Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.tips.2021.08.003}{doi:10.1016/j.tips.2021.08.003}.
\item Matthias Forstmann, Christina Sagioglou (2021). \textit{New Insights Into the Clinical and Nonclinical Effects of Psychedelic Substances}. European Psychologist. [published; OpenAlex]. \href{https://doi.org/10.1027/1016-9040/a000447}{doi:10.1027/1016-9040/a000447}.
\item de Vos CMH, Mason NL, Kuypers KPC. (2021). \textit{Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2021.724606}{doi:10.3389/fpsyt.2021.724606}.
\item Figueiredo I, Viegas F, Ferreira F, Santos A, Ramos J, Miranda J. (2021). \textit{Therapeutic interventions for PTSD - current evidence on the the role of psychedelics}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9475922}{source link}.
\item Fraga A, Esteves-Sousa D, Facucho-Oliveira J, Albuquerque M, Costa M, Dos Santos P, Moura N, Moutinho A. (2021). \textit{Effects of psilocybin-assisted therapy on treatment-resistant depression}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9480034}{source link}.
\item Wayne Hall, Michael Farrell (2021). \textit{What can we learn from the history of research on psychedelic drugs in the addictions?}. Addiction. [published; OpenAlex]. \href{https://doi.org/10.1111/add.15560}{doi:10.1111/add.15560}.
\item Waters K. (2021). \textit{Pharmacologic Similarities and Differences Among Hallucinogens.}. The Journal of Clinical Pharmacology. [published; Europe PMC]. \href{https://doi.org/10.1002/jcph.1917}{doi:10.1002/jcph.1917}.
\item Borroto-Escuela DO, Ambrogini P, Narvaez M, Di Liberto V, Beggiato S, Ferraro L, Fores-Pons R, Alvarez-Contino JE, Lopez-Salas A, Mudò G, Díaz-Cabiale Z, Fuxe K. (2021). \textit{Serotonin Heteroreceptor Complexes and Their Integration of Signals in Neurons and Astroglia-Relevance for Mental Diseases.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/cells10081902}{doi:10.3390/cells10081902}.
\item Madsen MK, Stenbæk DS, Arvidsson A, Armand S, Marstrand-Joergensen MR, Johansen SS, Linnet K, Ozenne B, Knudsen GM, Fisher PM. (2021). \textit{Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience.}. European Neuropsychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2021.06.001}{doi:10.1016/j.euroneuro.2021.06.001}.
\item Kevin McKernan, Liam T. Kane, Yvonne Helbert, Lei Zhang, Nathan Houde, Stephen McLaughlin (2021). \textit{A whole genome atlas of 81 Psilocybe genomes as a resource for psilocybin production.}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.5062843}{doi:10.5281/zenodo.5062843}.
\item Bao SH, Jiang H, Zhu LY, Yao G, Han PG, Wan XK, Wang K, Song TY, Liu CJ, Wang S, Zhang ZY, Zhang DY, Meng E. (2021). \textit{A dynamic and multilocus metabolic regulation strategy using quorum-sensing-controlled bacterial small RNA.}. Cell Reports. [published; Europe PMC]. \href{https://doi.org/10.1016/j.celrep.2021.109413}{doi:10.1016/j.celrep.2021.109413}.
\item McCulloch DE, Madsen MK, Stenbæk DS, Kristiansen S, Ozenne B, Jensen PS, Knudsen GM, Fisher PM. (2021). \textit{Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811211026454}{doi:10.1177/02698811211026454}.
\item Corrigan A, Burchill E, Pelton L, Marrocu A, Mazzoleni A, Shackshaft L. (2021). \textit{Psilocybin: the magic medicine for depression?}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC8770735}{source link}.
\item McCulloch DE, Knudsen GM, Barrett FS, Doss M, Deco G, Carhart-Harris R, Rosas F, Preller K, Ramaekers J, Mason N, Müller F, Fisher PM. (2021). \textit{Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analyses}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/64kyg}{doi:10.31234/osf.io/64kyg}.
\item Unknown authors (2021). \textit{Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analyses}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/64kyg\_v1}{source link}.
\item Amber Elyse Corrigan, Ella Burchill, Lucy Pelton, Alessia Marrocu, Adele Mazzoleni, Lydia Shackshaft (2021). \textit{Psilocybin: the magic medicine for depression?}. BJPsych Open. [published; OpenAlex]. \href{https://doi.org/10.1192/bjo.2021.456}{doi:10.1192/bjo.2021.456}.
\item Teixeira PJ, Johnson MW, Timmermann C, Watts R, Erritzoe D, Douglass H, Kettner H, Carhart-Harris RL. (2021). \textit{Psychedelics and health behaviour change.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811211008554}{doi:10.1177/02698811211008554}.
\item Unknown authors (2021). \textit{Future Directions for Clinical Psilocybin Research: The Relaxed Symptom Network}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.1037/pne0000290}{doi:10.1037/pne0000290}.
\item Lewis-Healey E, Laukkonen RE, van Elk M. (2021). \textit{Future Directions for Clinical Psilocybin Research: The Relaxed Symptom Network}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/q3ymd}{doi:10.31234/osf.io/q3ymd}.
\item Wayne Hall (2021). \textit{The need for publicly funded research on therapeutic use of psychedelic drugs}. World Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1002/wps.20847}{doi:10.1002/wps.20847}.
\item Forstmann M, Sagioglou C. (2021). \textit{New insights into the clinical and nonclinical effects of psychedelic substances: an integrative review}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/2489x}{doi:10.31234/osf.io/2489x}.
\item Unknown authors (2021). \textit{New insights into the clinical and nonclinical effects of psychedelic substances: an integrative review}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/2489x\_v1}{source link}.
\item Senese Nicolas, Nguyen Thu, Cologna Stephanie, Rasenick Mark (2021). \textit{Effects of the putative antidepressant psilocin on the lipid-raft proteome and lipid-raft signaling}. The FASEB Journal. [published; Crossref]. \href{https://doi.org/10.1096/fasebj.2021.35.s1.03168}{doi:10.1096/fasebj.2021.35.s1.03168}.
\item Hisham Alshaikhli, Redhwan Ahmed Al-Naggar, Gwen Erlam (2021). \textit{Effectiveness of Psilocybin on Depression: A Qualitative Study}. Electronic Journal of General Medicine. [published; OpenAlex]. \href{https://doi.org/10.29333/ejgm/10862}{doi:10.29333/ejgm/10862}.
\item Cumming P, Scheidegger M, Dornbierer D, Palner M, Quednow BB, Martin-Soelch C. (2021). \textit{Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/molecules26092451}{doi:10.3390/molecules26092451}.
\item Mason NL, Kuypers KPC, Reckweg JT, Müller F, Tse DHY, Da Rios B, Toennes SW, Stiers P, Feilding A, Ramaekers JG. (2021). \textit{Spontaneous and deliberate creative cognition during and after psilocybin exposure.}. Translational Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-021-01335-5}{doi:10.1038/s41398-021-01335-5}.
\item A. Fraga, Daniel Esteves-Sousa, João Facucho-Oliveira, Margarida Albuquerque, M. Costa, Paulo Santos, Nuno Moura, A. Moutinho (2021). \textit{Effects of psilocybin-assisted therapy on treatment-resistant depression}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/j.eurpsy.2021.1836}{doi:10.1192/j.eurpsy.2021.1836}.
\item Simonsson O, Sexton JD, Hendricks PS (2021). \textit{Associations between lifetime classic psychedelic use and markers of physical health.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881121996863}{doi:10.1177/0269881121996863}.
\item Earleywine M, Ueno LF, Mian MN, Altman BR. (2021). \textit{Cannabis-induced oceanic boundlessness.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881121997099}{doi:10.1177/0269881121997099}.
\item Teixeira PJ, Johnson M, Timmermann C, Watts R, Erritzoe D, Douglass H, Kettner H, Carhart-Harris R. (2021). \textit{Psychedelics and Health Behavior Change - Journal of Psychopharmacology (in press)}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/8vks6}{doi:10.31234/osf.io/8vks6}.
\item Unknown authors (2021). \textit{Psychedelics and Health Behavior Change - Journal of Psychopharmacology (in press)}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/8vks6\_v1}{source link}.
\item Perkins D, Sarris J, Rossell S, Bonomo Y, Forbes D, Davey C, Hoyer D, Loo C, Murray G, Hood S, Schubert V, Galvão-Coelho NL, O'Donnell M, Carter O, Liknaitzky P, Williams M, Siskind D, Penington D, Berk M, Castle D. (2021). \textit{Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm.}. Australian \& New Zealand Journal of Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1177/0004867421998785}{doi:10.1177/0004867421998785}.
\item Dos Santos RG, Hallak JE, Baker G, Dursun S. (2021). \textit{Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881120986422}{doi:10.1177/0269881120986422}.
\item Kozłowska U, Klimczak A, Wiatr K, Figiel M. (2021). \textit{The DMT and Psilocin Treatment Changes CD11b+ Activated Microglia Immunological Phenotype}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2021.03.07.434103}{doi:10.1101/2021.03.07.434103}.
\item Dos Santos RG, Bouso JC, Rocha JM, Rossi GN, Hallak JE. (2021). \textit{The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges.}. DOAJ (DOAJ: Directory of Open Access Journals). [published; Europe PMC]. \href{https://doi.org/10.2147/rmhp.s300656}{source link}.
\item Patocka J, Wu R, Nepovimova E, Valis M, Wu W, Kuca K. (2021). \textit{Chemistry and Toxicology of Major Bioactive Substances in Inocybe Mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms22042218}{doi:10.3390/ijms22042218}.
\item Winkelman MJ. (2021). \textit{The Evolved Psychology of Psychedelic Set and Setting: Inferences Regarding the Roles of Shamanism and Entheogenic Ecopsychology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2021.619890}{doi:10.3389/fphar.2021.619890}.
\item Peter G. Brindley (2021). \textit{How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence}. Anesthesia \& Analgesia. [published; OpenAlex]. \href{https://doi.org/10.1213/ane.0000000000005349}{doi:10.1213/ane.0000000000005349}.
\item Thomas CW, Blanco-Duque C, Bréant B, Goodwin GM, Sharp T, Bannerman DM, Vyazovskiy VV. (2021). \textit{Psilocin acutely disrupts sleep and affects local but not global sleep homeostasis in laboratory mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2021.02.16.431276}{doi:10.1101/2021.02.16.431276}.
\item Madsen MK, Stenbæk DS, Arvidsson A, Armand S, Marstrand-Joergensen MR, Johansen SS, Linnet K, Ozenne B, Knudsen GM, Fisher PM. (2021). \textit{Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2021.02.03.429325}{doi:10.1101/2021.02.03.429325}.
\item Tai SJ, Nielson EM, Lennard-Jones M, Johanna Ajantaival RL, Winzer R, Richards WA, Reinholdt F, Richards BD, Gasser P, Malievskaia E. (2021). \textit{Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research.}. Frontiers in Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2021.586682}{doi:10.3389/fpsyt.2021.586682}.
\item McCulloch DE, Madsen MK, Stenbæk DS, Kristiansen S, Ozenne B, Jensen PS, Knudsen GM, Fisher PM. (2021). \textit{Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2021.01.28.428377}{doi:10.1101/2021.01.28.428377}.
\item Joost J. Breeksema, Martijn H B Koolen, Metten Somers, Robert A. Schoevers (2021). \textit{Behandeling met psilocybine}. Data Archiving and Networked Services (DANS). [published; OpenAlex]. \href{https://research.rug.nl/en/publications/5e83b45d-b208-402a-a435-f0380fad6429}{source link}.
\item Breeksema JJ, Koolen MHB, Somers M, Schoevers RA. (2021). \textit{[Treatment with psilocybin: applications for patients with psychiatric disorders].}. PubMed. [published; Europe PMC]. \href{https://europepmc.org/article/MED/33560605}{source link}.
\item Mertens LJ, Preller KH. (2021). \textit{Classical Psychedelics as Therapeutics in Psychiatry - Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/a-1341-1907}{doi:10.1055/a-1341-1907}.
\item Healy CJ. (2021). \textit{The acute effects of classic psychedelics on memory in humans.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-020-05756-w}{doi:10.1007/s00213-020-05756-w}.
\item Inserra A, De Gregorio D, Gobbi G. (2020). \textit{Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1124/pharmrev.120.000056}{doi:10.1124/pharmrev.120.000056}.
\item Bouso JC, Ona G, Dos Santos RG, Hallak JEC. (2020). \textit{Psychedelic Medicines in Major Depression: Progress and Future Challenges.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/978-981-33-6044-0\_26}{doi:10.1007/978-981-33-6044-0\_26}.
\item Castro Santos H, Gama Marques J. (2020). \textit{What is the clinical evidence on psilocybin for the treatment of psychiatric disorders? A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/j.pbj.0000000000000128}{doi:10.1097/j.pbj.0000000000000128}.
\item Eleftheriou ME, Thomas E (2020). \textit{Examining the Potential Synergistic Effects Between Mindfulness Training and Psychedelic-Assisted Therapy.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.707057}{doi:10.3389/fpsyt.2021.707057}.
\item Kelly JR, Gillan CM, Prenderville J, Kelly C, Harkin A, Clarke G, O'Keane V (2020). \textit{Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.800072}{doi:10.3389/fpsyt.2021.800072}.
\item Daniela Dudysová, Karolína Janků, Michal Šmotek, Elizaveta Saifutdinová, Jana Kopřivová, Jitka Bušková, Bryce A. Mander, Martin Brunovský, Peter Zach, Jakub Korčák, Veronika Andrashko, Michaela Viktorinová, Filip Tylš, Anna Bravermanová, Tom Froese, Tomáš Páleníček, Jiřı́ Horáček (2020). \textit{The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant Action}. Frontiers in Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.3389/fphar.2020.602590}{doi:10.3389/fphar.2020.602590}.
\item Dudysová Daniela, Janku Karolina, Smotek Michal, Saifutdinova Elizaveta, Koprivova Jana, Bušková Jitka, Mander Bryce Anthony, Brunovský Martin, Zach Peter, Korčák Jakub, Andrashko Veronika, Viktorinová Michaela, Tylš Filip, Bravermanová Anna, Froese Tom, Páleníček Tomáš, Horáček Jiří (2020). \textit{The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant Action}. Institutional Repositories DataBase (IRDB). [published; OpenAlex]. \href{http://id.nii.ac.jp/1394/00001681/}{source link}.
\item Bottemanne H, Claret A, Fossati P. (2020). \textit{[Ketamine, psilocybin, and rapid acting antidepressant: new promise for psychiatry?]}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.encep.2020.08.006}{doi:10.1016/j.encep.2020.08.006}.
\item Courtney C. Walton, Paul Liknaitzky (2020). \textit{Advancing elite athlete mental health treatment with psychedelic-assisted psychotherapy}. Journal of Applied Sport Psychology. [published; OpenAlex]. \href{https://doi.org/10.1080/10413200.2020.1848941}{doi:10.1080/10413200.2020.1848941}.
\item University of Zurich (2020). \textit{Beyond the Self and Back: Neuropharmacological Mechanisms Underlying the Dissolution of the Self}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03736980}{source link}.
\item NYU Langone Health (2020). \textit{Effects of Psilocybin on Anxiety and Psychosocial Distress in Cancer Patients}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT00957359}{source link}.
\item Romeo B, Karila L, Martelli C, Benyamina A (2020). \textit{Efficacy of psychedelic treatments on depressive symptoms: A meta-analysis.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881120919957}{doi:10.1177/0269881120919957}.
\item Nicole Harrington Cirino (2020). \textit{Wait for the Science Before Widespread Use of Psilocybin}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2020.10a32}{doi:10.1176/appi.pn.2020.10a32}.
\item Lukasz Smigielski, Michael Kometer, Milan Scheidegger, Cornelia Stress, Katrin H. Preller, Thomas Koenig, Franz X. Vollenweider (2020). \textit{P300-mediated modulations in self-other processing under psychedelic psilocybin are related to connectedness and changed meaning: A window into the self-other overlap}. Human Brain Mapping. [published; OpenAlex]. \href{https://doi.org/10.1002/hbm.25174}{doi:10.1002/hbm.25174}.
\item John R. Kelly, Matthew Crockett, Laith Alexander, Martin Haran, Amanda Baker, Lisa M. Burke, Christine Brennan, Veronica O’Keane (2020). \textit{Psychedelic science in post-COVID-19 psychiatry}. Irish Journal of Psychological Medicine. [published; OpenAlex]. \href{https://doi.org/10.1017/ipm.2020.94}{doi:10.1017/ipm.2020.94}.
\item Jones NT, Zahid Z, Grady SM, Sultan ZW, Zheng Z, Banks MI, Wenthur CJ. (2020). \textit{Delayed Anxiolytic-Like Effects of Psilocybin in Male Mice Are Supported by Acute Glucocorticoid Release}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2020.08.12.248229}{doi:10.1101/2020.08.12.248229}.
\item Robin Carhart-Harris (2020). \textit{4 Psychedelics: therapeutic mechanisms}. Journal of Neurology Neurosurgery \& Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1136/jnnp-2020-bnpa.4}{doi:10.1136/jnnp-2020-bnpa.4}.
\item Edward Jacobs (2020). \textit{A potential role for psilocybin in the treatment of obsessive-compulsive disorder}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2020.00128}{doi:10.1556/2054.2020.00128}.
\item Greenway KT, Garel N, Jerome L, Feduccia AA (2020). \textit{Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments.}. Expert review of clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1080/17512433.2020.1772054}{doi:10.1080/17512433.2020.1772054}.
\item Krediet E, Bostoen T, Breeksema J, van Schagen A, Passie T, Vermetten E. (2020). \textit{Reviewing the Potential of Psychedelics for the Treatment of PTSD.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/ijnp/pyaa018}{doi:10.1093/ijnp/pyaa018}.
\item Frederick S. Barrett, Samuel R. Krimmel, Roland R. Griffiths, David A. Seminowicz, Brian N. Mathur (2020). \textit{Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention}. NeuroImage. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neuroimage.2020.116980}{doi:10.1016/j.neuroimage.2020.116980}.
\item Natasha L. Mason, Kim P. C. Kuypers, Felix Müller, Johannes T. Reckweg, Desmond H. Y. Tse, Stefan W. Toennes, Nadia R. P. W. Hutten, Jacobus F.A. Jansen, Peter Stiers, Amanda Feilding, Johannes G. Ramaekers (2020). \textit{Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin}. Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1038/s41386-020-0718-8}{doi:10.1038/s41386-020-0718-8}.
\item Katie R. Barnes, Stephanie N. Lewis (2020). \textit{Binding Interactions of Psilocin and Serotonin in the 5-HT2A Receptor}. VTechWorks (Virginia Tech). [published; OpenAlex]. \href{http://hdl.handle.net/10919/99299}{source link}.
\item Meghan Hibicke, Charles D. Nichols (2020). \textit{One Dose of Psilocybin in Late Adolescence Mitigates Deleterious Effects of Developmental Stress on Cognition and Behavioral Despair in Adult Female Rats}. The FASEB Journal. [published; OpenAlex]. \href{https://doi.org/10.1096/fasebj.2020.34.s1.02912}{doi:10.1096/fasebj.2020.34.s1.02912}.
\item Heuschkel K, Kuypers KPC. (2020). \textit{Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression. A Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2020.00224}{doi:10.3389/fpsyt.2020.00224}.
\item N. Milne, Philip Tinggaard Thomsen, Niels Aage Tvis Knudsen, P. Rubaszka, Mette Kristensen, Irina Borodina (2020). \textit{Metabolic engineering of Saccharomyces cerevisiae for the de novo production of psilocybin and related tryptamine derivatives}. Metabolic Engineering. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ymben.2019.12.007}{doi:10.1016/j.ymben.2019.12.007}.
\item Benko J, Vranková S. (2020). \textit{Natural Psychoplastogens As Antidepressant Agents.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/molecules25051172}{doi:10.3390/molecules25051172}.
\item Wendy Kline (2020). \textit{Psychedelic Birth: Bodies, Boundaries and the Perception of Pain in the 1970s}. Gender \& History. [published; OpenAlex]. \href{https://doi.org/10.1111/1468-0424.12471}{doi:10.1111/1468-0424.12471}.
\item Foldi CJ, Liknaitzky P, Williams M, Oldfield BJ. (2020). \textit{Rethinking Therapeutic Strategies for Anorexia Nervosa: Insights From Psychedelic Medicine and Animal Models.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fnins.2020.00043}{doi:10.3389/fnins.2020.00043}.
\item Lea J. Mertens, Matthew B. Wall, Leor Roseman, Lysia Demetriou, David Nutt, Robin Carhart-Harris (2020). \textit{Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/0269881119895520}{doi:10.1177/0269881119895520}.
\item Marcus Allgulin (2019). \textit{Psilocybin and LSD in the Treatment of Depression and Anxiety}. Diva portal (Dalarna University Library). [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18843}{source link}.
\item Sofia Gyllvik (2019). \textit{The Therapeutic Potential of Psilocybin and 3,4-Methylenedioxymethamphetamine in the Treatment of Depression and Post-Traumatic Stress Disorder}. Diva portal (Dalarna University Library). [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18729}{source link}.
\item Ammar Jawad (2019). \textit{Drugs and the Music Industry: How the Neurological and Visual Effects of LSD and Psilocybin Impact Creativity and Songwriting Abilities}. VCU Scholars Compass (Virginia Commonwealth University). [published; OpenAlex]. \href{https://scholarscompass.vcu.edu/uresposters/356}{source link}.
\item Moreton SG, Szalla L, Menzies RE, Arena AF (2019). \textit{Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-019-05391-0}{doi:10.1007/s00213-019-05391-0}.
\item Ho JT, Preller KH, Lenggenhager B (2019). \textit{Neuropharmacological modulation of the aberrant bodily self through psychedelics.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2019.12.006}{doi:10.1016/j.neubiorev.2019.12.006}.
\item Eric Vermetten, Erwin Krediet, Tijmen Bostoen, Joost J. Breeksema, Robert A. Schoevers, W van den Brink (2019). \textit{[Psychedelics in the treatment of PTSD].}. PubMed. [published; OpenAlex]. \href{https://pubmed.ncbi.nlm.nih.gov/32816292}{source link}.
\item Wolff M, Evens R, Mertens LJ, Koslowski M, Betzler F, Gründer G, Jungaberle H (2019). \textit{Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2020.00005}{doi:10.3389/fpsyt.2020.00005}.
\item Mathai DS, Meyer MJ, Storch EA, Kosten TR. (2019). \textit{The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2019.12.023}{doi:10.1016/j.jad.2019.12.023}.
\item Corne R, Mongeau R. (2019). \textit{[Neurotrophic mechanisms of psychedelic therapy].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1051/jbio/2019015}{doi:10.1051/jbio/2019015}.
\item Richard Demmler, Janis Fricke, Sebastian Dörner, Markus Gressler, Dirk Hoffmeister (2019). \textit{S-Adenosyl-l-Methionine Salvage Impacts Psilocybin Formation in “Magic” Mushrooms}. ChemBioChem. [published; OpenAlex]. \href{https://doi.org/10.1002/cbic.201900649}{doi:10.1002/cbic.201900649}.
\item Dos Santos RG, Hallak JEC. (2019). \textit{Therapeutic use of serotoninergic hallucinogens: A review of the evidence and of the biological and psychological mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2019.12.001}{doi:10.1016/j.neubiorev.2019.12.001}.
\item Laura Mertens, M.B. Wall, L. Roseman, L. Demetriou, D.J. Nutt, R.L. Carhart-Harris (2019). \textit{P.609 Therapeutic mechanisms of psychedelic drugs: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2019.09.593}{doi:10.1016/j.euroneuro.2019.09.593}.
\item Sally Meikle, Paul Liknaitzky, Susan L. Rossell, Margaret Ross, Nigel Strauss, Neil Thomas, Greg Murray, M.L. Williams, David Castle (2019). \textit{Psilocybin-assisted therapy for depression: How do we advance the field?}. Australian \& New Zealand Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1177/0004867419888575}{doi:10.1177/0004867419888575}.
\item Felix Blei, Sebastian Dörner, Janis Fricke, Florian Baldeweg, Felix Trottmann, Anna J. Komor, Florian Meyer, Christian Hertweck, Dirk Hoffmeister (2019). \textit{Simultaneous Production of Psilocybin and a Cocktail of β-Carboline Monoamine Oxidase Inhibitors in “Magic” Mushrooms}. Chemistry - A European Journal. [published; OpenAlex]. \href{https://doi.org/10.1002/chem.201904363}{doi:10.1002/chem.201904363}.
\item Lukasz Smigielski, Michael Kometer, Milan Scheidegger, Rainer Krähenmann, Theo Huber, Franz X. Vollenweider (2019). \textit{Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-019-50612-3}{doi:10.1038/s41598-019-50612-3}.
\item Megha Satyanarayana (2019). \textit{Modified E. coli pump out psilocybin}. C\&EN Global Enterprise. [published; OpenAlex]. \href{https://doi.org/10.1021/cen-09739-scicon9}{doi:10.1021/cen-09739-scicon9}.
\item Johns Hopkins University (2019). \textit{Measurement of Persisting Changes in Emotional Brain Functioning Produced by Psilocybin}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT02971605}{source link}.
\item Grandjean J, Buehlmann D, Buerge M, Sigrist H, Seifritz E, Vollenweider FX, Pryce CR, Rudin M. (2019). \textit{Psilocybin exerts distinct effects on resting state networks associated with serotonin and dopamine in mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/751255}{doi:10.1101/751255}.
\item King's College London (2019). \textit{A Randomised, Balanced, Double-blind Two-way Crossover Design Study to Evaluate the Effects of SRC Kinase Inhibitor, Saracatinib, on Brain Activity Associated With Visual Processing in Patients With Parkinson's Disease Psychosis.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03661125}{source link}.
\item Barnett L, Muthukumaraswamy SD, Carhart-Harris RL, Seth AK. (2019). \textit{Decreased Directed Functional Connectivity in the Psychedelic State}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/703660}{doi:10.1101/703660}.
\item Thomas Anderson, Rotem Petranker, Adam Christopher, Daniel Rosenbaum, Cory R. Weissman, Lê-Anh Dinh-Williams, Katrina Hui, Emma Hapke (2019). \textit{Psychedelic microdosing benefits and challenges: an empirical codebook}. Harm Reduction Journal. [published; OpenAlex]. \href{https://doi.org/10.1186/s12954-019-0308-4}{doi:10.1186/s12954-019-0308-4}.
\item Carhart-Harris RL, Friston KJ. (2019). \textit{REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1124/pr.118.017160}{doi:10.1124/pr.118.017160}.
\item Paul Summergrad (2019). \textit{Psychedelic Medicine: Careful Studies, Regulations Are the Answer}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2019.5a25}{doi:10.1176/appi.pn.2019.5a25}.
\item Witkin JM, Martin AE, Golani LK, Xu NZ, Smith JL. (2019). \textit{Rapid-acting antidepressants.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.apha.2019.03.002}{doi:10.1016/bs.apha.2019.03.002}.
\item Isabella Stendahl (2018). \textit{THE POTENTIAL THERAPEUTIC VALUE OF PSILOCYBIN: In Relation to Depression}. Diva portal (Dalarna University Library). [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-17749}{source link}.
\item Dinis-Oliveira RJ, Pereira CL, da Silva DD. (2018). \textit{Pharmacokinetic and Pharmacodynamic Aspects of Peyote and Mescaline: Clinical and Forensic Repercussions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/1874467211666181010154139}{doi:10.2174/1874467211666181010154139}.
\item Johnson MW, Hendricks PS, Barrett FS, Griffiths RR. (2018). \textit{Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pharmthera.2018.11.010}{doi:10.1016/j.pharmthera.2018.11.010}.
\item Jalal B. (2018). \textit{The neuropharmacology of sleep paralysis hallucinations: serotonin 2A activation and a novel therapeutic drug.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-018-5042-1}{doi:10.1007/s00213-018-5042-1}.
\item Blei F, Fricke J, Wick J, Slot JC, Hoffmeister D. (2018). \textit{Iterative l-Tryptophan Methylation in Psilocybe Evolved by Subdomain Duplication.}. ChemBioChem. [published; Europe PMC]. \href{https://doi.org/10.1002/cbic.201800336}{doi:10.1002/cbic.201800336}.
\item Robin Carhart-Harris (2018). \textit{Serotonin, psychedelics and psychiatry}. World Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1002/wps.20555}{doi:10.1002/wps.20555}.
\item De Gregorio D, Enns JP, Nuñez NA, Posa L, Gobbi G. (2018). \textit{d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.pbr.2018.07.008}{doi:10.1016/bs.pbr.2018.07.008}.
\item Flanagan TW, Nichols CD. (2018). \textit{Psychedelics as anti-inflammatory agents.}. International Review of Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1080/09540261.2018.1481827}{doi:10.1080/09540261.2018.1481827}.
\item Hendricks PS (2018). \textit{Awe: a putative mechanism underlying the effects of classic psychedelic-assisted psychotherapy.}. International review of psychiatry (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1080/09540261.2018.1474185}{doi:10.1080/09540261.2018.1474185}.
\item Boyce GR, Gluck-Thaler E, Slot JC, Stajich JE, Davis WJ, James TY, Cooley JR, Panaccione DG, Eilenberg J, Licht HHDF, Macias AM, Berger MC, Wickert KL, Stauder CM, Spahr EJ, Maust MD, Metheny AM, Simon C, Kritsky G, Hodge KT, Humber RA, Gullion T, Short DPG, Kijimoto T, Mozgai D, Arguedas N, Kasson MT. (2018). \textit{Psychoactive plant- and mushroom-associated alkaloids from two behavior modifying cicada pathogens}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/375105}{doi:10.1101/375105}.
\item Noorani T, Garcia-Romeu A, Swift TC, Griffiths RR, Johnson MW. (2018). \textit{Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881118780612}{doi:10.1177/0269881118780612}.
\item Erritzoe D, Roseman L, Nour MM, MacLean K, Kaelen M, Nutt DJ, Carhart-Harris RL. (2018). \textit{Effects of psilocybin therapy on personality structure.}. Acta Psychiatrica Scandinavica. [published; Europe PMC]. \href{https://doi.org/10.1111/acps.12904}{doi:10.1111/acps.12904}.
\item Aixalà M, Dos Santos RG, Hallak JEC, Bouso JC. (2018). \textit{Psychedelics and Personality.}. ACS Chemical Neuroscience. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.8b00237}{doi:10.1021/acschemneuro.8b00237}.
\item Gabay AS, Carhart-Harris RL, Mazibuko N, Kempton MJ, Morrison PD, Nutt DJ, Mehta MA. (2018). \textit{Psilocybin and MDMA reduce costly punishment in the Ultimatum Game.}. Scientific Reports. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-018-26656-2}{doi:10.1038/s41598-018-26656-2}.
\item Thiessen MS, Walsh Z, Bird BM, Lafrance A. (2018). \textit{Psychedelic use and intimate partner violence: The role of emotion regulation.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881118771782}{doi:10.1177/0269881118771782}.
\item Hoefgen S, Lin J, Fricke J, Stroe MC, Mattern DJ, Kufs JE, Hortschansky P, Brakhage AA, Hoffmeister D, Valiante V. (2018). \textit{Facile assembly and fluorescence-based screening method for heterologous expression of biosynthetic pathways in fungi.}. Metabolic Engineering. [published; Europe PMC]. \href{https://doi.org/10.1016/j.ymben.2018.05.014}{doi:10.1016/j.ymben.2018.05.014}.
\item Grimm O, Kraehenmann R, Preller KH, Seifritz E, Vollenweider FX. (2018). \textit{Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination.}. European Neuropsychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2018.03.016}{doi:10.1016/j.euroneuro.2018.03.016}.
\item Elaheh Mahmoudi, Mehrdad Faizi, Reza Hajiaghaee, Ali Razmi (2018). \textit{Alteration of Depressive-like Behaviors by Psilocybe cubensis Alkaloid Extract in Mice: the Role of Glutamate Pathway}. DOAJ (DOAJ: Directory of Open Access Journals). [published; OpenAlex]. \href{https://doi.org/10.22127/rjp.2018.58486}{doi:10.22127/rjp.2018.58486}.
\item Barrett FS, Schlienz NJ, Lembeck N, Waqas M, Vandrey R. (2018). \textit{"Hallucinations" Following Acute Cannabis Dosing: A Case Report and Comparison to Other Hallucinogenic Drugs.}. Cannabis and Cannabinoid Research. [published; Europe PMC]. \href{https://doi.org/10.1089/can.2017.0052}{doi:10.1089/can.2017.0052}.
\item Nielson EM, May DG, Forcehimes AA, Bogenschutz MP. (2018). \textit{The Psychedelic Debriefing in Alcohol Dependence Treatment: Illustrating Key Change Phenomena through Qualitative Content Analysis of Clinical Sessions.}. Frontiers in Pharmacology. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2018.00132}{doi:10.3389/fphar.2018.00132}.
\item Link Swanson (2017). \textit{Unlearning to See: Linking the Perceptual and Clinical Effects of Psychedelic Drugs.}. eScholarship (California Digital Library). [published; OpenAlex]. \href{https://escholarship.org/uc/item/67x0n7rq}{source link}.
\item Landon M. Klein (2017). \textit{If you give a mouse a mushroom: Behavioral effects of hallucinogens in mice}. eScholarship (California Digital Library). [published; OpenAlex]. \href{https://escholarship.org/uc/item/3bx3d6pf}{source link}.
\item Kometer M, Vollenweider FX. (2017). \textit{Serotonergic Hallucinogen-Induced Visual Perceptual Alterations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2016\_461}{doi:10.1007/7854\_2016\_461}.
\item Preller KH, Vollenweider FX (2017). \textit{Phenomenology, Structure, and Dynamic of Psychedelic States.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2016\_459}{doi:10.1007/7854\_2016\_459}.
\item Halberstadt AL, Geyer MA (2017). \textit{Effect of Hallucinogens on Unconditioned Behavior.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2016\_466}{doi:10.1007/7854\_2016\_466}.
\item Bogenschutz MP, Ross S. (2017). \textit{Therapeutic Applications of Classic Hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2016\_464}{doi:10.1007/7854\_2016\_464}.
\item Martin DA, Nichols CD. (2017). \textit{The Effects of Hallucinogens on Gene Expression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2017\_479}{doi:10.1007/7854\_2017\_479}.
\item López-Giménez JF, González-Maeso J. (2017). \textit{Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2017\_478}{doi:10.1007/7854\_2017\_478}.
\item Canal CE. (2017). \textit{Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/164\_2018\_107}{doi:10.1007/164\_2018\_107}.
\item Swanson LR (2017). \textit{Unifying Theories of Psychedelic Drug Effects.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2018.00172}{doi:10.3389/fphar.2018.00172}.
\item University of Helsinki (2017). \textit{Psilocybin and Depression - Assessing the Long-term Effects of a Single Administration of Psilocybin on the Psychiatric Symptoms and Brain Activity of Patients With Severe Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03380442}{source link}.
\item Joanna Stefaniuk (2017). \textit{„Terapia szokowa”, czyli agoniści receptor 5-HT2A w leczeniu depresji i lęku}. CeON Repository (Centre for Evaluation in Education and Science). [published; OpenAlex]. \href{https://depot.ceon.pl/handle/123456789/13483}{source link}.
\item Carbonaro TM, Johnson MW, Hurwitz E, Griffiths RR. (2017). \textit{Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-017-4769-4}{doi:10.1007/s00213-017-4769-4}.
\item Mason Marks (2017). \textit{Psychedelic Medicine for Mental Illness and Substance Use Disorders: Overcoming Social and Legal Obstacles}. SSRN Electronic Journal. [published; OpenAlex]. \href{https://papers.ssrn.com/sol3/Delivery.cfm/SSRN\_ID3181777\_code2827981.pdf?abstractid=3065035\&mirid=1}{source link}.
\item Carhart-Harris RL, Roseman L, Bolstridge M, Demetriou L, Pannekoek JN, Wall MB, Tanner M, Kaelen M, McGonigle J, Murphy K, Leech R, Curran HV, Nutt DJ. (2017). \textit{Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms.}. Scientific Reports. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-017-13282-7}{doi:10.1038/s41598-017-13282-7}.
\item Di Giovanni G, De Deurwaerdère P. (2017). \textit{TCB-2 [(7R)-3-bromo-2, 5-dimethoxy-bicyclo[4.2.0]octa-1,3,5-trien-7-yl]methanamine]: A hallucinogenic drug, a selective 5-HT2A receptor pharmacological tool, or none of the above?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2017.10.004}{doi:10.1016/j.neuropharm.2017.10.004}.
\item Kyzar EJ, Nichols CD, Gainetdinov RR, Nichols DE, Kalueff AV. (2017). \textit{Psychedelic Drugs in Biomedicine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.tips.2017.08.003}{doi:10.1016/j.tips.2017.08.003}.
\item STEVE RITTER (2017). \textit{‘Magic mushroom’ enzyme mystery solved}. C\&EN Global Enterprise. [published; OpenAlex]. \href{https://doi.org/10.1021/cen-09533-notw1}{doi:10.1021/cen-09533-notw1}.
\item Chris Letheby (2017). \textit{NATURALIZING PSYCHEDELIC SPIRITUALITY}. Zygon®. [published; OpenAlex]. \href{https://doi.org/10.1111/zygo.12353}{doi:10.1111/zygo.12353}.
\item Johnson MW, Griffiths RR. (2017). \textit{Potential Therapeutic Effects of Psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s13311-017-0542-y}{doi:10.1007/s13311-017-0542-y}.
\item Thomas Cody Swift, Alexander Belser, Gabrielle Agin-Liebes, Neşe Devenot, Sara Terrana, Harris L. Friedman, Jeffrey Guss, Anthony P. Bossis, Stephen Ross (2017). \textit{Cancer at the Dinner Table: Experiences of Psilocybin-Assisted Psychotherapy for the Treatment of Cancer-Related Distress}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/0022167817715966}{doi:10.1177/0022167817715966}.
\item Alexander Belser, Gabrielle Agin-Liebes, Thomas Cody Swift, Sara Terrana, Neşe Devenot, Harris L. Friedman, Jeffrey Guss, Anthony P. Bossis, Stephen Ross (2017). \textit{Patient Experiences of Psilocybin-Assisted Psychotherapy: An Interpretative Phenomenological Analysis}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/0022167817706884}{doi:10.1177/0022167817706884}.
\item Dos Santos RG, Bouso JC, Hallak JEC. (2017). \textit{Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/2045125316689030}{doi:10.1177/2045125316689030}.
\item Johnson MW, Garcia-Romeu A, Johnson PS, Griffiths RR. (2017). \textit{An online survey of tobacco smoking cessation associated with naturalistic psychedelic use.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881116684335}{doi:10.1177/0269881116684335}.
\item Unknown authors (2016). \textit{Magic mushrooms as a treatment for depression}. Clinical pharmacist. [published; OpenAlex]. \href{https://doi.org/10.1211/cp.2017.20204046}{doi:10.1211/cp.2017.20204046}.
\item Keli A. Herr (2016). \textit{Sex Differences in Serotonergic and Dopaminergic Mediation of LSD Discrimination in Rats}. ScholarWorks - WMU (Western Michigan University). [published; OpenAlex]. \href{https://scholarworks.wmich.edu/dissertations/3170}{source link}.
\item Albert Garcia-Romeu (2016). \textit{Psychedelics as change agents in addiction and mood disorders.}. Unknown journal. [published; OpenAlex]. \href{https://www.drugsandalcohol.ie/29118/}{source link}.
\item Golden C. (2016). \textit{Neuronal dynamics of the anterior cingulate cortex during working memory and serotonergic manipulation}. Imperial College London. [published; Europe PMC]. \href{https://doi.org/10.25560/45527}{doi:10.25560/45527}.
\item Nichols DE, Johnson MW, Nichols CD. (2016). \textit{Psychedelics as Medicines: An Emerging New Paradigm.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cpt.557}{doi:10.1002/cpt.557}.
\item Michael P. Bogenschutz, Alyssa A. Forcehimes (2016). \textit{Development of a Psychotherapeutic Model for Psilocybin-Assisted Treatment of Alcoholism}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/0022167816673493}{doi:10.1177/0022167816673493}.
\item Patra S. (2016). \textit{Return of the psychedelics: Psilocybin for treatment resistant depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.ajp.2016.08.010}{doi:10.1016/j.ajp.2016.08.010}.
\item de Veen BT, Schellekens AF, Verheij MM, Homberg JR. (2016). \textit{Psilocybin for treating substance use disorders?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/14737175.2016.1220834}{doi:10.1080/14737175.2016.1220834}.
\item Maqueda AE, Valle M, Addy PH, Antonijoan RM, Puntes M, Coimbra J, Ballester MR, Garrido M, González M, Claramunt J, Barker S, Lomnicka I, Waguespack M, Johnson MW, Griffiths RR, Riba J. (2016). \textit{Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans.}. The International Journal of Neuropsychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1093/ijnp/pyw016}{doi:10.1093/ijnp/pyw016}.
\item Tylš F, Páleníček T, Kadeřábek L, Lipski M, Kubešová A, Horáček J. (2016). \textit{Sex differences and serotonergic mechanisms in the behavioural effects of psilocin.}. Behavioural Pharmacology. [published; Europe PMC]. \href{https://doi.org/10.1097/fbp.0000000000000198}{doi:10.1097/fbp.0000000000000198}.
\item Dimitria Electra Gatzia, Berit Brogaard (2015). \textit{Psilocybin, LSD, Mescaline and drug-induced synesthesia}. PhilPapers (PhilPapers Foundation). [published; OpenAlex]. \href{https://philarchive.org/rec/BROPLM}{source link}.
\item Sweat NW, Bates LW, Hendricks PS (2015). \textit{The Associations of Naturalistic Classic Psychedelic Use, Mystical Experience, and Creative Problem Solving.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2016.1234090}{doi:10.1080/02791072.2016.1234090}.
\item Kraehenmann R, Schmidt A, Friston K, Preller KH, Seifritz E, Vollenweider FX. (2015). \textit{The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity.}. NeuroImage Clinical. [published; Europe PMC]. \href{https://doi.org/10.1016/j.nicl.2015.08.009}{doi:10.1016/j.nicl.2015.08.009}.
\item Kometer M, Pokorny T, Seifritz E, Volleinweider FX. (2015). \textit{Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-015-4026-7}{doi:10.1007/s00213-015-4026-7}.
\item Lebedev AV, Lövdén M, Rosenthal G, Feilding A, Nutt DJ, Carhart-Harris RL. (2015). \textit{Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin.}. Human Brain Mapping. [published; Europe PMC]. \href{https://doi.org/10.1002/hbm.22833}{doi:10.1002/hbm.22833}.
\item Araújo AM, Carvalho F, Bastos Mde L, Guedes de Pinho P, Carvalho M. (2015). \textit{The hallucinogenic world of tryptamines: an updated review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00204-015-1513-x}{doi:10.1007/s00204-015-1513-x}.
\item Bogenschutz MP, Johnson MW. (2015). \textit{Classic hallucinogens in the treatment of addictions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2015.03.002}{doi:10.1016/j.pnpbp.2015.03.002}.
\item Majić T, Schmidt TT, Gallinat J (2015). \textit{Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences?}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881114568040}{doi:10.1177/0269881114568040}.
\item Bogenschutz MP, Forcehimes AA, Pommy JA, Wilcox CE, Barbosa PC, Strassman RJ. (2015). \textit{Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881114565144}{doi:10.1177/0269881114565144}.
\item Tittarelli R, Mannocchi G, Pantano F, Romolo FS. (2014). \textit{Recreational use, analysis and toxicity of tryptamines.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/1570159x13666141210222409}{doi:10.2174/1570159x13666141210222409}.
\item Sakashita Y, Abe K, Katagiri N, Kambe T, Saitoh T, Utsunomiya I, Horiguchi Y, Taguchi K. (2014). \textit{Effect of psilocin on extracellular dopamine and serotonin levels in the mesoaccumbens and mesocortical pathway in awake rats.}. Biological and Pharmaceutical Bulletin. [published; Europe PMC]. \href{https://doi.org/10.1248/bpb.b14-00315}{doi:10.1248/bpb.b14-00315}.
\item Unknown authors (2014). \textit{Hallucinogens induce a specific barcode of phosphorylation on the serotonin2A receptor that underlies a weaker receptor desensitization and internalization}. Receptors \& Clinical Investigation. [published; OpenAlex]. \href{https://doi.org/10.14800/rci.230}{doi:10.14800/rci.230}.
\item Baumeister D, Barnes G, Giaroli G, Tracy D (2014). \textit{Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/2045125314527985}{doi:10.1177/2045125314527985}.
\item Albert Garcia-Romeu, Matthew W. Johnson, Roland R. Griffiths (2014). \textit{Examining the psychological mechanisms of psilocybin-assisted smoking cessation treatment: A pilot study}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2014.02.200}{doi:10.1016/j.drugalcdep.2014.02.200}.
\item Roseman L, Leech R, Feilding A, Nutt DJ, Carhart-Harris RL. (2014). \textit{The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers.}. Frontiers in Human Neuroscience. [published; Europe PMC]. \href{https://doi.org/10.3389/fnhum.2014.00204}{doi:10.3389/fnhum.2014.00204}.
\item Karaki S, Becamel C, Murat S, Mannoury la Cour C, Millan MJ, Prézeau L, Bockaert J, Marin P, Vandermoere F. (2014). \textit{Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists.}. Molecular \& Cellular Proteomics. [published; Europe PMC]. \href{https://doi.org/10.1074/mcp.m113.036558}{doi:10.1074/mcp.m113.036558}.
\item Javier González-Maeso (2013). \textit{EPA-1211 - Role of 5-HT2a and mglu2 as a gpcr heterocomplex in antipsychotic action}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-9338(14)78457-3}{doi:10.1016/s0924-9338(14)78457-3}.
\item Icaza EE, Mashour GA. (2013). \textit{Altered states: psychedelics and anesthetics.}. Anesthesiology. [published; Europe PMC]. \href{https://doi.org/10.1097/01.anes.0000435635.42332.ee}{doi:10.1097/01.anes.0000435635.42332.ee}.
\item Brogaard B. (2013). \textit{Serotonergic hyperactivity as a potential factor in developmental, acquired and drug-induced synesthesia.}. Frontiers in Human Neuroscience. [published; Europe PMC]. \href{https://doi.org/10.3389/fnhum.2013.00657}{doi:10.3389/fnhum.2013.00657}.
\item Muthukumaraswamy SD, Carhart-Harris RL, Moran RJ, Brookes MJ, Williams TM, Errtizoe D, Sessa B, Papadopoulos A, Bolstridge M, Singh KD, Feilding A, Friston KJ, Nutt DJ. (2013). \textit{Broadband cortical desynchronization underlies the human psychedelic state.}. Journal of Neuroscience. [published; Europe PMC]. \href{https://doi.org/10.1523/jneurosci.2063-13.2013}{doi:10.1523/jneurosci.2063-13.2013}.
\item Halberstadt AL, Geyer MA. (2013). \textit{Serotonergic hallucinogens as translational models relevant to schizophrenia.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s1461145713000722}{doi:10.1017/s1461145713000722}.
\item Robin Carhart-Harris (2013). \textit{PSYCHEDELIC DRUGS, MAGICAL THINKING AND PSYCHOSIS}. Journal of Neurology Neurosurgery \& Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1136/jnnp-2013-306103.17}{doi:10.1136/jnnp-2013-306103.17}.
\item Stebelska K. (2013). \textit{Fungal hallucinogens psilocin, ibotenic acid, and muscimol: analytical methods and biologic activities.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/ftd.0b013e31828741a5}{doi:10.1097/ftd.0b013e31828741a5}.
\item Bernasconi F, Schmidt A, Pokorny T, Kometer M, Seifritz E, Vollenweider FX. (2013). \textit{Spatiotemporal brain dynamics of emotional face processing modulations induced by the serotonin 1A/2A receptor agonist psilocybin.}. Cerebral Cortex. [published; Europe PMC]. \href{https://doi.org/10.1093/cercor/bht178}{doi:10.1093/cercor/bht178}.
\item Young SN. (2013). \textit{Single treatments that have lasting effects: some thoughts on the antidepressant effects of ketamine and botulinum toxin and the anxiolytic effect of psilocybin.}. Фундаментальные исследования (Fundamental Research). [published; Europe PMC]. \href{https://doi.org/10.1503/jpn.120128}{doi:10.1503/jpn.120128}.
\item Hanks JB, González-Maeso J. (2012). \textit{Animal models of serotonergic psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/cn300138m}{doi:10.1021/cn300138m}.
\item Kometer M, Schmidt A, Bachmann R, Studerus E, Seifritz E, Vollenweider FX. (2012). \textit{Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors.}. Biological Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1016/j.biopsych.2012.04.005}{doi:10.1016/j.biopsych.2012.04.005}.
\item David Luke, Devin B. Terhune, Ross Friday (2011). \textit{Psychedelic synaesthesia: Evidence for a serotonergic role in synaesthesia}. Seeing and Perceiving. [published; OpenAlex]. \href{https://doi.org/10.1163/187847612x646956}{doi:10.1163/187847612x646956}.
\item Johnson MW, Sewell RA, Griffiths RR. (2011). \textit{Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers.}. Drug and Alcohol Dependence. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drugalcdep.2011.10.029}{doi:10.1016/j.drugalcdep.2011.10.029}.
\item Schmidt A, Bachmann R, Kometer M, Csomor PA, Stephan KE, Seifritz E, Vollenweider FX. (2011). \textit{Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/npp.2011.261}{doi:10.1038/npp.2011.261}.
\item Robin Carhart-Harris, David Erritzøe, James Stone, Rjs Wise, David Nutt (2011). \textit{P.1.e.017 The functional brain correlates of the psychedelic state: an arterial spin labelling study with psilocybin}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-977x(11)70495-3}{doi:10.1016/s0924-977x(11)70495-3}.
\item Moreno JL, Kurita M, Holloway T, López J, Cadagan R, Martínez-Sobrido L, García-Sastre A, González-Maeso J. (2011). \textit{Maternal influenza viral infection causes schizophrenia-like alterations of 5-HT₂A and mGlu₂ receptors in the adult offspring.}. Journal of Neuroscience. [published; Europe PMC]. \href{https://doi.org/10.1523/jneurosci.4230-10.2011}{doi:10.1523/jneurosci.4230-10.2011}.
\item Moreno JL, Holloway T, Albizu L, Sealfon SC, González-Maeso J. (2011). \textit{Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neulet.2011.01.046}{doi:10.1016/j.neulet.2011.01.046}.
\item Matthew J. Baggott, Jennifer D. Siegrist, Gantt P. Galloway, Lynn C. Robertson, Jeremy Coyle, John Mendelson (2010). \textit{Investigating the Mechanisms of Hallucinogen-Induced Visions Using 3,4-Methylenedioxyamphetamine (MDA): A Randomized Controlled Trial in Humans}. PLoS ONE. [published; OpenAlex]. \href{https://doi.org/10.1371/journal.pone.0014074}{doi:10.1371/journal.pone.0014074}.
\item Vollenweider FX, Kometer M. (2010). \textit{The neurobiology of psychedelic drugs: implications for the treatment of mood disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/nrn2884}{doi:10.1038/nrn2884}.
\item Matthias Karst, John H. Halpern, Michael Bernateck, Torsten Passie (2010). \textit{The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: An open, non-randomized case series}. Cephalalgia. [published; OpenAlex]. \href{https://doi.org/10.1177/0333102410363490}{doi:10.1177/0333102410363490}.
\item Matthew J. Baggott (2009). \textit{Other Times I Can Barely See: The Effects of Hallucinogens on Vision and Attention}. eScholarship (California Digital Library). [published; OpenAlex]. \href{https://escholarship.org/uc/item/7409s4th}{source link}.
\item Kovacic P, Somanathan R. (2009). \textit{Novel, unifying mechanism for mescaline in the central nervous system: electrochemistry, catechol redox metabolite, receptor, cell signaling and structure activity relationships.}. Oxidative Medicine and Cellular Longevity. [published; Europe PMC]. \href{https://doi.org/10.4161/oxim.2.4.9380}{doi:10.4161/oxim.2.4.9380}.
\item González-Maeso J, Sealfon SC. (2008). \textit{Agonist-trafficking and hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/092986709787581851}{doi:10.2174/092986709787581851}.
\item Nef HM, Möllmann H, Hilpert P, Krause N, Troidl C, Weber M, Rolf A, Dill T, Hamm C, Elsässer A. (2008). \textit{Apical regional wall motion abnormalities reminiscent to Tako-Tsubo cardiomyopathy following consumption of psychoactive fungi.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.ijcard.2007.12.064}{doi:10.1016/j.ijcard.2007.12.064}.
\item Briony J. Catlow (2007). \textit{Involvement of 5-HT2A Receptor in the Regulation of Hippocampal-Dependent Learning and Neurogenesis}. Digital Commons - University of South Florida (University of South Florida). [published; OpenAlex]. \href{https://digitalcommons.usf.edu/etd/166}{source link}.
\item González-Maeso J, Weisstaub NV, Zhou M, Chan P, Ivic L, Ang R, Lira A, Bradley-Moore M, Ge Y, Zhou Q, Sealfon SC, Gingrich JA. (2007). \textit{Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuron.2007.01.008}{doi:10.1016/j.neuron.2007.01.008}.
\item Majdanik S, Borowiak K, Brzezńska M, Machoy-Mokrzyńska A. (2006). \textit{[Concentration of selected microelements in blood serum of rats exposed to the action of psilocin and phenylethylamine].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/20143700}{source link}.
\item David L. Eldridge, Karin Hillenbrand (2006). \textit{Hallucinogens}. Pediatrics in Review. [published; OpenAlex]. \href{https://doi.org/10.1542/pir.27.8.314}{doi:10.1542/pir.27.8.314}.
\item Carter OL, Pettigrew JD, Hasler F, Wallis GM, Liu GB, Hell D, Vollenweider FX. (2005). \textit{Modulating the rate and rhythmicity of perceptual rivalry alternations with the mixed 5-HT2A and 5-HT1A agonist psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/sj.npp.1300621}{doi:10.1038/sj.npp.1300621}.
\item Saviuc P, Flesch F. (2003). \textit{[Acute higher funghi mushroom poisoning and its treatment].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/14534493}{source link}.
\item Riba J, Rodríguez-Fornells A, Barbanoj MJ. (2002). \textit{Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-002-1237-5}{doi:10.1007/s00213-002-1237-5}.
\item Rabin RA, Regina M, Doat M, Winter JC. (2002). \textit{5-HT2A receptor-stimulated phosphoinositide hydrolysis in the stimulus effects of hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0091-3057(01)00720-1}{doi:10.1016/s0091-3057(01)00720-1}.
\item Bressloff PC, Cowan JD, Golubitsky M, Thomas PJ, Wiener MC. (2002). \textit{What geometric visual hallucinations tell us about the visual cortex.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1162/089976602317250861}{doi:10.1162/089976602317250861}.
\item Fukuda K. (2002). \textit{Possible mechanisms of panic attack and schizophrenia via APUD system.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1054/mehy.2001.1473}{doi:10.1054/mehy.2001.1473}.
\item Vollenweider FX. (2001). \textit{Brain mechanisms of hallucinogens and entactogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.31887/dcns.2001.3.4/fxvollenweider}{doi:10.31887/dcns.2001.3.4/fxvollenweider}.
\item Vollenweider FX, Geyer MA. (2001). \textit{A systems model of altered consciousness: integrating natural and drug-induced psychoses.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0361-9230(01)00646-3}{doi:10.1016/s0361-9230(01)00646-3}.
\item McBride MC. (2000). \textit{Bufotenine: toward an understanding of possible psychoactive mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2000.10400456}{doi:10.1080/02791072.2000.10400456}.
\item Gouzoulis-Mayfrank E, Schreckenberger M, Sabri O, Arning C, Thelen B, Spitzer M, Kovar KA, Hermle L, Büll U, Sass H. (1999). \textit{Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0893-133x(98)00089-x}{doi:10.1016/s0893-133x(98)00089-x}.
\item Martin WR, Sloan JW. (1986). \textit{Relationship of CNS tryptaminergic processes and the action of LSD-like hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0091-3057(86)90369-2}{doi:10.1016/0091-3057(86)90369-2}.
\item McDonald A. (1980). \textit{Mushrooms and madness. Hallucinogenic mushrooms and some psychopharmacological implications.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/070674378002500709}{doi:10.1177/070674378002500709}.
\item Trulson ME, Stark AD, Jacobs BL. (1977). \textit{Comparative effects of hallucinogenic drugs on rotational behavior in rats with unilateral 6-hydroxydopamine lesions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0014-2999(77)90097-8}{doi:10.1016/0014-2999(77)90097-8}.
\item Rech RH, Tilson HA, Marquis WJ. (1974). \textit{Adaptive changes in behavior after repeated administration of various psychoactive drugs.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/1163377}{source link}.
\item Marc Julià, JOEL DE ROSNAY (1971). \textit{ChemInform Abstract: CHLORIERTE 2-HYDROXY- UND2-METHOXY-PHENOXYAETHYLAMINE, ANALOGA VON PSILOCYBIN}. Chemischer Informationsdienst Organische Chemie. [published; OpenAlex]. \href{https://doi.org/10.1002/chin.197110243}{doi:10.1002/chin.197110243}.
\end{enumerate}
\end{document}
